NDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH,PRIMARY_ICD10,ALL_ICD10_MAPPINGS,MAPPING_CONFIDENCE
0113-0029,HUMAN OTC DRUG,Good Sense Nicotine,,Nicotine Polacrilex,"GUM, CHEWING",ORAL,20050506,,ANDA,ANDA076775,L. Perrigo Company,NICOTINE,2,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0032,HUMAN OTC DRUG,Good Sense Dual Action Complete,,"famotidine, calcium carbonate and magnesium hydroxide","TABLET, CHEWABLE",ORAL,20160106,,ANDA,ANDA077355,L. Perrigo Company,CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE,800; 10; 165,mg/1; mg/1; mg/1,"Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0050,HUMAN OTC DRUG,good sense ibuprofen pm,,"diphenhydramine citrate, ibuprofen","TABLET, FILM COATED",ORAL,20090305,,ANDA,ANDA079113,L. Perrigo Company,DIPHENHYDRAMINE CITRATE; IBUPROFEN,38; 200,mg/1; mg/1,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20261231,M79.3,"[{""icd10_code"":""M79.3"",""description"":""Panniculitis, unspecified"",""confidence"":0.3,""context"":""general pain/inflammation""},{""icd10_code"":""M25.50"",""description"":""Pain in unspecified joint"",""confidence"":0.25,""context"":""joint pain""},{""icd10_code"":""R50.9"",""description"":""Fever, unspecified"",""confidence"":0.2,""context"":""fever reduction""},{""icd10_code"":""G43.909"",""description"":""Migraine, unspecified, not intractable, without status migrainosus"",""confidence"":0.15,""context"":""headache""},{""icd10_code"":""M79.1"",""description"":""Myalgia"",""confidence"":0.1,""context"":""muscle pain""}]",0.30
0113-0052,HUMAN OTC DRUG,good sense sleep time,,Diphenhydramine HCl,"CAPSULE, LIQUID FILLED",ORAL,20140206,20250731,OTC MONOGRAPH DRUG,M010,L. Perrigo Company,DIPHENHYDRAMINE HYDROCHLORIDE,25,mg/1,"Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0053,HUMAN OTC DRUG,Good Sense Nicotine,,Nicotine Polacrilex,"GUM, CHEWING",ORAL,20170427,,ANDA,ANDA206393,L. Perrigo Company,NICOTINE,4,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0054,HUMAN OTC DRUG,Good Sense Suphedrine,12 Hour,Pseudoephedrine Hydrochloride,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,19991029,,ANDA,ANDA075153,L. Perrigo Company,PSEUDOEPHEDRINE HYDROCHLORIDE,120,mg/1,"Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0056,HUMAN OTC DRUG,good sense night time,,"Acetaminophen, Dextromethorphan HBr, Doxylamine succinate","CAPSULE, LIQUID FILLED",ORAL,20140530,,OTC MONOGRAPH DRUG,M012,L. Perrigo Company,ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE,325; 15; 6.25,mg/1; mg/1; mg/1,"Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0057,HUMAN OTC DRUG,Good Sense ibuprofen,infants,ibuprofen,SUSPENSION,ORAL,20000208,,ANDA,ANDA075217,L. Perrigo Company,IBUPROFEN,50,mg/1.25mL,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20251231,M79.3,"[{""icd10_code"":""M79.3"",""description"":""Panniculitis, unspecified"",""confidence"":0.3,""context"":""general pain/inflammation""},{""icd10_code"":""M25.50"",""description"":""Pain in unspecified joint"",""confidence"":0.25,""context"":""joint pain""},{""icd10_code"":""R50.9"",""description"":""Fever, unspecified"",""confidence"":0.2,""context"":""fever reduction""},{""icd10_code"":""G43.909"",""description"":""Migraine, unspecified, not intractable, without status migrainosus"",""confidence"":0.15,""context"":""headache""},{""icd10_code"":""M79.1"",""description"":""Myalgia"",""confidence"":0.1,""context"":""muscle pain""}]",0.30
0113-0058,HUMAN OTC DRUG,Good Sense Omeprazole and Sodium Bicarbonate,,"Omeprazole, sodium bicarbonate","CAPSULE, GELATIN COATED",ORAL,20170619,,ANDA,ANDA201361,L. Perrigo Company,OMEPRAZOLE; SODIUM BICARBONATE,20; 1100,mg/1; mg/1,"Cytochrome P450 2C19 Inhibitors [MoA], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]",,N,20251231,K21.9,"[{""icd10_code"":""K21.9"",""description"":""Gastro-esophageal reflux disease without esophagitis"",""confidence"":0.5,""context"":""GERD""},{""icd10_code"":""K25.9"",""description"":""Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.25,""context"":""gastric ulcer""},{""icd10_code"":""K27.9"",""description"":""Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.15,""context"":""peptic ulcer""},{""icd10_code"":""K30"",""description"":""Functional dyspepsia"",""confidence"":0.1,""context"":""dyspepsia""}]",0.50
0113-0081,HUMAN OTC DRUG,Good Sense Miconazole 3,,Miconazole nitrate,KIT,,20070402,,ANDA,ANDA075329,L. Perrigo Company,,,,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0084,HUMAN OTC DRUG,Good Sense First Aid Antibiotic,,"bacitracin zinc, neomycin, polymyxin B",OINTMENT,TOPICAL,20140428,,OTC MONOGRAPH DRUG,M004,L. Perrigo Company,BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE,400; 3.5; 5000,[USP'U]/g; mg/g; [USP'U]/g,"Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]",,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0113-0087,HUMAN OTC DRUG,good sense anti diarrheal anti gas,,"loperamide hydrochloride, simethicone",TABLET,ORAL,20181011,,ANDA,ANDA209837,L. Perrigo Company,DIMETHICONE; LOPERAMIDE HYDROCHLORIDE,125; 2,mg/1; mg/1,"Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0116,HUMAN OTC DRUG,Good Sense Lansoprazole,,Lansoprazole,"TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE",ORAL,20171128,,NDA,NDA208025,L. Perrigo Company,LANSOPRAZOLE,15,mg/1,"Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0141,HUMAN OTC DRUG,good sense acid reducer,,Famotidine,"TABLET, FILM COATED",ORAL,20091023,,ANDA,ANDA075400,L. Perrigo Company,FAMOTIDINE,10,mg/1,"Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0147,HUMAN OTC DRUG,good sense all day allergy d,,"Cetirizine hydrochloride, Pseudoephedrine hydrochloride","TABLET, FILM COATED, EXTENDED RELEASE",ORAL,20201227,,ANDA,ANDA210719,L. Perrigo Company,CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE,5; 120,mg/1; mg/1,"Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0161,HUMAN OTC DRUG,Good Sense pain and fever,,Acetaminophen,SUSPENSION,ORAL,20110921,,OTC MONOGRAPH DRUG,M013,L. Perrigo Company,ACETAMINOPHEN,160,mg/5mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0166,HUMAN OTC DRUG,good sense ibuprofen,childrens,Ibuprofen,SUSPENSION,ORAL,20020504,,ANDA,ANDA074937,L. Perrigo Company,IBUPROFEN,100,mg/5mL,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20261231,M79.3,"[{""icd10_code"":""M79.3"",""description"":""Panniculitis, unspecified"",""confidence"":0.3,""context"":""general pain/inflammation""},{""icd10_code"":""M25.50"",""description"":""Pain in unspecified joint"",""confidence"":0.25,""context"":""joint pain""},{""icd10_code"":""R50.9"",""description"":""Fever, unspecified"",""confidence"":0.2,""context"":""fever reduction""},{""icd10_code"":""G43.909"",""description"":""Migraine, unspecified, not intractable, without status migrainosus"",""confidence"":0.15,""context"":""headache""},{""icd10_code"":""M79.1"",""description"":""Myalgia"",""confidence"":0.1,""context"":""muscle pain""}]",0.30
0113-0170,HUMAN OTC DRUG,Good Sense Nicotine,,Nicotine Polacrilex,"GUM, CHEWING",ORAL,20050506,,ANDA,ANDA076789,L. Perrigo Company,NICOTINE,4,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0186,HUMAN OTC DRUG,Good Sense Sleep Time,,Diphenhydramine HCl,SOLUTION,ORAL,20130702,,OTC MONOGRAPH DRUG,M010,L. Perrigo Company,DIPHENHYDRAMINE HYDROCHLORIDE,50,mg/30mL,"Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0188,HUMAN OTC DRUG,Good Sense Hemorrhoidal,,"mineral oil, petrolatum, phenylephrine HCl",OINTMENT,RECTAL,20131121,,OTC MONOGRAPH DRUG,M015,L. Perrigo Company,MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE,14; 74.9; .25,g/100g; g/100g; g/100g,"Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0189,HUMAN OTC DRUG,Good Sense Childrens All Day Allergy,,Cetirizine HCl,SOLUTION,ORAL,20140103,,ANDA,ANDA204226,L. Perrigo Company,CETIRIZINE HYDROCHLORIDE,5,mg/5mL,"Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0194,HUMAN OTC DRUG,Good Sense Acid Reducer,,Famotidine,"TABLET, FILM COATED",ORAL,20070316,,ANDA,ANDA077351,L. Perrigo Company,FAMOTIDINE,20,mg/1,"Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0206,HUMAN OTC DRUG,good sense nicotine,mint,Nicotine Polacrilex,"GUM, CHEWING",ORAL,19910415,,ANDA,ANDA078325,L. Perrigo Company,NICOTINE,2,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0212,HUMAN OTC DRUG,Good Sense Childrens Pain and Fever,,Acetaminophen,SUSPENSION,ORAL,19930225,,OTC MONOGRAPH DRUG,M013,L. Perrigo Company,ACETAMINOPHEN,160,mg/5mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0214,HUMAN OTC DRUG,Good Sense Miconazole 7,,Miconazole nitrate,CREAM,VAGINAL,19990730,,ANDA,ANDA074760,L Perrigo Company,MICONAZOLE NITRATE,2,g/100g,"Azole Antifungal [EPC], Azoles [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0224,HUMAN OTC DRUG,Good Sense anti diarrheal,,Loperamide Hydrochloride,"TABLET, FILM COATED",ORAL,20030225,,ANDA,ANDA075232,L. Perrigo Company,LOPERAMIDE HYDROCHLORIDE,2,mg/1,"Opioid Agonist [EPC], Opioid Agonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0241,HUMAN OTC DRUG,good sense levocetirizine,,levocetirizine dihydrochloride,"TABLET, FILM COATED",ORAL,20200911,,ANDA,ANDA211983,L. Perrigo Company,LEVOCETIRIZINE DIHYDROCHLORIDE,5,mg/1,"Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0274,HUMAN OTC DRUG,Good Sense aspirin,,Aspirin,"TABLET, CHEWABLE",ORAL,19970808,,OTC MONOGRAPH DRUG,M013,L. Perrigo Company,ASPIRIN,81,mg/1,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]",,N,20251231,Z79.02,"[{""icd10_code"":""Z79.02"",""description"":""Long term use of antithrombotics/antiplatelets"",""confidence"":0.8,""context"":""cardioprotection""},{""icd10_code"":""I25.10"",""description"":""Atherosclerotic heart disease without angina pectoris"",""confidence"":0.2,""context"":""CAD prevention""}]",0.80
0113-0279,HUMAN OTC DRUG,Good Sense Hemorrhoidal,,"cocoa butter, phenylephrine HCl",SUPPOSITORY,RECTAL,20140904,,OTC MONOGRAPH DRUG,M015,L. Perrigo Company,COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE,2211; 6.5,mg/1; mg/1,"Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0285,HUMAN OTC DRUG,Good Sense 24 hour allergy nasal,,Fluticasone Propionate,"SPRAY, METERED",NASAL,20171129,,ANDA,ANDA207957,L. Perrigo Company,FLUTICASONE PROPIONATE,50,ug/1,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0298,HUMAN OTC DRUG,good sense ibuprofen,,Ibuprofen,"CAPSULE, LIQUID FILLED",ORAL,20180220,,ANDA,ANDA203599,L. Perrigo Company,IBUPROFEN,200,mg/1,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20261231,M79.3,"[{""icd10_code"":""M79.3"",""description"":""Panniculitis, unspecified"",""confidence"":0.3,""context"":""general pain/inflammation""},{""icd10_code"":""M25.50"",""description"":""Pain in unspecified joint"",""confidence"":0.25,""context"":""joint pain""},{""icd10_code"":""R50.9"",""description"":""Fever, unspecified"",""confidence"":0.2,""context"":""fever reduction""},{""icd10_code"":""G43.909"",""description"":""Migraine, unspecified, not intractable, without status migrainosus"",""confidence"":0.15,""context"":""headache""},{""icd10_code"":""M79.1"",""description"":""Myalgia"",""confidence"":0.1,""context"":""muscle pain""}]",0.30
0113-0304,HUMAN OTC DRUG,Good Sense Nasal,,oxymetazoline hydrochloride,SPRAY,NASAL,19890915,,OTC MONOGRAPH DRUG,M012,L. Perrigo Company,OXYMETAZOLINE HYDROCHLORIDE,0.5,mg/mL,"Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0306,HUMAN OTC DRUG,Good Sense Clear Lax,,Polyethylene Glycol 3350,"POWDER, FOR SOLUTION",ORAL,20091007,,ANDA,ANDA090685,L. Perrigo Company,POLYETHYLENE GLYCOL 3350,17,g/17g,"Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0335,HUMAN OTC DRUG,good sense night time,,"Acetaminophen, Dextromethorphan HBr, Doxylamine succinate",SOLUTION,ORAL,20110819,,OTC MONOGRAPH DRUG,M012,L. Perrigo Company,ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE,650; 30; 12.5,mg/30mL; mg/30mL; mg/30mL,"Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0344,HUMAN OTC DRUG,Good Sense Nicotine,,Nicotine Polacrilex,LOZENGE,ORAL,20060725,,ANDA,ANDA077007,L. Perrigo Company,NICOTINE,2,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0374,HUMAN OTC DRUG,good sense migraine formula,,"Acetaminophen, Aspirin, Caffeine","TABLET, FILM COATED",ORAL,20020417,,ANDA,ANDA075794,L. Perrigo Company,ACETAMINOPHEN; ASPIRIN; CAFFEINE,250; 250; 65,mg/1; mg/1; mg/1,"Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0379,HUMAN OTC DRUG,good sense allergy,,Diphenhydramine HCl,SOLUTION,ORAL,19890915,,OTC MONOGRAPH DRUG,M012,L. Perrigo Company,DIPHENHYDRAMINE HYDROCHLORIDE,12.5,mg/5mL,"Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0384,HUMAN OTC DRUG,good sense cough dm,,dextromethorphan polistirex,SUSPENSION,ORAL,20130201,,ANDA,ANDA091135,L. Perrigo Company,DEXTROMETHORPHAN HYDROBROMIDE,30,mg/5mL,"Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0388,HUMAN OTC DRUG,good sense nasal,,Oxymetazoline HCl,"SPRAY, METERED",NASAL,20020513,,OTC MONOGRAPH DRUG,M012,L. Perrigo Company,OXYMETAZOLINE HYDROCHLORIDE,0.05,g/100mL,"Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0401,HUMAN OTC DRUG,Zephrex D,,pseudoephedrine hydrochloride,"CAPSULE, GELATIN COATED",ORAL,20161104,,OTC MONOGRAPH DRUG,M012,L. Perrigo Company,PSEUDOEPHEDRINE HYDROCHLORIDE,30,mg/1,"Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0403,HUMAN OTC DRUG,good sense pain relief,,Acetaminophen,TABLET,ORAL,19890815,,OTC MONOGRAPH DRUG,M013,L. Perrigo Company,ACETAMINOPHEN,325,mg/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0422,HUMAN OTC DRUG,Good Sense Nicotine,,Nicotine Polacrilex,"GUM, CHEWING",ORAL,20050422,,ANDA,ANDA078326,L. Perrigo Company,NICOTINE,4,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0426,HUMAN OTC DRUG,good sense tioconazole 1,,Tioconazole,OINTMENT,VAGINAL,20191022,,ANDA,ANDA075915,L. Perrigo Company,TIOCONAZOLE,6.5,g/100g,"Azole Antifungal [EPC], Azoles [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0428,HUMAN OTC DRUG,Good Sense Gas Relief,Extra Strength,Simethicone,"CAPSULE, LIQUID FILLED",ORAL,19990209,,OTC MONOGRAPH DRUG,M002,L. Perrigo Company,DIMETHICONE,125,mg/1,Skin Barrier Activity [PE],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0431,HUMAN OTC DRUG,good sense nighttime sleep aid,,Diphenhydramine Hydrochloride,"TABLET, FILM COATED",ORAL,20010425,,OTC MONOGRAPH DRUG,M010,L. Perrigo Company,DIPHENHYDRAMINE HYDROCHLORIDE,25,mg/1,"Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0432,HUMAN OTC DRUG,Good Sense Nasal Decongestant,,Pseudoephedrine HCl,"TABLET, FILM COATED",ORAL,19890915,,OTC MONOGRAPH DRUG,M012,L. Perrigo Company,PSEUDOEPHEDRINE HYDROCHLORIDE,30,mg/1,"Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0437,HUMAN OTC DRUG,good sense pain relief pm,extra strength,"Acetaminophen, Diphenhydramine HCl","TABLET, FILM COATED",ORAL,19920723,,OTC MONOGRAPH DRUG,M013,L. Perrigo Company,ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE,500; 25,mg/1; mg/1,"Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0441,HUMAN OTC DRUG,Good sense sleep aid,,Doxylamine succinate,TABLET,ORAL,19970414,,ANDA,ANDA040167,L. Perrigo Company,DOXYLAMINE SUCCINATE,25,mg/1,"Antihistamine [EPC], Histamine Receptor Antagonists [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0443,HUMAN OTC DRUG,Good Sense Nasal Allergy,,Triamcinolone acetonide,"SPRAY, METERED",NASAL,20170209,,ANDA,ANDA078104,L. Perrigo Company,TRIAMCINOLONE ACETONIDE,55,ug/1,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0456,HUMAN OTC DRUG,Good Sense Nicotine,,Nicotine Polacrilex,"GUM, CHEWING",ORAL,20070307,,ANDA,ANDA076777,L. Perrigo Company,NICOTINE,2,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0459,HUMAN OTC DRUG,good sense nighttime,,"Acetaminophen, Dextromethorphan HBr, Doxylamine succinate",SOLUTION,ORAL,20110822,,OTC MONOGRAPH DRUG,M012,L. Perrigo Company,ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE,650; 30; 12.5,mg/30mL; mg/30mL; mg/30mL,"Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0467,HUMAN OTC DRUG,good sense aspirin,,Aspirin,"TABLET, CHEWABLE",ORAL,19921104,,OTC MONOGRAPH DRUG,M013,L. Perrigo Company,ASPIRIN,81,mg/1,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]",,N,20251231,Z79.02,"[{""icd10_code"":""Z79.02"",""description"":""Long term use of antithrombotics/antiplatelets"",""confidence"":0.8,""context"":""cardioprotection""},{""icd10_code"":""I25.10"",""description"":""Atherosclerotic heart disease without angina pectoris"",""confidence"":0.2,""context"":""CAD prevention""}]",0.80
0113-0471,HUMAN OTC DRUG,Good Sense Anti Itch,,hydrocortisone,OINTMENT,TOPICAL,20210123,,OTC MONOGRAPH DRUG,M017,L. Perrigo Company,HYDROCORTISONE,1,g/100g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0113-0479,HUMAN OTC DRUG,good sense allergy relief,,Diphenhydramine Hydrochloride,TABLET,ORAL,19910820,,OTC MONOGRAPH DRUG,M012,L. Perrigo Company,DIPHENHYDRAMINE HYDROCHLORIDE,25,mg/1,"Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0484,HUMAN OTC DRUG,Good Sense Pain Relief,,Acetaminophen,TABLET,ORAL,19890915,,OTC MONOGRAPH DRUG,M013,L. Perrigo Company,ACETAMINOPHEN,500,mg/1,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0503,HUMAN OTC DRUG,Good Sense Childrens All Day Allergy,,Cetirizine HCl,SOLUTION,ORAL,20160111,,ANDA,ANDA204226,L. Perrigo Company,CETIRIZINE HYDROCHLORIDE,5,mg/5mL,"Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0517,HUMAN OTC DRUG,Good Sense ibuprofen,,Ibuprofen,"TABLET, FILM COATED",ORAL,20060427,,ANDA,ANDA077349,L. Perrigo Company,IBUPROFEN,200,mg/1,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20251231,M79.3,"[{""icd10_code"":""M79.3"",""description"":""Panniculitis, unspecified"",""confidence"":0.3,""context"":""general pain/inflammation""},{""icd10_code"":""M25.50"",""description"":""Pain in unspecified joint"",""confidence"":0.25,""context"":""joint pain""},{""icd10_code"":""R50.9"",""description"":""Fever, unspecified"",""confidence"":0.2,""context"":""fever reduction""},{""icd10_code"":""G43.909"",""description"":""Migraine, unspecified, not intractable, without status migrainosus"",""confidence"":0.15,""context"":""headache""},{""icd10_code"":""M79.1"",""description"":""Myalgia"",""confidence"":0.1,""context"":""muscle pain""}]",0.30
0113-0520,HUMAN OTC DRUG,good sense omeprazole,,omeprazole,"TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE",ORAL,20180619,,NDA,NDA209400,L. Perrigo Company,OMEPRAZOLE,20,mg/1,"Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]",,N,20261231,K21.9,"[{""icd10_code"":""K21.9"",""description"":""Gastro-esophageal reflux disease without esophagitis"",""confidence"":0.5,""context"":""GERD""},{""icd10_code"":""K25.9"",""description"":""Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.25,""context"":""gastric ulcer""},{""icd10_code"":""K27.9"",""description"":""Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.15,""context"":""peptic ulcer""},{""icd10_code"":""K30"",""description"":""Functional dyspepsia"",""confidence"":0.1,""context"":""dyspepsia""}]",0.50
0113-0532,HUMAN OTC DRUG,Good Sense Nicotine,,Nicotine Polacrilex,"GUM, CHEWING",ORAL,19900715,,ANDA,ANDA076779,L. Perrigo Company,NICOTINE,4,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0541,HUMAN OTC DRUG,good sense anti itch,,Hydrocortisone,CREAM,TOPICAL,20060224,,OTC MONOGRAPH DRUG,M017,L. Perrigo Company,HYDROCORTISONE,1,g/100g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0113-0544,HUMAN OTC DRUG,good sense pain relief,arthritis pain,Acetaminophen,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,20051121,,ANDA,ANDA075077,L. Perrigo Company,ACETAMINOPHEN,650,mg/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0603,HUMAN OTC DRUG,Good Sense Severe Daytime Cold and Flu,,"acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl",SOLUTION,ORAL,20131119,,OTC MONOGRAPH DRUG,M012,L. Perrigo Company,ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE,325; 10; 200; 5,mg/15mL; mg/15mL; mg/15mL; mg/15mL,"Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0604,HUMAN OTC DRUG,good sense ibuprofen,,Ibuprofen,"TABLET, FILM COATED",ORAL,19890915,,ANDA,ANDA072096,L. Perrigo Company,IBUPROFEN,200,mg/1,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20261231,M79.3,"[{""icd10_code"":""M79.3"",""description"":""Panniculitis, unspecified"",""confidence"":0.3,""context"":""general pain/inflammation""},{""icd10_code"":""M25.50"",""description"":""Pain in unspecified joint"",""confidence"":0.25,""context"":""joint pain""},{""icd10_code"":""R50.9"",""description"":""Fever, unspecified"",""confidence"":0.2,""context"":""fever reduction""},{""icd10_code"":""G43.909"",""description"":""Migraine, unspecified, not intractable, without status migrainosus"",""confidence"":0.15,""context"":""headache""},{""icd10_code"":""M79.1"",""description"":""Myalgia"",""confidence"":0.1,""context"":""muscle pain""}]",0.30
0113-0608,HUMAN OTC DRUG,good sense childrens pain and fever,,Acetaminophen,SUSPENSION,ORAL,20130528,,OTC MONOGRAPH DRUG,M013,L. Perrigo Company,ACETAMINOPHEN,160,mg/5mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0612,HUMAN OTC DRUG,good sense allergy relief,,Loratadine,TABLET,ORAL,20040921,,ANDA,ANDA076301,L. Perrigo Company,LORATADINE,10,mg/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0622,HUMAN OTC DRUG,good sense itch relief,,"Diphenhydramine Hydrochloride, Zinc Acetate",CREAM,TOPICAL,20060718,,OTC MONOGRAPH DRUG,M017,L. Perrigo Company,DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE,2; .1,g/100g; g/100g,"Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0113-0647,HUMAN OTC DRUG,good sense ibuprofen,,Ibuprofen,"TABLET, FILM COATED",ORAL,19910215,,ANDA,ANDA072096,L. Perrigo Company,IBUPROFEN,200,mg/1,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20251231,M79.3,"[{""icd10_code"":""M79.3"",""description"":""Panniculitis, unspecified"",""confidence"":0.3,""context"":""general pain/inflammation""},{""icd10_code"":""M25.50"",""description"":""Pain in unspecified joint"",""confidence"":0.25,""context"":""joint pain""},{""icd10_code"":""R50.9"",""description"":""Fever, unspecified"",""confidence"":0.2,""context"":""fever reduction""},{""icd10_code"":""G43.909"",""description"":""Migraine, unspecified, not intractable, without status migrainosus"",""confidence"":0.15,""context"":""headache""},{""icd10_code"":""M79.1"",""description"":""Myalgia"",""confidence"":0.1,""context"":""muscle pain""}]",0.30
0113-0648,HUMAN OTC DRUG,Good Sense Nasal Four,,Phenylephrine hydrochloride,SPRAY,NASAL,20020809,,OTC MONOGRAPH DRUG,M012,L. Perrigo Company,PHENYLEPHRINE HYDROCHLORIDE,1,g/100mL,"Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0651,HUMAN OTC DRUG,good sense esomeprazole magnesium,,esomeprazole,"CAPSULE, DELAYED RELEASE",ORAL,20200405,,ANDA,ANDA207193,L. Perrigo Company,ESOMEPRAZOLE,20,mg/1,"Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]",,N,20251231,K21.9,"[{""icd10_code"":""K21.9"",""description"":""Gastro-esophageal reflux disease without esophagitis"",""confidence"":0.5,""context"":""GERD""},{""icd10_code"":""K25.9"",""description"":""Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.25,""context"":""gastric ulcer""},{""icd10_code"":""K27.9"",""description"":""Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.15,""context"":""peptic ulcer""},{""icd10_code"":""K30"",""description"":""Functional dyspepsia"",""confidence"":0.1,""context"":""dyspepsia""}]",0.50
0113-0656,HUMAN OTC DRUG,Good Sense Daytime,non drowsy cold and flu,"acetaminophen, dextromethorphan Hbr, Phenylephrine HCl",SOLUTION,ORAL,20060725,,OTC MONOGRAPH DRUG,M012,L. Perrigo Company,ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE,325; 10; 5,mg/15mL; mg/15mL; mg/15mL,"Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0657,HUMAN OTC DRUG,good sense gas relief,,Simethicone,"CAPSULE, LIQUID FILLED",ORAL,20020405,,OTC MONOGRAPH DRUG,M002,L. Perrigo Company,DIMETHICONE,180,mg/1,Skin Barrier Activity [PE],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0660,HUMAN OTC DRUG,Good Sense Ibuprofen,Childrens,Ibuprofen,SUSPENSION,ORAL,20020409,,ANDA,ANDA074937,L. Perrigo Company,IBUPROFEN,100,mg/5mL,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20261231,M79.3,"[{""icd10_code"":""M79.3"",""description"":""Panniculitis, unspecified"",""confidence"":0.3,""context"":""general pain/inflammation""},{""icd10_code"":""M25.50"",""description"":""Pain in unspecified joint"",""confidence"":0.25,""context"":""joint pain""},{""icd10_code"":""R50.9"",""description"":""Fever, unspecified"",""confidence"":0.2,""context"":""fever reduction""},{""icd10_code"":""G43.909"",""description"":""Migraine, unspecified, not intractable, without status migrainosus"",""confidence"":0.15,""context"":""headache""},{""icd10_code"":""M79.1"",""description"":""Myalgia"",""confidence"":0.1,""context"":""muscle pain""}]",0.30
0113-0668,HUMAN OTC DRUG,Good Sense Nighttime Cough,,"Dextromethorphan Hydrobromide, Doxylamine Succinate",SOLUTION,ORAL,20021103,20250731,OTC MONOGRAPH DRUG,M012,L. Perrigo Company,DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE,30; 12.5,mg/30mL; mg/30mL,"Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0671,HUMAN OTC DRUG,Good Sense childrens allergy relief,,Loratadine,SOLUTION,ORAL,20200802,,ANDA,ANDA075728,L. Perrigo Company,LORATADINE,5,mg/5mL,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0679,HUMAN OTC DRUG,Good Sense Triple Antibiotic,and Pain Relief,"Bacitracin, Neomycin, Polymyxin B, Pramoxine HCl",OINTMENT,TOPICAL,20060214,,OTC MONOGRAPH DRUG,M004,L. Perrigo Company,BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE,500; 3.5; 10000; 10,[USP'U]/g; mg/g; [USP'U]/g; mg/g,"Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0113-0685,HUMAN OTC DRUG,Good Sense Ibuprofen,,Ibuprofen,SUSPENSION,ORAL,20110428,,ANDA,ANDA074937,L. Perrigo Company,IBUPROFEN,100,mg/5mL,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20261231,M79.3,"[{""icd10_code"":""M79.3"",""description"":""Panniculitis, unspecified"",""confidence"":0.3,""context"":""general pain/inflammation""},{""icd10_code"":""M25.50"",""description"":""Pain in unspecified joint"",""confidence"":0.25,""context"":""joint pain""},{""icd10_code"":""R50.9"",""description"":""Fever, unspecified"",""confidence"":0.2,""context"":""fever reduction""},{""icd10_code"":""G43.909"",""description"":""Migraine, unspecified, not intractable, without status migrainosus"",""confidence"":0.15,""context"":""headache""},{""icd10_code"":""M79.1"",""description"":""Myalgia"",""confidence"":0.1,""context"":""muscle pain""}]",0.30
0113-0703,HUMAN OTC DRUG,Good Sense Tussin CF,,"Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride",SOLUTION,ORAL,20140729,20250831,OTC MONOGRAPH DRUG,M012,L. Perrigo Company,DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE,20; 200; 10,mg/10mL; mg/10mL; mg/10mL,"Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0734,HUMAN OTC DRUG,Good Sense Nicotine,,Nicotine Polacrilex,LOZENGE,ORAL,20130422,,ANDA,ANDA203690,L. Perrigo Company,NICOTINE,2,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0763,HUMAN OTC DRUG,Good Sense Severe NightTime Cold and Flu,,"Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl",SOLUTION,ORAL,20131119,,OTC MONOGRAPH DRUG,M012,L. Perrigo Company,ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE,650; 20; 12.5; 10,mg/30mL; mg/30mL; mg/30mL; mg/30mL,"Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0798,HUMAN OTC DRUG,Good Sense Hair Regrowth Treatment,for Men,Minoxidil,SOLUTION,TOPICAL,20100210,,ANDA,ANDA075598,L. Perrigo Company,MINOXIDIL,3,g/60mL,"Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0113-0812,HUMAN OTC DRUG,good sense mucus dm,,"dextromethorphan HBr, guaifenesin","TABLET, EXTENDED RELEASE",ORAL,20180621,,ANDA,ANDA207602,L Perrigo Company,DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN,60; 1200,mg/1; mg/1,"Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0817,HUMAN OTC DRUG,Good Sense Nasal,,oxymetazoline hydrochloride,SPRAY,NASAL,19960418,20260331,OTC MONOGRAPH DRUG,M012,L. Perrigo Company,OXYMETAZOLINE HYDROCHLORIDE,0.05,g/100mL,"Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0825,HUMAN OTC DRUG,good sense miconazole 7,,Miconazole nitrate,CREAM,VAGINAL,20000222,,ANDA,ANDA074760,L. Perrigo Company,MICONAZOLE NITRATE,2,g/100g,"Azole Antifungal [EPC], Azoles [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0839,HUMAN OTC DRUG,Good Sense Childrens Mucus Relief,,"dextromethorphan HBr, guaifenesin, phenylephrine HCl",LIQUID,ORAL,20140325,20250731,OTC MONOGRAPH DRUG,M012,L. Perrigo Company,DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE,5; 100; 2.5,mg/5mL; mg/5mL; mg/5mL,"Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0847,HUMAN OTC DRUG,good sense aller ease,,fexofenadine hydrochloride,"TABLET, FILM COATED",ORAL,20210910,,ANDA,ANDA212971,L. Perrigo Company,FEXOFENADINE HYDROCHLORIDE,180,mg/1,"Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0854,HUMAN OTC DRUG,Good Sense Nicotine,,Nicotine polacrilex,"GUM, CHEWING",ORAL,20130514,,ANDA,ANDA078546,L. Perrigo Company,NICOTINE,4,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0873,HUMAN OTC DRUG,good sense nicotine,,Nicotine Polacrilex,LOZENGE,ORAL,20061227,,ANDA,ANDA077007,L. Perrigo Company,NICOTINE,4,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0897,HUMAN OTC DRUG,good sense ibuprofen,childrens,Ibuprofen,SUSPENSION,ORAL,19990107,,ANDA,ANDA074937,L. Perrigo Company,IBUPROFEN,100,mg/5mL,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20261231,M79.3,"[{""icd10_code"":""M79.3"",""description"":""Panniculitis, unspecified"",""confidence"":0.3,""context"":""general pain/inflammation""},{""icd10_code"":""M25.50"",""description"":""Pain in unspecified joint"",""confidence"":0.25,""context"":""joint pain""},{""icd10_code"":""R50.9"",""description"":""Fever, unspecified"",""confidence"":0.2,""context"":""fever reduction""},{""icd10_code"":""G43.909"",""description"":""Migraine, unspecified, not intractable, without status migrainosus"",""confidence"":0.15,""context"":""headache""},{""icd10_code"":""M79.1"",""description"":""Myalgia"",""confidence"":0.1,""context"":""muscle pain""}]",0.30
0113-0898,HUMAN OTC DRUG,Good Sense Esomeprazole Magnesium,,Esomeprazole,"CAPSULE, DELAYED RELEASE",ORAL,20170922,,ANDA,ANDA207193,L. Perrigo Company,ESOMEPRAZOLE,20,mg/1,"Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]",,N,20251231,K21.9,"[{""icd10_code"":""K21.9"",""description"":""Gastro-esophageal reflux disease without esophagitis"",""confidence"":0.5,""context"":""GERD""},{""icd10_code"":""K25.9"",""description"":""Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.25,""context"":""gastric ulcer""},{""icd10_code"":""K27.9"",""description"":""Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.15,""context"":""peptic ulcer""},{""icd10_code"":""K30"",""description"":""Functional dyspepsia"",""confidence"":0.1,""context"":""dyspepsia""}]",0.50
0113-0901,HUMAN OTC DRUG,Good Sense Naproxen Sodium,,Naproxen Sodium,"TABLET, FILM COATED",ORAL,20140423,,ANDA,ANDA074661,L. Perrigo Company,NAPROXEN SODIUM,220,mg/1,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0915,HUMAN OTC DRUG,Good Sense Omeprazole,,Omeprazole,"TABLET, DELAYED RELEASE",ORAL,20080228,,NDA,NDA022032,L. Perrigo Company,OMEPRAZOLE,20,mg/1,"Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]",,N,20251231,K21.9,"[{""icd10_code"":""K21.9"",""description"":""Gastro-esophageal reflux disease without esophagitis"",""confidence"":0.5,""context"":""GERD""},{""icd10_code"":""K25.9"",""description"":""Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.25,""context"":""gastric ulcer""},{""icd10_code"":""K27.9"",""description"":""Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.15,""context"":""peptic ulcer""},{""icd10_code"":""K30"",""description"":""Functional dyspepsia"",""confidence"":0.1,""context"":""dyspepsia""}]",0.50
0113-0927,HUMAN OTC DRUG,Good Sense Tussin DM Max,,"Dextromethorphan HBr, Guaifenesin",SOLUTION,ORAL,20180801,,OTC MONOGRAPH DRUG,M012,L. Perrigo Company,DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN,20; 400,mg/20mL; mg/20mL,"Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0944,HUMAN OTC DRUG,Good Sense Hemorrhoidal,Maximum Strength Pain Relief,"glycerin, phenylephrine HCl, pramoxine HCl, white petrolatum",CREAM,TOPICAL,20080228,,OTC MONOGRAPH DRUG,M015,L. Perrigo Company,GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE,14.4; 15; .25; 1,g/100g; g/100g; g/100g; g/100g,"Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0113-0946,HUMAN OTC DRUG,good sense pain and fever,infants,Acetaminophen,SUSPENSION,ORAL,20111108,,OTC MONOGRAPH DRUG,M013,L. Perrigo Company,ACETAMINOPHEN,160,mg/5mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0957,HUMAN OTC DRUG,Good Sense Nicotine,,Nicotine Polacrilex,LOZENGE,ORAL,20130427,,ANDA,ANDA203690,L. Perrigo Company,NICOTINE,4,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0958,HUMAN OTC DRUG,Good Sense Cough DM,,dextromethorphan polistirex,SUSPENSION,ORAL,20130620,,ANDA,ANDA091135,L. Perrigo Company,DEXTROMETHORPHAN HYDROBROMIDE,30,mg/5mL,"Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0981,HUMAN OTC DRUG,Good Sense All Day Allergy,,cetirizine hydrochloride,"CAPSULE, LIQUID FILLED",ORAL,20220901,,ANDA,ANDA213105,L. Perrigo Company,CETIRIZINE HYDROCHLORIDE,10,mg/1,"Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0987,HUMAN OTC DRUG,Good Sense Childrens Cold and Cough,,"Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl",SOLUTION,ORAL,20070224,,OTC MONOGRAPH DRUG,M012,L. Perrigo Company,BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE,2; 10; 5,mg/10mL; mg/10mL; mg/10mL,"Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-0994,HUMAN OTC DRUG,good sense daytime,,"Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl","CAPSULE, LIQUID FILLED",ORAL,20070118,,OTC MONOGRAPH DRUG,M012,L. Perrigo Company,ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE,325; 10; 5,mg/1; mg/1; mg/1,"Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-1011,HUMAN OTC DRUG,good sense tussin cf max,,"Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride",SOLUTION,ORAL,20230331,,OTC MONOGRAPH DRUG,M012,L. Perrigo Company,ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE,650; 20; 400; 10,mg/20mL; mg/20mL; mg/20mL; mg/20mL,"Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-1019,HUMAN OTC DRUG,good sense childrens allergy relief,,loratadine,"TABLET, CHEWABLE",ORAL,20190731,,ANDA,ANDA210033,L. Perrigo Company,LORATADINE,5,mg/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-1023,HUMAN OTC DRUG,good sense clearlax,,Polyethylene Glycol 3350,"POWDER, FOR SOLUTION",ORAL,20221227,,ANDA,ANDA090685,L. Perrigo Company,POLYETHYLENE GLYCOL 3350,17,g/17g,"Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-1032,HUMAN OTC DRUG,Good Sense Hair Regrowth Treatment,,minoxidil,SOLUTION,TOPICAL,20210525,,ANDA,ANDA075598,L. Perrigo Company,MINOXIDIL,5,g/100mL,"Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0113-1087,HUMAN OTC DRUG,Good Sense Anti Diarrheal Anti Gas,,"loperamide hydrochloride, simethicone",TABLET,ORAL,20190129,,ANDA,ANDA209837,L. Perrigo Company,DIMETHICONE; LOPERAMIDE HYDROCHLORIDE,125; 2,mg/1; mg/1,"Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-1114,HUMAN OTC DRUG,Good Sense Lansoprazole,,Lansoprazole,"CAPSULE, DELAYED RELEASE",ORAL,20211122,,ANDA,ANDA202319,L. Perrigo Company,LANSOPRAZOLE,15,mg/1,"Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-1125,HUMAN OTC DRUG,Good Sense Nicotine,,Nicotine Polacrilex,LOZENGE,ORAL,20200707,,ANDA,ANDA090711,L. Perrigo Company,NICOTINE,2,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-1129,HUMAN OTC DRUG,Good Sense Hair Regrowth Treatment,,Minoxidil,"AEROSOL, FOAM",TOPICAL,20190129,,ANDA,ANDA091344,L. Perrigo Company,MINOXIDIL,50,mg/g,"Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0113-1140,HUMAN OTC DRUG,good sense triple antibiotic,,"Bacitracin Zinc, Neomycin sulfate, Polymyxin B, Pramoxine HCl",OINTMENT,TOPICAL,20181229,,OTC MONOGRAPH DRUG,M004,L. Perrigo Company,BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE,500; 3.5; 10000; 10,[USP'U]/g; mg/g; [USP'U]/g; mg/g,"Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0113-1189,HUMAN OTC DRUG,good sense arthritis pain,,diclofenac sodium,GEL,TOPICAL,20200822,,ANDA,ANDA211253,L. Perrigo Company,DICLOFENAC SODIUM,10,mg/g,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0113-1190,HUMAN OTC DRUG,good sense nicotine,,Nicotine Polacrilex,LOZENGE,ORAL,20190227,,ANDA,ANDA090711,L. Perrigo Company,NICOTINE,4,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-1191,HUMAN OTC DRUG,good sense allergy relief,,loratadine,"TABLET, ORALLY DISINTEGRATING",ORAL,20200806,,ANDA,ANDA076011,L. Perrigo Company,LORATADINE,10,mg/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-1212,HUMAN OTC DRUG,Good Sense Ibuprofen,,Ibuprofen,"TABLET, FILM COATED",ORAL,20201019,,ANDA,ANDA072096,L. Perrigo Company,IBUPROFEN,200,mg/1,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20251231,M79.3,"[{""icd10_code"":""M79.3"",""description"":""Panniculitis, unspecified"",""confidence"":0.3,""context"":""general pain/inflammation""},{""icd10_code"":""M25.50"",""description"":""Pain in unspecified joint"",""confidence"":0.25,""context"":""joint pain""},{""icd10_code"":""R50.9"",""description"":""Fever, unspecified"",""confidence"":0.2,""context"":""fever reduction""},{""icd10_code"":""G43.909"",""description"":""Migraine, unspecified, not intractable, without status migrainosus"",""confidence"":0.15,""context"":""headache""},{""icd10_code"":""M79.1"",""description"":""Myalgia"",""confidence"":0.1,""context"":""muscle pain""}]",0.30
0113-1352,HUMAN OTC DRUG,good sense nicotine,,Nicotine Polacrilex,"GUM, CHEWING",ORAL,20181129,,ANDA,ANDA078547,L. Perrigo Company,NICOTINE,2,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-1369,HUMAN OTC DRUG,good sense anti itch,,Hydrocortisone,CREAM,TOPICAL,20190604,20250630,OTC MONOGRAPH DRUG,M017,L. Perrigo Company,HYDROCORTISONE,1,g/100g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0113-1412,HUMAN OTC DRUG,good sense naproxen sodium,,naproxen sodium,"TABLET, FILM COATED",ORAL,20211109,,ANDA,ANDA074661,L. Perrigo Company,NAPROXEN SODIUM,220,mg/1,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-1612,HUMAN OTC DRUG,good sense allergy relief,,Loratadine,TABLET,ORAL,20180926,,ANDA,ANDA076301,L. Perrigo Company,LORATADINE,10,mg/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-1619,HUMAN OTC DRUG,good sense migraine formula,,"acetaminophen, aspirin, caffeine","TABLET, FILM COATED",ORAL,20220624,,ANDA,ANDA075794,L. Perrigo Company,ACETAMINOPHEN; ASPIRIN; CAFFEINE,250; 250; 65,mg/1; mg/1; mg/1,"Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-1645,HUMAN OTC DRUG,Good Sense antidiarrheal,,loperamide HCl,SOLUTION,ORAL,20180521,,ANDA,ANDA091292,L. Perrigo Company,LOPERAMIDE HYDROCHLORIDE,1,mg/7.5mL,"Opioid Agonist [EPC], Opioid Agonists [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-1719,HUMAN OTC DRUG,good sense childrens allergy relief,,Loratadine,SOLUTION,ORAL,20190530,,ANDA,ANDA075728,L. Perrigo Company,LORATADINE,5,mg/5mL,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-1720,HUMAN OTC DRUG,Nasonex,,mometasone furoate,"SPRAY, METERED",NASAL,20220629,,NDA,NDA215712,L. Perrigo Company,MOMETASONE FUROATE MONOHYDRATE,50,ug/1,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-1723,HUMAN OTC DRUG,Good Sense Omeprazole,,Omeprazole,"TABLET, DELAYED RELEASE",ORAL,20190522,,NDA,NDA022032,L. Perrigo Company,OMEPRAZOLE,20,mg/1,"Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]",,N,20251231,K21.9,"[{""icd10_code"":""K21.9"",""description"":""Gastro-esophageal reflux disease without esophagitis"",""confidence"":0.5,""context"":""GERD""},{""icd10_code"":""K25.9"",""description"":""Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.25,""context"":""gastric ulcer""},{""icd10_code"":""K27.9"",""description"":""Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.15,""context"":""peptic ulcer""},{""icd10_code"":""K30"",""description"":""Functional dyspepsia"",""confidence"":0.1,""context"":""dyspepsia""}]",0.50
0113-1725,HUMAN OTC DRUG,good sense tussin dm,,"dextromethorphan hydrobromide, guaifenesin",SOLUTION,ORAL,20220416,,OTC MONOGRAPH DRUG,M012,L. Perrigo Company,DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN,20; 200,mg/20mL; mg/20mL,"Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-1803,HUMAN OTC DRUG,good sense omeprazole delayed release,,omeprazole,"TABLET, DELAYED RELEASE",ORAL,20211221,,NDA,NDA022032,L. Perrigo Company,OMEPRAZOLE,20,mg/1,"Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]",,N,20251231,K21.9,"[{""icd10_code"":""K21.9"",""description"":""Gastro-esophageal reflux disease without esophagitis"",""confidence"":0.5,""context"":""GERD""},{""icd10_code"":""K25.9"",""description"":""Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.25,""context"":""gastric ulcer""},{""icd10_code"":""K27.9"",""description"":""Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.15,""context"":""peptic ulcer""},{""icd10_code"":""K30"",""description"":""Functional dyspepsia"",""confidence"":0.1,""context"":""dyspepsia""}]",0.50
0113-1855,HUMAN OTC DRUG,good sense headache relief,,"acetaminophen, aspirin, caffeine","TABLET, FILM COATED",ORAL,20220218,,OTC MONOGRAPH DRUG,M013,L. Perrigo Company,ACETAMINOPHEN; ASPIRIN; CAFFEINE,250; 250; 65,mg/1; mg/1; mg/1,"Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-1889,HUMAN OTC DRUG,good sense pain relief,,acetaminophen,"TABLET, FILM COATED",ORAL,20200122,,OTC MONOGRAPH DRUG,M013,L. Perrigo Company,ACETAMINOPHEN,500,mg/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-1910,HUMAN OTC DRUG,good sense lice killing creme rinse,,Permethrin,LOTION,TOPICAL,20190724,,ANDA,ANDA076090,L. Perrigo Company,PERMETHRIN,1,mg/100mL,"Pyrethrins [CS], Pyrethroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0113-1975,HUMAN OTC DRUG,Good Sense Pain Relief,,Acetaminophen,TABLET,ORAL,20220123,,OTC MONOGRAPH DRUG,M013,L. Perrigo Company,ACETAMINOPHEN,500,mg/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-1999,HUMAN OTC DRUG,Childrens Nasonex,,mometasone furoate,"SPRAY, METERED",NASAL,20230207,,NDA,NDA215712,L. Perrigo Company,MOMETASONE FUROATE,50,ug/1,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-2003,HUMAN OTC DRUG,Option 2,,levonorgestrel,TABLET,ORAL,20160129,,ANDA,ANDA202334,L. Perrigo Company,LEVONORGESTREL,1.5,mg/1,"Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-2007,HUMAN OTC DRUG,Allergy and Congestion Relief,,"loratadine, Pseudoephedrine sulfate","TABLET, FILM COATED, EXTENDED RELEASE",ORAL,20180412,,ANDA,ANDA076050,L. Perrigo Company,LORATADINE; PSEUDOEPHEDRINE SULFATE,5; 120,mg/1; mg/1,"Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-2022,HUMAN OTC DRUG,good sense esomeprazole magnesium,,esomeprazole,"CAPSULE, DELAYED RELEASE",ORAL,20240424,,ANDA,ANDA207193,L. Perrigo Company,ESOMEPRAZOLE,20,mg/1,"Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]",,N,20251231,K21.9,"[{""icd10_code"":""K21.9"",""description"":""Gastro-esophageal reflux disease without esophagitis"",""confidence"":0.5,""context"":""GERD""},{""icd10_code"":""K25.9"",""description"":""Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.25,""context"":""gastric ulcer""},{""icd10_code"":""K27.9"",""description"":""Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.15,""context"":""peptic ulcer""},{""icd10_code"":""K30"",""description"":""Functional dyspepsia"",""confidence"":0.1,""context"":""dyspepsia""}]",0.50
0113-2023,HUMAN OTC DRUG,good sense mucus er,,guaifenesin,"TABLET, MULTILAYER, EXTENDED RELEASE",ORAL,20200704,,ANDA,ANDA078912,L. Perrigo Company,GUAIFENESIN,600,mg/1,"Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-2219,HUMAN OTC DRUG,Good Sense Mucus DM,,"dextromethorphan hydrobromide, guaifenesin","TABLET, EXTENDED RELEASE",ORAL,20190710,,ANDA,ANDA207602,L. Perrigo Company,DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN,30; 600,mg/1; mg/1,"Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-2224,HUMAN OTC DRUG,anti diarrheal,,Loperamide HCl,"TABLET, FILM COATED",ORAL,20180625,,ANDA,ANDA075232,L. Perrigo Company,LOPERAMIDE HYDROCHLORIDE,2,mg/1,"Opioid Agonist [EPC], Opioid Agonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-2299,HUMAN OTC DRUG,good sense day time cold and flu,,"acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride",SOLUTION,ORAL,20230705,,OTC MONOGRAPH DRUG,M012,L. Perrigo Company,ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE,325; 10; 200; 5,mg/15mL; mg/15mL; mg/15mL; mg/15mL,"Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-2461,HUMAN OTC DRUG,Good Sense Childrens Ibuprofen,,Ibuprofen,"TABLET, CHEWABLE",ORAL,20191009,,ANDA,ANDA076359,L. Perrigo Company,IBUPROFEN,100,mg/1,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20261231,M79.3,"[{""icd10_code"":""M79.3"",""description"":""Panniculitis, unspecified"",""confidence"":0.3,""context"":""general pain/inflammation""},{""icd10_code"":""M25.50"",""description"":""Pain in unspecified joint"",""confidence"":0.25,""context"":""joint pain""},{""icd10_code"":""R50.9"",""description"":""Fever, unspecified"",""confidence"":0.2,""context"":""fever reduction""},{""icd10_code"":""G43.909"",""description"":""Migraine, unspecified, not intractable, without status migrainosus"",""confidence"":0.15,""context"":""headache""},{""icd10_code"":""M79.1"",""description"":""Myalgia"",""confidence"":0.1,""context"":""muscle pain""}]",0.30
0113-2501,HUMAN OTC DRUG,good sense night time cold and flu,,"acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride",SOLUTION,ORAL,20230705,,OTC MONOGRAPH DRUG,M012,L. Perrigo Company,ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE,325; 10; 6.25; 5,mg/15mL; mg/15mL; mg/15mL; mg/15mL,"Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-2502,HUMAN OTC DRUG,Good Sense Nicotine,,Nicotine Polacrilex,LOZENGE,ORAL,20240321,,ANDA,ANDA077007,L. Perrigo Company,NICOTINE,2,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-3650,HUMAN OTC DRUG,Good Sense Mucus ER,,Guaifenesin,"TABLET, MULTILAYER, EXTENDED RELEASE",ORAL,20210320,,ANDA,ANDA213420,L. Perrigo Company,GUAIFENESIN,1200,mg/1,"Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-4032,HUMAN OTC DRUG,good sense sleep aid ultra,,doxylamine succinate,"TABLET, COATED",ORAL,20250227,,ANDA,ANDA040167,L. Perrigo Company,DOXYLAMINE SUCCINATE,25,mg/1,"Antihistamine [EPC], Histamine Receptor Antagonists [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-4368,HUMAN OTC DRUG,Good Sense Naproxen Sodium,,Naproxen Sodium,"TABLET, FILM COATED",ORAL,20140331,,ANDA,ANDA074661,L. Perrigo Company,NAPROXEN SODIUM,220,mg/1,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-4500,HUMAN OTC DRUG,good sense severe day time cold and flu,,"acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride","TABLET, FILM COATED",ORAL,20191202,,OTC MONOGRAPH DRUG,M012,L. Perrigo Company,ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE,325; 10; 200; 5,mg/1; mg/1; mg/1; mg/1,"Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-4501,HUMAN OTC DRUG,good sense ibuprofen,,ibuprofen,"CAPSULE, LIQUID FILLED",ORAL,20220123,,ANDA,ANDA203599,L. Perrigo Company,IBUPROFEN,200,mg/1,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20261231,M79.3,"[{""icd10_code"":""M79.3"",""description"":""Panniculitis, unspecified"",""confidence"":0.3,""context"":""general pain/inflammation""},{""icd10_code"":""M25.50"",""description"":""Pain in unspecified joint"",""confidence"":0.25,""context"":""joint pain""},{""icd10_code"":""R50.9"",""description"":""Fever, unspecified"",""confidence"":0.2,""context"":""fever reduction""},{""icd10_code"":""G43.909"",""description"":""Migraine, unspecified, not intractable, without status migrainosus"",""confidence"":0.15,""context"":""headache""},{""icd10_code"":""M79.1"",""description"":""Myalgia"",""confidence"":0.1,""context"":""muscle pain""}]",0.30
0113-5023,HUMAN OTC DRUG,Good Sense Nicotine,,nicotine polacrilex,LOZENGE,ORAL,20240418,,ANDA,ANDA077007,L. Perrigo Company,NICOTINE,4,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-5129,HUMAN OTC DRUG,minoxidil,,Minoxidil,"AEROSOL, FOAM",TOPICAL,20240308,,ANDA,ANDA091344,L. Perrigo Company,MINOXIDIL,50,mg/g,"Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0113-5299,HUMAN OTC DRUG,Good Sense Dual Action Back Pain,,"acetaminophen, ibuprofen","TABLET, FILM COATED",ORAL,20240307,,ANDA,ANDA214836,L. Perrigo Company,ACETAMINOPHEN; IBUPROFEN,250; 125,mg/1; mg/1,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20251231,M79.3,"[{""icd10_code"":""M79.3"",""description"":""Panniculitis, unspecified"",""confidence"":0.3,""context"":""general pain/inflammation""},{""icd10_code"":""M25.50"",""description"":""Pain in unspecified joint"",""confidence"":0.25,""context"":""joint pain""},{""icd10_code"":""R50.9"",""description"":""Fever, unspecified"",""confidence"":0.2,""context"":""fever reduction""},{""icd10_code"":""G43.909"",""description"":""Migraine, unspecified, not intractable, without status migrainosus"",""confidence"":0.15,""context"":""headache""},{""icd10_code"":""M79.1"",""description"":""Myalgia"",""confidence"":0.1,""context"":""muscle pain""}]",0.30
0113-5300,HUMAN OTC DRUG,good sense dual action,,"Acetaminophen, Ibuprofen","TABLET, FILM COATED",ORAL,20230301,,ANDA,ANDA214836,L Perrigo Company,ACETAMINOPHEN; IBUPROFEN,250; 125,mg/1; mg/1,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20251231,M79.3,"[{""icd10_code"":""M79.3"",""description"":""Panniculitis, unspecified"",""confidence"":0.3,""context"":""general pain/inflammation""},{""icd10_code"":""M25.50"",""description"":""Pain in unspecified joint"",""confidence"":0.25,""context"":""joint pain""},{""icd10_code"":""R50.9"",""description"":""Fever, unspecified"",""confidence"":0.2,""context"":""fever reduction""},{""icd10_code"":""G43.909"",""description"":""Migraine, unspecified, not intractable, without status migrainosus"",""confidence"":0.15,""context"":""headache""},{""icd10_code"":""M79.1"",""description"":""Myalgia"",""confidence"":0.1,""context"":""muscle pain""}]",0.30
0113-6002,HUMAN OTC DRUG,Prevacid 24 HR,,lansoprazole,"CAPSULE, DELAYED RELEASE",ORAL,20201105,,NDA,NDA022327,L. Perrigo Company,LANSOPRAZOLE,15,mg/1,"Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-6004,HUMAN OTC DRUG,injoy diarrhea relief,,Loperamide HCl,"TABLET, FILM COATED",ORAL,20220809,,ANDA,ANDA075232,L. Perrigo Company,LOPERAMIDE HYDROCHLORIDE,2,mg/1,"Opioid Agonist [EPC], Opioid Agonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-6023,HUMAN OTC DRUG,injoy heartburn relief,,"famotidine, calcium carbonate and magnesium hydroxide","TABLET, CHEWABLE",ORAL,20220809,,ANDA,ANDA077355,L. Perrigo Company,CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE,800; 10; 165,mg/1; mg/1; mg/1,"Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-6044,HUMAN OTC DRUG,good sense sleep aid ultra,,Doxylamine Succinate,TABLET,ORAL,20220806,,ANDA,ANDA040167,L. Perrigo Company,DOXYLAMINE SUCCINATE,25,mg/1,"Antihistamine [EPC], Histamine Receptor Antagonists [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-6117,HUMAN OTC DRUG,Prevacid 24 HR,,lansoprazole,"CAPSULE, DELAYED RELEASE",ORAL,20230330,,ANDA,ANDA202319,L. Perrigo Company,LANSOPRAZOLE,15,mg/1,"Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-6900,HUMAN OTC DRUG,injoy constipation relief,,Polyethylene Glycol 3350,"POWDER, FOR SOLUTION",ORAL,20220809,,ANDA,ANDA090685,L. Perrigo Company,POLYETHYLENE GLYCOL 3350,17,g/17g,"Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-7777,HUMAN OTC DRUG,perrigo allergy d,,"loratadine, Pseudoephedrine sulfate","TABLET, FILM COATED, EXTENDED RELEASE",ORAL,20211008,,ANDA,ANDA076050,L. Perrigo Company,LORATADINE; PSEUDOEPHEDRINE SULFATE,5; 120,mg/1; mg/1,"Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-8100,HUMAN OTC DRUG,good sense nicotine,,nicotine polacrilex,"GUM, CHEWING",ORAL,20230621,,ANDA,ANDA206394,L. Perrigo Company,NICOTINE,2,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-8101,HUMAN OTC DRUG,Opill,,norgestrel,TABLET,ORAL,20240304,,NDA,NDA017031,L. Perrigo Company,NORGESTREL,0.075,mg/1,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-8264,HUMAN OTC DRUG,good sense naproxen sodium,,"diphenhydramine hydrochloride, naproxen sodium","TABLET, FILM COATED",ORAL,20181228,,ANDA,ANDA208499,L. Perrigo Company,DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM,25; 220,mg/1; mg/1,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-8600,HUMAN OTC DRUG,good sense nicotine,,nicotine polacrilex,"GUM, CHEWING",ORAL,20230823,,ANDA,ANDA206393,L. Perrigo Company,NICOTINE,4,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-8959,HUMAN OTC DRUG,Good Sense Pain and Fever,,Acetaminophen,SUSPENSION,ORAL,20120322,,OTC MONOGRAPH DRUG,M013,L. Perrigo Company,ACETAMINOPHEN,160,mg/5mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-9458,HUMAN OTC DRUG,Good Sense all day allergy,,Cetirizine Hydrochloride,"TABLET, FILM COATED",ORAL,20080116,,ANDA,ANDA078336,L. Perrigo Company,CETIRIZINE HYDROCHLORIDE,10,mg/1,"Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0113-9755,HUMAN OTC DRUG,good sense allergy relief,,loratadine,"TABLET, ORALLY DISINTEGRATING",ORAL,20200911,,ANDA,ANDA076011,L. Perrigo Company,LORATADINE,10,mg/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1010,HUMAN PRESCRIPTION DRUG,Baclofen,,Baclofen,TABLET,ORAL,20071027,,ANDA,ANDA077971,Amneal Pharmaceuticals of New York LLC,BACLOFEN,10,mg/1,"GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1011,HUMAN PRESCRIPTION DRUG,Baclofen,,Baclofen,TABLET,ORAL,20210601,,ANDA,ANDA077971,Amneal Pharmaceuticals of New York LLC,BACLOFEN,5,mg/1,"GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1012,HUMAN PRESCRIPTION DRUG,Baclofen,,Baclofen,TABLET,ORAL,20071027,,ANDA,ANDA077971,Amneal Pharmaceuticals of New York LLC,BACLOFEN,20,mg/1,"GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1070,HUMAN PRESCRIPTION DRUG,Dipyridamole,,DIPYRIDAMOLE,TABLET,ORAL,20210830,,ANDA,ANDA040782,Amneal Pharmaceuticals of New York LLC,DIPYRIDAMOLE,25,mg/1,"Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1071,HUMAN PRESCRIPTION DRUG,Dipyridamole,,DIPYRIDAMOLE,TABLET,ORAL,20210830,,ANDA,ANDA040782,Amneal Pharmaceuticals of New York LLC,DIPYRIDAMOLE,50,mg/1,"Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1072,HUMAN PRESCRIPTION DRUG,Dipyridamole,,DIPYRIDAMOLE,TABLET,ORAL,20210830,,ANDA,ANDA040782,Amneal Pharmaceuticals of New York LLC,DIPYRIDAMOLE,75,mg/1,"Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1231,HUMAN PRESCRIPTION DRUG,Oxymorphone hydrochloride,,Oxymorphone hydrochloride,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,20130102,,ANDA,ANDA079087,Amneal Pharmaceuticals of New York LLC,OXYMORPHONE HYDROCHLORIDE,5,mg/1,"Full Opioid Agonists [MoA], Opioid Agonist [EPC]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1232,HUMAN PRESCRIPTION DRUG,Oxymorphone hydrochloride,,Oxymorphone hydrochloride,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,20130102,,ANDA,ANDA079087,Amneal Pharmaceuticals of New York LLC,OXYMORPHONE HYDROCHLORIDE,10,mg/1,"Full Opioid Agonists [MoA], Opioid Agonist [EPC]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1233,HUMAN PRESCRIPTION DRUG,Oxymorphone hydrochloride,,Oxymorphone hydrochloride,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,20130102,,ANDA,ANDA079087,Amneal Pharmaceuticals of New York LLC,OXYMORPHONE HYDROCHLORIDE,20,mg/1,"Full Opioid Agonists [MoA], Opioid Agonist [EPC]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1234,HUMAN PRESCRIPTION DRUG,Oxymorphone hydrochloride,,Oxymorphone hydrochloride,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,20130102,,ANDA,ANDA079087,Amneal Pharmaceuticals of New York LLC,OXYMORPHONE HYDROCHLORIDE,40,mg/1,"Full Opioid Agonists [MoA], Opioid Agonist [EPC]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1248,HUMAN PRESCRIPTION DRUG,Carvedilol Phosphate,,CARVEDILOL PHOSPHATE,"CAPSULE, EXTENDED RELEASE",ORAL,20240101,,ANDA,ANDA204717,Amneal Pharmaceuticals of New York LLC,CARVEDILOL PHOSPHATE,10,mg/1,"Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1249,HUMAN PRESCRIPTION DRUG,Carvedilol Phosphate,,CARVEDILOL PHOSPHATE,"CAPSULE, EXTENDED RELEASE",ORAL,20240101,,ANDA,ANDA204717,Amneal Pharmaceuticals of New York LLC,CARVEDILOL PHOSPHATE,20,mg/1,"Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1250,HUMAN PRESCRIPTION DRUG,Carvedilol Phosphate,,CARVEDILOL PHOSPHATE,"CAPSULE, EXTENDED RELEASE",ORAL,20240101,,ANDA,ANDA204717,Amneal Pharmaceuticals of New York LLC,CARVEDILOL PHOSPHATE,40,mg/1,"Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1251,HUMAN PRESCRIPTION DRUG,Carvedilol Phosphate,,CARVEDILOL PHOSPHATE,"CAPSULE, EXTENDED RELEASE",ORAL,20240101,,ANDA,ANDA204717,Amneal Pharmaceuticals of New York LLC,CARVEDILOL PHOSPHATE,80,mg/1,"Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1277,HUMAN PRESCRIPTION DRUG,Morphine Sulfate,,MORPHINE SULFATE,"CAPSULE, EXTENDED RELEASE",ORAL,20160412,,ANDA,ANDA200411,Amneal Pharmaceuticals of New York LLC,MORPHINE SULFATE,20,mg/1,"Full Opioid Agonists [MoA], Opioid Agonist [EPC]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1278,HUMAN PRESCRIPTION DRUG,Morphine Sulfate,,MORPHINE SULFATE,"CAPSULE, EXTENDED RELEASE",ORAL,20160412,,ANDA,ANDA200411,Amneal Pharmaceuticals of New York LLC,MORPHINE SULFATE,30,mg/1,"Full Opioid Agonists [MoA], Opioid Agonist [EPC]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1279,HUMAN PRESCRIPTION DRUG,Morphine Sulfate,,MORPHINE SULFATE,"CAPSULE, EXTENDED RELEASE",ORAL,20160412,,ANDA,ANDA200411,Amneal Pharmaceuticals of New York LLC,MORPHINE SULFATE,50,mg/1,"Full Opioid Agonists [MoA], Opioid Agonist [EPC]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1280,HUMAN PRESCRIPTION DRUG,Morphine Sulfate,,MORPHINE SULFATE,"CAPSULE, EXTENDED RELEASE",ORAL,20160412,,ANDA,ANDA200411,Amneal Pharmaceuticals of New York LLC,MORPHINE SULFATE,60,mg/1,"Full Opioid Agonists [MoA], Opioid Agonist [EPC]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1281,HUMAN PRESCRIPTION DRUG,Morphine Sulfate,,MORPHINE SULFATE,"CAPSULE, EXTENDED RELEASE",ORAL,20160412,,ANDA,ANDA200411,Amneal Pharmaceuticals of New York LLC,MORPHINE SULFATE,80,mg/1,"Full Opioid Agonists [MoA], Opioid Agonist [EPC]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1282,HUMAN PRESCRIPTION DRUG,Morphine Sulfate,,MORPHINE SULFATE,"CAPSULE, EXTENDED RELEASE",ORAL,20160412,,ANDA,ANDA200411,Amneal Pharmaceuticals of New York LLC,MORPHINE SULFATE,100,mg/1,"Full Opioid Agonists [MoA], Opioid Agonist [EPC]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1315,HUMAN PRESCRIPTION DRUG,Oxymorphone hydrochloride,,Oxymorphone hydrochloride,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,20130102,,ANDA,ANDA079087,Amneal Pharmaceuticals of New York LLC,OXYMORPHONE HYDROCHLORIDE,7.5,mg/1,"Full Opioid Agonists [MoA], Opioid Agonist [EPC]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1316,HUMAN PRESCRIPTION DRUG,Oxymorphone hydrochloride,,Oxymorphone hydrochloride,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,20130102,,ANDA,ANDA079087,Amneal Pharmaceuticals of New York LLC,OXYMORPHONE HYDROCHLORIDE,15,mg/1,"Full Opioid Agonists [MoA], Opioid Agonist [EPC]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1317,HUMAN PRESCRIPTION DRUG,Oxymorphone hydrochloride,,Oxymorphone hydrochloride,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,20130102,,ANDA,ANDA079087,Amneal Pharmaceuticals of New York LLC,OXYMORPHONE HYDROCHLORIDE,30,mg/1,"Full Opioid Agonists [MoA], Opioid Agonist [EPC]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1320,HUMAN PRESCRIPTION DRUG,Colesevelam Hydrochloride,,COLESEVELAM HYDROCHLORIDE,"TABLET, COATED",ORAL,20180517,,ANDA,ANDA091600,Amneal Pharmaceuticals of New York LLC,COLESEVELAM HYDROCHLORIDE,625,mg/1,"Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1324,HUMAN PRESCRIPTION DRUG,Fenofibric Acid,,FENOFIBRIC ACID,"CAPSULE, DELAYED RELEASE",ORAL,20240601,,ANDA,ANDA200264,Amneal Pharmaceuticals of New York LLC,FENOFIBRIC ACID,45,mg/1,Peroxisome Proliferator Receptor alpha Agonist [EPC],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1325,HUMAN PRESCRIPTION DRUG,Fenofibric Acid,,FENOFIBRIC ACID,"CAPSULE, DELAYED RELEASE",ORAL,20240601,,ANDA,ANDA200264,Amneal Pharmaceuticals of New York LLC,FENOFIBRIC ACID,135,mg/1,Peroxisome Proliferator Receptor alpha Agonist [EPC],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1365,HUMAN PRESCRIPTION DRUG,sevelamer carbonate,,sevelamer carbonate,"POWDER, FOR SUSPENSION",ORAL,20201120,,ANDA,ANDA211316,Amneal Pharmaceuticals of New York LLC,SEVELAMER CARBONATE,800,mg/1,"Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1366,HUMAN PRESCRIPTION DRUG,sevelamer carbonate,,sevelamer carbonate,"POWDER, FOR SUSPENSION",ORAL,20201120,,ANDA,ANDA211316,Amneal Pharmaceuticals of New York LLC,SEVELAMER CARBONATE,2400,mg/1,"Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1408,HUMAN PRESCRIPTION DRUG,MethylTESTOSTERone,,METHYLTESTOSTERONE,CAPSULE,ORAL,20150921,,ANDA,ANDA204851,Amneal Pharmaceuticals of New York LLC,METHYLTESTOSTERONE,10,mg/1,"Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]",CIII,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1436,HUMAN PRESCRIPTION DRUG,Cyclobenzaprine Hydrochloride,,Cyclobenzaprine Hydrochloride,"CAPSULE, EXTENDED RELEASE",ORAL,20190301,,NDA AUTHORIZED GENERIC,NDA021777,Amneal Pharmaceuticals of New York LLC,CYCLOBENZAPRINE HYDROCHLORIDE,15,mg/1,"Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1437,HUMAN PRESCRIPTION DRUG,Cyclobenzaprine Hydrochloride,,Cyclobenzaprine Hydrochloride,"CAPSULE, EXTENDED RELEASE",ORAL,20190301,,NDA AUTHORIZED GENERIC,NDA021777,Amneal Pharmaceuticals of New York LLC,CYCLOBENZAPRINE HYDROCHLORIDE,30,mg/1,"Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1479,HUMAN PRESCRIPTION DRUG,Morphine Sulfate,,MORPHINE SULFATE,"CAPSULE, EXTENDED RELEASE",ORAL,20181005,,ANDA,ANDA200411,Amneal Pharmaceuticals of New York LLC,MORPHINE SULFATE,40,mg/1,"Full Opioid Agonists [MoA], Opioid Agonist [EPC]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1483,HUMAN PRESCRIPTION DRUG,Diclofenac Sodium,,Diclofenac Sodium,GEL,TOPICAL,20131121,,ANDA,ANDA200936,Amneal Pharmaceuticals of New York LLC,DICLOFENAC SODIUM,30,mg/g,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0115-1486,HUMAN PRESCRIPTION DRUG,"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate",,"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate",CAPSULE,ORAL,20160216,,ANDA,ANDA076852,Amneal Pharmaceuticals of New York LLC,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,1.25; 1.25; 1.25; 1.25,mg/1; mg/1; mg/1; mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1487,HUMAN PRESCRIPTION DRUG,"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate",,"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate",CAPSULE,ORAL,20160216,,ANDA,ANDA076852,Amneal Pharmaceuticals of New York LLC,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,2.5; 2.5; 2.5; 2.5,mg/1; mg/1; mg/1; mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1488,HUMAN PRESCRIPTION DRUG,"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate",,"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate",CAPSULE,ORAL,20160216,,ANDA,ANDA076852,Amneal Pharmaceuticals of New York LLC,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,3.75; 3.75; 3.75; 3.75,mg/1; mg/1; mg/1; mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1489,HUMAN PRESCRIPTION DRUG,"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate",,"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate",CAPSULE,ORAL,20160216,,ANDA,ANDA076852,Amneal Pharmaceuticals of New York LLC,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,5; 5; 5; 5,mg/1; mg/1; mg/1; mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1490,HUMAN PRESCRIPTION DRUG,"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate",,"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate",CAPSULE,ORAL,20160216,,ANDA,ANDA076852,Amneal Pharmaceuticals of New York LLC,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,6.25; 6.25; 6.25; 6.25,mg/1; mg/1; mg/1; mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1491,HUMAN PRESCRIPTION DRUG,"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate",,"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate",CAPSULE,ORAL,20160216,,ANDA,ANDA076852,Amneal Pharmaceuticals of New York LLC,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,7.5; 7.5; 7.5; 7.5,mg/1; mg/1; mg/1; mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1522,HUMAN PRESCRIPTION DRUG,Fenofibrate,,Fenofibrate,TABLET,ORAL,20150624,20250831,NDA AUTHORIZED GENERIC,NDA022118,Amneal Pharmaceuticals of New York LLC,FENOFIBRATE,40,mg/1,Peroxisome Proliferator Receptor alpha Agonist [EPC],,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1523,HUMAN PRESCRIPTION DRUG,Fenofibrate,,Fenofibrate,TABLET,ORAL,20150624,20250831,NDA AUTHORIZED GENERIC,NDA022118,Amneal Pharmaceuticals of New York LLC,FENOFIBRATE,120,mg/1,Peroxisome Proliferator Receptor alpha Agonist [EPC],,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1526,HUMAN PRESCRIPTION DRUG,Lamotrigine,,LAMOTRIGINE,"TABLET, ORALLY DISINTEGRATING",ORAL,20150109,,ANDA,ANDA200828,Amneal Pharmaceuticals of New York LLC,LAMOTRIGINE,25,mg/1,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1527,HUMAN PRESCRIPTION DRUG,Lamotrigine,,LAMOTRIGINE,"TABLET, ORALLY DISINTEGRATING",ORAL,20150109,,ANDA,ANDA200828,Amneal Pharmaceuticals of New York LLC,LAMOTRIGINE,50,mg/1,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1528,HUMAN PRESCRIPTION DRUG,Lamotrigine,,LAMOTRIGINE,"TABLET, ORALLY DISINTEGRATING",ORAL,20150109,,ANDA,ANDA200828,Amneal Pharmaceuticals of New York LLC,LAMOTRIGINE,100,mg/1,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1529,HUMAN PRESCRIPTION DRUG,Lamotrigine,,LAMOTRIGINE,"TABLET, ORALLY DISINTEGRATING",ORAL,20150109,,ANDA,ANDA200828,Amneal Pharmaceuticals of New York LLC,LAMOTRIGINE,200,mg/1,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1554,HUMAN PRESCRIPTION DRUG,Fenofibric Acid,,Fenofibric Acid,"CAPSULE, DELAYED RELEASE",ORAL,20160912,,NDA AUTHORIZED GENERIC,NDA022224,Amneal Pharmaceuticals of New York LLC,FENOFIBRIC ACID,45,mg/1,Peroxisome Proliferator Receptor alpha Agonist [EPC],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1555,HUMAN PRESCRIPTION DRUG,Fenofibric Acid,,Fenofibric Acid,"CAPSULE, DELAYED RELEASE",ORAL,20160912,,NDA AUTHORIZED GENERIC,NDA022224,Amneal Pharmaceuticals of New York LLC,FENOFIBRIC ACID,135,mg/1,Peroxisome Proliferator Receptor alpha Agonist [EPC],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1643,HUMAN PRESCRIPTION DRUG,Nitrofurantoin Macrocrystals,,Nitrofurantoin Macrocrystals,CAPSULE,ORAL,20070308,,ANDA,ANDA073671,Amneal Pharmaceuticals of New York LLC,NITROFURANTOIN,50,mg/1,"Nitrofuran Antibacterial [EPC], Nitrofurans [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1645,HUMAN PRESCRIPTION DRUG,Nitrofurantoin Macrocrystals,,Nitrofurantoin Macrocrystals,CAPSULE,ORAL,20070308,,ANDA,ANDA073652,Amneal Pharmaceuticals of New York LLC,NITROFURANTOIN,100,mg/1,"Nitrofuran Antibacterial [EPC], Nitrofurans [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1659,HUMAN PRESCRIPTION DRUG,Propranolol Hydrochloride,,Propranolol Hydrochloride,TABLET,ORAL,20160919,,ANDA,ANDA070175,Amneal Pharmaceuticals of New York LLC,PROPRANOLOL HYDROCHLORIDE,10,mg/1,"Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1660,HUMAN PRESCRIPTION DRUG,Propranolol Hydrochloride,,Propranolol Hydrochloride,TABLET,ORAL,20160919,,ANDA,ANDA070176,Amneal Pharmaceuticals of New York LLC,PROPRANOLOL HYDROCHLORIDE,20,mg/1,"Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1661,HUMAN PRESCRIPTION DRUG,Propranolol Hydrochloride,,Propranolol Hydrochloride,TABLET,ORAL,20160919,,ANDA,ANDA070177,Amneal Pharmaceuticals of New York LLC,PROPRANOLOL HYDROCHLORIDE,40,mg/1,"Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1662,HUMAN PRESCRIPTION DRUG,Propranolol Hydrochloride,,Propranolol Hydrochloride,TABLET,ORAL,20160919,,ANDA,ANDA070178,Amneal Pharmaceuticals of New York LLC,PROPRANOLOL HYDROCHLORIDE,80,mg/1,"Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1676,HUMAN PRESCRIPTION DRUG,Alendronate Sodium,,Alendronate Sodium,TABLET,ORAL,20080206,,ANDA,ANDA075710,Amneal Pharmaceuticals of New York LLC,ALENDRONATE SODIUM,5,mg/1,"Bisphosphonate [EPC], Diphosphonates [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1678,HUMAN PRESCRIPTION DRUG,Alendronate Sodium,,Alendronate Sodium,TABLET,ORAL,20080206,,ANDA,ANDA075710,Amneal Pharmaceuticals of New York LLC,ALENDRONATE SODIUM,10,mg/1,"Bisphosphonate [EPC], Diphosphonates [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1679,HUMAN PRESCRIPTION DRUG,Alendronate Sodium,,Alendronate Sodium,TABLET,ORAL,20080206,,ANDA,ANDA075710,Amneal Pharmaceuticals of New York LLC,ALENDRONATE SODIUM,35,mg/1,"Bisphosphonate [EPC], Diphosphonates [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1680,HUMAN PRESCRIPTION DRUG,Alendronate Sodium,,Alendronate Sodium,TABLET,ORAL,20080206,,ANDA,ANDA075710,Amneal Pharmaceuticals of New York LLC,ALENDRONATE SODIUM,40,mg/1,"Bisphosphonate [EPC], Diphosphonates [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1681,HUMAN PRESCRIPTION DRUG,Alendronate Sodium,,Alendronate Sodium,TABLET,ORAL,20080206,,ANDA,ANDA075710,Amneal Pharmaceuticals of New York LLC,ALENDRONATE SODIUM,70,mg/1,"Bisphosphonate [EPC], Diphosphonates [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1682,HUMAN PRESCRIPTION DRUG,Dexmethylphenidate hydrochloride,,Dexmethylphenidate hydrochloride,"CAPSULE, EXTENDED RELEASE",ORAL,20150806,,ANDA,ANDA079108,Amneal Pharmaceuticals of New York LLC,DEXMETHYLPHENIDATE HYDROCHLORIDE,5,mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1683,HUMAN PRESCRIPTION DRUG,Dexmethylphenidate hydrochloride,,Dexmethylphenidate hydrochloride,"CAPSULE, EXTENDED RELEASE",ORAL,20150806,,ANDA,ANDA079108,Amneal Pharmaceuticals of New York LLC,DEXMETHYLPHENIDATE HYDROCHLORIDE,10,mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1684,HUMAN PRESCRIPTION DRUG,Dexmethylphenidate hydrochloride,,Dexmethylphenidate hydrochloride,"CAPSULE, EXTENDED RELEASE",ORAL,20141111,,ANDA,ANDA079108,Amneal Pharmaceuticals of New York LLC,DEXMETHYLPHENIDATE HYDROCHLORIDE,15,mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1685,HUMAN PRESCRIPTION DRUG,Dexmethylphenidate hydrochloride,,Dexmethylphenidate hydrochloride,"CAPSULE, EXTENDED RELEASE",ORAL,20151221,,ANDA,ANDA079108,Amneal Pharmaceuticals of New York LLC,DEXMETHYLPHENIDATE HYDROCHLORIDE,20,mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1686,HUMAN PRESCRIPTION DRUG,Dexmethylphenidate hydrochloride,,Dexmethylphenidate hydrochloride,"CAPSULE, EXTENDED RELEASE",ORAL,20140224,,ANDA,ANDA079108,Amneal Pharmaceuticals of New York LLC,DEXMETHYLPHENIDATE HYDROCHLORIDE,30,mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1687,HUMAN PRESCRIPTION DRUG,Budesonide Inhalation,,Budesonide,SUSPENSION,RESPIRATORY (INHALATION),20160804,,ANDA,ANDA078404,Amneal Pharmaceuticals of New York LLC,BUDESONIDE,0.25,mg/2mL,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1689,HUMAN PRESCRIPTION DRUG,Budesonide Inhalation,,Budesonide,SUSPENSION,RESPIRATORY (INHALATION),20160804,,ANDA,ANDA078404,Amneal Pharmaceuticals of New York LLC,BUDESONIDE,0.5,mg/2mL,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1694,HUMAN PRESCRIPTION DRUG,epinephrine,,epinephrine,INJECTION,SUBCUTANEOUS,20100401,,NDA AUTHORIZED GENERIC,NDA020800,Amneal Pharmaceuticals of New York LLC,EPINEPHRINE,0.3,mg/.3mL,"Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1695,HUMAN PRESCRIPTION DRUG,epinephrine,,epinephrine,INJECTION,SUBCUTANEOUS,20100401,,NDA AUTHORIZED GENERIC,NDA020800,Amneal Pharmaceuticals of New York LLC,EPINEPHRINE,0.15,mg/.15mL,"Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1696,HUMAN PRESCRIPTION DRUG,HYDROCORTISONE,,hydrocortisone,TABLET,ORAL,20070330,,ANDA,ANDA040646,Amneal Pharmaceuticals of New York LLC,HYDROCORTISONE,5,mg/1,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1697,HUMAN PRESCRIPTION DRUG,HYDROCORTISONE,,hydrocortisone,TABLET,ORAL,20070330,,ANDA,ANDA040646,Amneal Pharmaceuticals of New York LLC,HYDROCORTISONE,10,mg/1,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1700,HUMAN PRESCRIPTION DRUG,HYDROCORTISONE,,hydrocortisone,TABLET,ORAL,20070330,,ANDA,ANDA040646,Amneal Pharmaceuticals of New York LLC,HYDROCORTISONE,20,mg/1,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1701,HUMAN PRESCRIPTION DRUG,Albendazole,,albendazole,"TABLET, FILM COATED",ORAL,19960611,,NDA,NDA020666,Amneal Pharmaceuticals of New York LLC,ALBENDAZOLE,200,mg/1,"Anthelmintic [EPC], Cytochrome P450 1A Inducers [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1709,HUMAN PRESCRIPTION DRUG,Dexmethylphenidate hydrochloride,,Dexmethylphenidate hydrochloride,"CAPSULE, EXTENDED RELEASE",ORAL,20170705,,ANDA,ANDA203614,Amneal Pharmaceuticals of New York LLC,DEXMETHYLPHENIDATE HYDROCHLORIDE,25,mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1710,HUMAN PRESCRIPTION DRUG,Dexmethylphenidate hydrochloride,,Dexmethylphenidate hydrochloride,"CAPSULE, EXTENDED RELEASE",ORAL,20170705,,ANDA,ANDA203614,Amneal Pharmaceuticals of New York LLC,DEXMETHYLPHENIDATE HYDROCHLORIDE,35,mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1721,HUMAN PRESCRIPTION DRUG,Apixaban,,Apixaban,"TABLET, FILM COATED",ORAL,20180831,,ANDA,ANDA209810,Amneal Pharmaceuticals of New York LLC,APIXABAN,2.5,mg/1,"Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1722,HUMAN PRESCRIPTION DRUG,Apixaban,,Apixaban,"TABLET, FILM COATED",ORAL,20180831,,ANDA,ANDA209810,Amneal Pharmaceuticals of New York LLC,APIXABAN,5,mg/1,"Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1724,HUMAN PRESCRIPTION DRUG,Ultramicrosize Griseofulvin,,Ultramicrosize Griseofulvin Tablets,"TABLET, COATED",ORAL,20140929,,ANDA,ANDA204371,Amneal Pharmaceuticals of New York LLC,GRISEOFULVIN,125,mg/1,"Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1725,HUMAN PRESCRIPTION DRUG,Ultramicrosize Griseofulvin,,Ultramicrosize Griseofulvin Tablets,"TABLET, COATED",ORAL,20140929,,ANDA,ANDA204371,Amneal Pharmaceuticals of New York LLC,GRISEOFULVIN,250,mg/1,"Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1736,HUMAN PRESCRIPTION DRUG,Methylphenidate Hydrochloride,,Methylphenidate Hydrochloride,"CAPSULE, EXTENDED RELEASE",ORAL,20160920,,ANDA,ANDA205105,Amneal Pharmaceuticals of New York LLC,METHYLPHENIDATE HYDROCHLORIDE,10,mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1737,HUMAN PRESCRIPTION DRUG,Methylphenidate Hydrochloride,,Methylphenidate Hydrochloride,"CAPSULE, EXTENDED RELEASE",ORAL,20160920,,ANDA,ANDA205105,Amneal Pharmaceuticals of New York LLC,METHYLPHENIDATE HYDROCHLORIDE,20,mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1738,HUMAN PRESCRIPTION DRUG,Methylphenidate Hydrochloride,,Methylphenidate Hydrochloride,"CAPSULE, EXTENDED RELEASE",ORAL,20160920,,ANDA,ANDA205105,Amneal Pharmaceuticals of New York LLC,METHYLPHENIDATE HYDROCHLORIDE,30,mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1739,HUMAN PRESCRIPTION DRUG,Methylphenidate Hydrochloride,,Methylphenidate Hydrochloride,"CAPSULE, EXTENDED RELEASE",ORAL,20160920,,ANDA,ANDA205105,Amneal Pharmaceuticals of New York LLC,METHYLPHENIDATE HYDROCHLORIDE,40,mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1740,HUMAN PRESCRIPTION DRUG,Methylphenidate Hydrochloride,,Methylphenidate Hydrochloride,"CAPSULE, EXTENDED RELEASE",ORAL,20160920,,ANDA,ANDA205105,Amneal Pharmaceuticals of New York LLC,METHYLPHENIDATE HYDROCHLORIDE,50,mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1741,HUMAN PRESCRIPTION DRUG,Methylphenidate Hydrochloride,,Methylphenidate Hydrochloride,"CAPSULE, EXTENDED RELEASE",ORAL,20160920,,ANDA,ANDA205105,Amneal Pharmaceuticals of New York LLC,METHYLPHENIDATE HYDROCHLORIDE,60,mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1745,HUMAN PRESCRIPTION DRUG,Metaxalone,,Metaxalone,TABLET,ORAL,20160526,,ANDA,ANDA040486,Amneal Pharmaceuticals of New York LLC,METAXALONE,400,mg/1,"Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1750,HUMAN PRESCRIPTION DRUG,Acitretin,,Acitretin,CAPSULE,ORAL,20160104,,ANDA,ANDA202552,Amneal Pharmaceuticals of New York LLC,ACITRETIN,10,mg/1,"Retinoid [EPC], Retinoids [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1751,HUMAN PRESCRIPTION DRUG,Acitretin,,Acitretin,CAPSULE,ORAL,20160104,,ANDA,ANDA202552,Amneal Pharmaceuticals of New York LLC,ACITRETIN,17.5,mg/1,"Retinoid [EPC], Retinoids [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1752,HUMAN PRESCRIPTION DRUG,Acitretin,,Acitretin,CAPSULE,ORAL,20160104,,ANDA,ANDA202552,Amneal Pharmaceuticals of New York LLC,ACITRETIN,22.5,mg/1,"Retinoid [EPC], Retinoids [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1753,HUMAN PRESCRIPTION DRUG,Acitretin,,Acitretin,CAPSULE,ORAL,20160104,,ANDA,ANDA202552,Amneal Pharmaceuticals of New York LLC,ACITRETIN,25,mg/1,"Retinoid [EPC], Retinoids [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1757,HUMAN PRESCRIPTION DRUG,Cyproheptadine Hydrochloride,,Cyproheptadine Hydrochloride,TABLET,ORAL,20150729,,ANDA,ANDA040537,Amneal Pharmaceuticals of New York LLC,CYPROHEPTADINE HYDROCHLORIDE,4,mg/1,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1800,HUMAN PRESCRIPTION DRUG,METHYLPHENIDATE HYDROCHLORIDE,,METHYLPHENIDATE HYDROCHLORIDE,TABLET,ORAL,20140407,,ANDA,ANDA091159,Amneal Pharmaceuticals of New York LLC,METHYLPHENIDATE HYDROCHLORIDE,5,mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]",CII,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1801,HUMAN PRESCRIPTION DRUG,METHYLPHENIDATE HYDROCHLORIDE,,METHYLPHENIDATE HYDROCHLORIDE,TABLET,ORAL,20140407,,ANDA,ANDA091159,Amneal Pharmaceuticals of New York LLC,METHYLPHENIDATE HYDROCHLORIDE,10,mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]",CII,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1802,HUMAN PRESCRIPTION DRUG,METHYLPHENIDATE HYDROCHLORIDE,,METHYLPHENIDATE HYDROCHLORIDE,TABLET,ORAL,20140407,,ANDA,ANDA091159,Amneal Pharmaceuticals of New York LLC,METHYLPHENIDATE HYDROCHLORIDE,20,mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]",CII,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1803,HUMAN PRESCRIPTION DRUG,Hydroxyzine Pamoate,,Hydroxyzine Pamoate,CAPSULE,ORAL,19960715,,ANDA,ANDA040156,Amneal Pharmaceuticals of New York LLC,HYDROXYZINE PAMOATE,25,mg/1,"Antihistamine [EPC], Histamine Receptor Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1804,HUMAN PRESCRIPTION DRUG,Hydroxyzine Pamoate,,Hydroxyzine Pamoate,CAPSULE,ORAL,19960615,,ANDA,ANDA040156,Amneal Pharmaceuticals of New York LLC,HYDROXYZINE PAMOATE,50,mg/1,"Antihistamine [EPC], Histamine Receptor Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1864,HUMAN PRESCRIPTION DRUG,Colesevelam hydrochloride,,Colesevelam hydrochloride,FOR SUSPENSION,ORAL,20230120,,ANDA,ANDA212886,Amneal Pharmaceuticals of New York LLC,COLESEVELAM HYDROCHLORIDE,3.75,g/1,"Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-1911,HUMAN PRESCRIPTION DRUG,Rimantadine Hydrochloride,,Rimantadine Hydrochloride,"TABLET, FILM COATED",ORAL,20211116,,ANDA,ANDA076132,Amneal Pharmaceuticals of New York LLC,RIMANTADINE HYDROCHLORIDE,100,mg/1,"Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-2134,HUMAN PRESCRIPTION DRUG,Pyridostigmine Bromide,,PYRIDOSTIGMINE BROMIDE,TABLET,ORAL,20220808,,ANDA,ANDA040502,Amneal Pharmaceuticals of New York LLC,PYRIDOSTIGMINE BROMIDE,30,mg/1,"Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-2611,HUMAN PRESCRIPTION DRUG,TERBUTALINE SULFATE,,TERBUTALINE SULFATE,TABLET,ORAL,20010626,,ANDA,ANDA075877,Amneal Pharmaceuticals of New York LLC,TERBUTALINE SULFATE,2.5,mg/1,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-2622,HUMAN PRESCRIPTION DRUG,TERBUTALINE SULFATE,,TERBUTALINE SULFATE,TABLET,ORAL,20010626,,ANDA,ANDA075877,Amneal Pharmaceuticals of New York LLC,TERBUTALINE SULFATE,5,mg/1,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-2790,HUMAN PRESCRIPTION DRUG,Chloroquine Phosphate,,CHLOROQUINE PHOSPHATE,TABLET,ORAL,20220510,,ANDA,ANDA080880,Amneal Pharmaceuticals of New York LLC,CHLOROQUINE PHOSPHATE,250,mg/1,Antimalarial [EPC],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-3511,HUMAN PRESCRIPTION DRUG,Pyridostigmine Bromide,,PYRIDOSTIGMINE BROMIDE,TABLET,ORAL,20030424,,ANDA,ANDA040502,Amneal Pharmaceuticals of New York LLC,PYRIDOSTIGMINE BROMIDE,60,mg/1,"Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-4411,HUMAN PRESCRIPTION DRUG,Dantrolene Sodium,,Dantrolene Sodium,CAPSULE,ORAL,20050301,,ANDA,ANDA076856,Amneal Pharmaceuticals of New York LLC,DANTROLENE SODIUM,25,mg/1,"Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-4422,HUMAN PRESCRIPTION DRUG,Dantrolene Sodium,,Dantrolene Sodium,CAPSULE,ORAL,20050301,,ANDA,ANDA076856,Amneal Pharmaceuticals of New York LLC,DANTROLENE SODIUM,50,mg/1,"Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-4433,HUMAN PRESCRIPTION DRUG,Dantrolene Sodium,,Dantrolene Sodium,CAPSULE,ORAL,20050301,,ANDA,ANDA076856,Amneal Pharmaceuticals of New York LLC,DANTROLENE SODIUM,100,mg/1,"Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-5211,HUMAN PRESCRIPTION DRUG,COLESTIPOL HYDROCHLORIDE,,COLESTIPOL HYDROCHLORIDE,"TABLET, FILM COATED",ORAL,20210817,,ANDA,ANDA077510,Amneal Pharmaceuticals of New York LLC,COLESTIPOL HYDROCHLORIDE,1,g/1,"Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-5212,HUMAN PRESCRIPTION DRUG,COLESTIPOL HYDROCHLORIDE,,COLESTIPOL HYDROCHLORIDE,SUSPENSION,ORAL,20060502,,ANDA,ANDA077277,Amneal Pharmaceuticals of New York LLC,COLESTIPOL HYDROCHLORIDE,5,g/1,"Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-5213,HUMAN PRESCRIPTION DRUG,COLESTIPOL HYDROCHLORIDE,,COLESTIPOL HYDROCHLORIDE,SUSPENSION,ORAL,20060502,,ANDA,ANDA077277,Amneal Pharmaceuticals of New York LLC,COLESTIPOL HYDROCHLORIDE,5,g/1,"Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-5445,HUMAN PRESCRIPTION DRUG,Bupropion Hydrochloride,,BUPROPION HYDROCHLORIDE,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,20041203,,ANDA,ANDA076711,Amneal Pharmaceuticals of New York LLC,BUPROPION HYDROCHLORIDE,200,mg/1,"Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-5511,HUMAN PRESCRIPTION DRUG,FENOFIBRATE,,FENOFIBRATE,TABLET,ORAL,20100201,,ANDA,ANDA076509,Amneal Pharmaceuticals of New York LLC,FENOFIBRATE,54,mg/1,Peroxisome Proliferator Receptor alpha Agonist [EPC],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-5522,HUMAN PRESCRIPTION DRUG,FENOFIBRATE,,FENOFIBRATE,TABLET,ORAL,20100201,,ANDA,ANDA076509,Amneal Pharmaceuticals of New York LLC,FENOFIBRATE,160,mg/1,Peroxisome Proliferator Receptor alpha Agonist [EPC],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-6811,HUMAN PRESCRIPTION DRUG,Bupropion Hydrochloride,,BUPROPION HYDROCHLORIDE,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,20090501,,ANDA,ANDA077415,Amneal Pharmaceuticals of New York LLC,BUPROPION HYDROCHLORIDE,150,mg/1,"Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-7010,HUMAN PRESCRIPTION DRUG,Chloroquine Phosphate,,CHLOROQUINE PHOSPHATE,TABLET,ORAL,20220510,,ANDA,ANDA040516,Amneal Pharmaceuticals of New York LLC,CHLOROQUINE PHOSPHATE,500,mg/1,Antimalarial [EPC],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-7033,HUMAN PRESCRIPTION DRUG,Fludrocortisone Acetate,,FLUDROCORTISONE ACETATE,TABLET,ORAL,20020318,,ANDA,ANDA040431,Amneal Pharmaceuticals of New York LLC,FLUDROCORTISONE ACETATE,0.1,mg/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-7037,HUMAN PRESCRIPTION DRUG,METHITEST,,METHYLTESTOSTERONE,TABLET,ORAL,19741017,,ANDA,ANDA080767,Amneal Pharmaceuticals of New York LLC,METHYLTESTOSTERONE,10,mg/1,"Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]",CIII,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-8211,HUMAN PRESCRIPTION DRUG,Tamsulosin Hydrochloride,,TAMSULOSIN HYDROCHLORIDE,CAPSULE,ORAL,20250401,,ANDA,ANDA090377,Amneal Pharmaceuticals of New York LLC,TAMSULOSIN HYDROCHLORIDE,0.4,mg/1,"Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-9811,HUMAN PRESCRIPTION DRUG,Digoxin,,DIGOXIN,TABLET,ORAL,20090720,,ANDA,ANDA078556,Amneal Pharmaceuticals of New York LLC,DIGOXIN,125,ug/1,"Cardiac Glycoside [EPC], Cardiac Glycosides [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-9822,HUMAN PRESCRIPTION DRUG,Digoxin,,DIGOXIN,TABLET,ORAL,20090720,,ANDA,ANDA078556,Amneal Pharmaceuticals of New York LLC,DIGOXIN,250,ug/1,"Cardiac Glycoside [EPC], Cardiac Glycosides [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-9918,HUMAN PRESCRIPTION DRUG,Dexmethylphenidate hydrochloride,,Dexmethylphenidate hydrochloride,"CAPSULE, EXTENDED RELEASE",ORAL,20150806,,ANDA,ANDA079108,Amneal Pharmaceuticals of New York LLC,DEXMETHYLPHENIDATE HYDROCHLORIDE,5,mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-9919,HUMAN PRESCRIPTION DRUG,Dexmethylphenidate hydrochloride,,Dexmethylphenidate hydrochloride,"CAPSULE, EXTENDED RELEASE",ORAL,20150806,,ANDA,ANDA079108,Amneal Pharmaceuticals of New York LLC,DEXMETHYLPHENIDATE HYDROCHLORIDE,10,mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-9920,HUMAN PRESCRIPTION DRUG,Dexmethylphenidate hydrochloride,,Dexmethylphenidate hydrochloride,"CAPSULE, EXTENDED RELEASE",ORAL,20141111,,ANDA,ANDA079108,Amneal Pharmaceuticals of New York LLC,DEXMETHYLPHENIDATE HYDROCHLORIDE,15,mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-9921,HUMAN PRESCRIPTION DRUG,Dexmethylphenidate hydrochloride,,Dexmethylphenidate hydrochloride,"CAPSULE, EXTENDED RELEASE",ORAL,20151221,,ANDA,ANDA079108,Amneal Pharmaceuticals of New York LLC,DEXMETHYLPHENIDATE HYDROCHLORIDE,20,mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-9922,HUMAN PRESCRIPTION DRUG,Dexmethylphenidate hydrochloride,,Dexmethylphenidate hydrochloride,"CAPSULE, EXTENDED RELEASE",ORAL,20140224,,ANDA,ANDA079108,Amneal Pharmaceuticals of New York LLC,DEXMETHYLPHENIDATE HYDROCHLORIDE,30,mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-9927,HUMAN PRESCRIPTION DRUG,Dextroamphetamine Sulfate,Extended-Release,Dextroamphetamine Sulfate,"CAPSULE, EXTENDED RELEASE",ORAL,19760802,,NDA AUTHORIZED GENERIC,NDA017078,Amneal Pharmaceuticals of New York LLC,DEXTROAMPHETAMINE SULFATE,5,mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-9928,HUMAN PRESCRIPTION DRUG,Dextroamphetamine Sulfate,Extended-Release,Dextroamphetamine Sulfate,"CAPSULE, EXTENDED RELEASE",ORAL,19760802,,NDA AUTHORIZED GENERIC,NDA017078,Amneal Pharmaceuticals of New York LLC,DEXTROAMPHETAMINE SULFATE,10,mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-9929,HUMAN PRESCRIPTION DRUG,Dextroamphetamine Sulfate,Extended-Release,Dextroamphetamine Sulfate,"CAPSULE, EXTENDED RELEASE",ORAL,19760802,,NDA AUTHORIZED GENERIC,NDA017078,Amneal Pharmaceuticals of New York LLC,DEXTROAMPHETAMINE SULFATE,15,mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-9930,HUMAN PRESCRIPTION DRUG,Levalbuterol,,Levalbuterol Hydrochloride,SOLUTION,RESPIRATORY (INHALATION),20160322,,ANDA,ANDA203653,Amneal Pharmaceuticals of New York LLC,LEVALBUTEROL HYDROCHLORIDE,0.31,mg/3mL,"Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]",,N,20251231,J45.9,"[{""icd10_code"":""J45.9"",""description"":""Asthma, unspecified"",""confidence"":0.7,""context"":""asthma rescue""},{""icd10_code"":""J44.1"",""description"":""Chronic obstructive pulmonary disease with acute exacerbation"",""confidence"":0.2,""context"":""COPD exacerbation""},{""icd10_code"":""J44.0"",""description"":""Chronic obstructive pulmonary disease with acute lower respiratory infection"",""confidence"":0.1,""context"":""COPD with infection""}]",0.70
0115-9931,HUMAN PRESCRIPTION DRUG,Levalbuterol,,Levalbuterol Hydrochloride,SOLUTION,RESPIRATORY (INHALATION),20160322,,ANDA,ANDA203653,Amneal Pharmaceuticals of New York LLC,LEVALBUTEROL HYDROCHLORIDE,0.63,mg/3mL,"Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]",,N,20251231,J45.9,"[{""icd10_code"":""J45.9"",""description"":""Asthma, unspecified"",""confidence"":0.7,""context"":""asthma rescue""},{""icd10_code"":""J44.1"",""description"":""Chronic obstructive pulmonary disease with acute exacerbation"",""confidence"":0.2,""context"":""COPD exacerbation""},{""icd10_code"":""J44.0"",""description"":""Chronic obstructive pulmonary disease with acute lower respiratory infection"",""confidence"":0.1,""context"":""COPD with infection""}]",0.70
0115-9932,HUMAN PRESCRIPTION DRUG,Levalbuterol,,Levalbuterol Hydrochloride,SOLUTION,RESPIRATORY (INHALATION),20160322,,ANDA,ANDA203653,Amneal Pharmaceuticals of New York LLC,LEVALBUTEROL HYDROCHLORIDE,1.25,mg/3mL,"Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]",,N,20251231,J45.9,"[{""icd10_code"":""J45.9"",""description"":""Asthma, unspecified"",""confidence"":0.7,""context"":""asthma rescue""},{""icd10_code"":""J44.1"",""description"":""Chronic obstructive pulmonary disease with acute exacerbation"",""confidence"":0.2,""context"":""COPD exacerbation""},{""icd10_code"":""J44.0"",""description"":""Chronic obstructive pulmonary disease with acute lower respiratory infection"",""confidence"":0.1,""context"":""COPD with infection""}]",0.70
0115-9939,HUMAN PRESCRIPTION DRUG,Lamotrigine,,LAMOTRIGINE,"TABLET, ORALLY DISINTEGRATING",ORAL,20181227,,ANDA,ANDA200828,Amneal Pharmaceuticals of New York LLC,LAMOTRIGINE,25,mg/1,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-9940,HUMAN PRESCRIPTION DRUG,Lamotrigine,,LAMOTRIGINE,"TABLET, ORALLY DISINTEGRATING",ORAL,20181227,,ANDA,ANDA200828,Amneal Pharmaceuticals of New York LLC,LAMOTRIGINE,50,mg/1,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-9941,HUMAN PRESCRIPTION DRUG,Lamotrigine,,LAMOTRIGINE,"TABLET, ORALLY DISINTEGRATING",ORAL,20181227,,ANDA,ANDA200828,Amneal Pharmaceuticals of New York LLC,LAMOTRIGINE,100,mg/1,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0115-9942,HUMAN PRESCRIPTION DRUG,Lamotrigine,,LAMOTRIGINE,"TABLET, ORALLY DISINTEGRATING",ORAL,20181227,,ANDA,ANDA200828,Amneal Pharmaceuticals of New York LLC,LAMOTRIGINE,200,mg/1,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0116-0003,HUMAN PRESCRIPTION DRUG,Chlorhexidine Gluconate 0.12% Oral Rinse,,CHLORHEXIDINE GLUCONATE,LIQUID,BUCCAL,20140120,,ANDA,ANDA077789,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,1.2,[iU]/mL,Decreased Cell Wall Integrity [PE],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0116-0038,HUMAN OTC DRUG,Bactoshield CHG,,Chlorhexidine Gluconate 2%,SOLUTION,TOPICAL,20221116,,NDA,NDA019422,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,2,mg/100mL,Decreased Cell Wall Integrity [PE],,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-0039,HUMAN OTC DRUG,Bactoshield CHG,,Chlorhexidine Gluconate 4%,SOLUTION,TOPICAL,20221121,,NDA,NDA019125,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,2,mg/100mL,Decreased Cell Wall Integrity [PE],,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-0039,HUMAN OTC DRUG,Bactoshield CHG,,Chlorhexidine Gluconate 4%,SOLUTION,TOPICAL,20221122,,NDA,NDA019125,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,2,mg/100mL,Decreased Cell Wall Integrity [PE],,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-0061,HUMAN OTC DRUG,Cardinal Health,,CHLORHEXIDINE GLUCONATE 4%,LIQUID,TOPICAL,20150724,,NDA,NDA019125,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,4,g/100mL,Decreased Cell Wall Integrity [PE],,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-0101,HUMAN PRESCRIPTION DRUG,Chlorhexidine Gluconate,,Chlorhexidine Gluconate,LIQUID,ORAL,20160122,,ANDA,ANDA077789,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,0.12,mg/mL,Decreased Cell Wall Integrity [PE],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0116-0113,HUMAN OTC DRUG,Cardinal Health Antiseptic Skin Cleanser,,CHLORHEXIDINE GLUCONATE 2%,SOLUTION,TOPICAL,20150501,,NDA,NDA019422,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,2,g/100mL,Decreased Cell Wall Integrity [PE],,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-0115,HUMAN OTC DRUG,Antiseptic Skin Cleanser,,Chlorhexidine Gluconate 4%,LIQUID,TOPICAL,20140220,,NDA,NDA019125,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,4,mg/100mL,Decreased Cell Wall Integrity [PE],,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-0137,HUMAN OTC DRUG,Antiseptic Skin Cleanser,,Chlorhexidine Gluconate 4%,LIQUID,TOPICAL,20130401,,NDA,NDA019125,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,4,mg/100mL,Decreased Cell Wall Integrity [PE],,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-0150,HUMAN OTC DRUG,Betadine,,10% Povidone-iodine,LIQUID,TOPICAL,20241105,,OTC MONOGRAPH DRUG,M003,"Xttrium Laboratories, Inc.",POVIDONE-IODINE,10,mg/mL,,,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-0150,HUMAN OTC DRUG,Betadine,,10% Povidone-iodine,LIQUID,TOPICAL,20241106,,OTC MONOGRAPH DRUG,M003,"Xttrium Laboratories, Inc",POVIDONE-IODINE,10,mg/mL,,,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-0151,HUMAN OTC DRUG,Betadine,,Povidone-Iodine,LIQUID,TOPICAL,20241107,,OTC MONOGRAPH DRUG,M003,"Xttrium Laboratories, Inc.",POVIDONE-IODINE,0.075,mg/mL,,,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-0160,HUMAN OTC DRUG,Betadine,,Povidone-Iodine,LIQUID,TOPICAL,20241107,,OTC MONOGRAPH DRUG,M003,"Xttrium Laboratories, Inc.",POVIDONE-IODINE,5,mg/mL,,,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-0161,HUMAN OTC DRUG,Antiseptic Skin Cleanser,,Chlorhexidine Gluconate 4%,LIQUID,TOPICAL,20110501,,NDA,NDA019125,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,4,mg/100mL,Decreased Cell Wall Integrity [PE],,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-0162,HUMAN OTC DRUG,Antiseptic Skin Cleanser,,Chlorhexidine Gluconate 4%,LIQUID,TOPICAL,20140101,,NDA,NDA019125,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,4,mg/100mL,Decreased Cell Wall Integrity [PE],,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-0175,HUMAN PRESCRIPTION DRUG,Chlorhexidine Gluconate,,Chlorhexidine Gluconate,RINSE,ORAL,20090618,,ANDA,ANDA077789,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,1.2,mg/mL,Decreased Cell Wall Integrity [PE],,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0116-0181,HUMAN OTC DRUG,Betadine,,Povidone Iodine,LIQUID,ORAL,20241107,,OTC MONOGRAPH DRUG,M022,"Xttrium Laboratories, Inc.",POVIDONE-IODINE,0.05,mg/mL,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0116-0200,HUMAN PRESCRIPTION DRUG,BETASEPT,,Antiseptic Surgical Scrub,SOLUTION,TOPICAL,19930601,,NDA,NDA019125,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,0.04,mg/mL,Decreased Cell Wall Integrity [PE],,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-0228,HUMAN OTC DRUG,Antiseptic Skin Cleanser,,Chlorhexidine Gluconate 4%,LIQUID,TOPICAL,20121030,,NDA,NDA019125,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,4,mg/100mL,Decreased Cell Wall Integrity [PE],,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-0237,HUMAN OTC DRUG,Antiseptic Skin Cleanser,,Chlorhexidine Gluconate 4%,LIQUID,TOPICAL,20140220,,NDA,NDA019125,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,4,mg/100mL,Decreased Cell Wall Integrity [PE],,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-0244,HUMAN PRESCRIPTION DRUG,Denti-Care Denti-Rinse,Chlorhexidine Gluconate Oral Rinse,Chlorhexidine Gluconante,LIQUID,DENTAL,20060602,,ANDA,ANDA077789,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,1.2,mg/mL,Decreased Cell Wall Integrity [PE],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0116-0301,HUMAN PRESCRIPTION DRUG,Chlorhexidine Gluconate,,Chlorhexidine Gluconate,RINSE,ORAL,20100805,,ANDA,ANDA077789,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,1.2,mg/mL,Decreased Cell Wall Integrity [PE],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0116-0401,HUMAN OTC DRUG,Antiseptic Skin Cleanser,,Chlorhexidine Gluconate 4%,LIQUID,TOPICAL,20131101,,NDA,NDA019125,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,4,mg/100mL,Decreased Cell Wall Integrity [PE],,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-0407,HUMAN PRESCRIPTION DRUG,ANTISEPTIC SKIN CLEANSER,,CHLORHEXIDINE GLUCONATE,SOLUTION,TOPICAL,20120101,,NDA,NDA019125,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,4,g/100mL,Decreased Cell Wall Integrity [PE],,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-0505,HUMAN OTC DRUG,BD E-Z Scrub,,chlorhexidine gluconate,SOLUTION,TOPICAL,20060101,,NDA,NDA019127,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,40,g/1000mL,Decreased Cell Wall Integrity [PE],,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-0506,HUMAN OTC DRUG,BD E-Z Scrub,,chlorhexidine gluconate,SOLUTION,TOPICAL,20010401,,NDA,NDA019422,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,20,mg/mL,Decreased Cell Wall Integrity [PE],,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-0620,HUMAN PRESCRIPTION DRUG,Peridex,,chlorhexidine gluconate,RINSE,ORAL,19860813,,NDA,NDA019028,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,1.2,mg/mL,Decreased Cell Wall Integrity [PE],,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0116-0722,HUMAN OTC DRUG,Scrub Care,Exidine-2 CHG,CHLORHEXIDINE GLUCONATE,SOLUTION,TOPICAL,20151201,,NDA,NDA019422,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,2,mg/100mL,Decreased Cell Wall Integrity [PE],,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-0767,HUMAN OTC DRUG,Antiseptic Skin Cleanser,,CHLORHEXIDINE GLUCONATE 4%,LIQUID,TOPICAL,20110831,,NDA,NDA019125,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,4,g/100mL,Decreased Cell Wall Integrity [PE],,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-0800,HUMAN PRESCRIPTION DRUG,NUPRO Chlorhexidine Gluconate,,CHLORHEXIDINE GLUCONATE,RINSE,ORAL,20170117,,ANDA,ANDA077789,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,1.2,mg/mL,Decreased Cell Wall Integrity [PE],,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0116-0901,HUMAN OTC DRUG,CliniClean,,Chlorhexidine Gluconate 4%,SOLUTION,TOPICAL,20230315,,NDA,NDA019125,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,4,g/100mL,Decreased Cell Wall Integrity [PE],,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-0901,HUMAN OTC DRUG,CliniClean,,CHLORHEXIDINE GLUCONATE 4%,SOLUTION,TOPICAL,20230323,,NDA,NDA019125,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,4,g/100mL,Decreased Cell Wall Integrity [PE],,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-0901,HUMAN OTC DRUG,CliniClean,,Chlorhexidine Gluconate 4%,SOLUTION,TOPICAL,20230323,,NDA,NDA019125,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,4,g/100mL,Decreased Cell Wall Integrity [PE],,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-1021,HUMAN OTC DRUG,DYNA-HEX,2,Chlorhexidine Gluconate,LIQUID,TOPICAL,20140101,,NDA,NDA019422,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,2,g/100mL,Decreased Cell Wall Integrity [PE],,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-1021,HUMAN OTC DRUG,DYNA-HEX,2,Chlorhexidine gluconate,LIQUID,TOPICAL,20140101,,NDA,NDA019422,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,2,g/100mL,Decreased Cell Wall Integrity [PE],,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-1022,HUMAN OTC DRUG,Dyna-Hex 2,,Chlorhexidine Gluconate 2%,SOLUTION,TOPICAL,20231214,,NDA,NDA019422,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,20,mg/mL,Decreased Cell Wall Integrity [PE],,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-1022,HUMAN OTC DRUG,Dyna-Hex 2,,Chlorhexidine Gluconate 2%,SOLUTION,TOPICAL,20160129,,NDA,NDA019422,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,20,mg/mL,Decreased Cell Wall Integrity [PE],,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-1060,HUMAN OTC DRUG,DYNA-HEX 4,,Chlorhexidine Gluconate,LIQUID,TOPICAL,20160101,,NDA,NDA019125,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,4,g/100mL,Decreased Cell Wall Integrity [PE],,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-1060,HUMAN OTC DRUG,Dyna-Hex 4,,Chlorhexidine Gluconate,LIQUID,TOPICAL,20231115,,NDA,NDA019127,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,4,g/100mL,Decreased Cell Wall Integrity [PE],,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-1061,HUMAN OTC DRUG,ANTISEPTIC SKIN CLEANSER,,Chlorhexidine Gluconate,SOLUTION,TOPICAL,20110831,,NDA,NDA019125,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,4,g/100mL,Decreased Cell Wall Integrity [PE],,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-1061,HUMAN OTC DRUG,ANTISEPTIC SKIN CLEANSER,,CHLORHEXIDINE GLUCONATE,SOLUTION,TOPICAL,20110831,,NDA,NDA019125,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,4,g/100mL,Decreased Cell Wall Integrity [PE],,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-1061,HUMAN OTC DRUG,ANTISEPTIC SKIN CLEANSER,,Chlorhexidine Gluconate,SOLUTION,TOPICAL,20180801,,NDA,NDA019125,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,4,g/100mL,Decreased Cell Wall Integrity [PE],,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-1221,HUMAN OTC DRUG,Foster and Thrive,,Chlorhexidine Gluconate 4%,SOLUTION,TOPICAL,20231027,,NDA,NDA019125,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,4,g/100mL,Decreased Cell Wall Integrity [PE],,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-2001,HUMAN PRESCRIPTION DRUG,Chlorhexidine Gluconate,,Chlorhexidine Gluconate,RINSE,ORAL,20100601,,ANDA,ANDA077789,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,1.2,mg/mL,Decreased Cell Wall Integrity [PE],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0116-2800,HUMAN OTC DRUG,Antiseptic Skin Cleanser,Exidine-2 CHG,CHLORHEXIDINE GLUCONATE,SOLUTION,TOPICAL,20160701,,NDA,NDA019422,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,2,mg/100mL,Decreased Cell Wall Integrity [PE],,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-3678,HUMAN OTC DRUG,Antiseptic Skin Cleanser,,Chlorhexidine Gluconate 4%,LIQUID,TOPICAL,20130101,,NDA,NDA019125,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,4,mg/100mL,Decreased Cell Wall Integrity [PE],,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0116-4005,HUMAN PRESCRIPTION DRUG,Lactulose,,Lactulose,SOLUTION,ORAL,20220701,,ANDA,ANDA075911,"Xttrium Laboratories, Inc.",LACTULOSE,10,g/15mL,"Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0116-4010,HUMAN PRESCRIPTION DRUG,Amantadine,,Amantadine,SOLUTION,ORAL,20241105,,ANDA,ANDA075060,"Xttrium Laboratories, Inc",AMANTADINE HYDROCHLORIDE,50,mg/5mL,"Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0116-4011,HUMAN PRESCRIPTION DRUG,Megestrol Acetate,,Megestrol Acetate,SUSPENSION,ORAL,20250328,,ANDA,ANDA076721,"Xttrium Laboratories, Inc.",MEGESTROL ACETATE,40,mg/mL,"Progesterone Congeners [CS], Progestin [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0116-4023,HUMAN PRESCRIPTION DRUG,PROMETHAZINE HYDROCHLORIDE,,promethazine hydrochloride,SYRUP,ORAL,20250407,,ANDA,ANDA087953,"Xttrium Laboratories, Inc.",PROMETHAZINE HYDROCHLORIDE,6.25,mg/5mL,"Phenothiazine [EPC], Phenothiazines [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0116-4024,HUMAN PRESCRIPTION DRUG,Promethazine Hydrochloride and Dextromethorphan Hydrobromide,,Promethazine Hydrochloride and Dextromethorphan Hydrobromide,SYRUP,ORAL,20250407,,ANDA,ANDA088864,"Xttrium Laboratories, Inc",DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE,15; 6.25,mg/5mL; mg/5mL,"Phenothiazine [EPC], Phenothiazines [CS], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0116-4075,HUMAN PRESCRIPTION DRUG,Acclean Chlorhexidine Gluconate 0.12% Oral Rinse,,Chlorhexidine Gluconate 0.12% Oral Rinse,LIQUID,ORAL,20091001,,ANDA,ANDA077789,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,1.2,mg/mL,Decreased Cell Wall Integrity [PE],,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0116-6000,HUMAN PRESCRIPTION DRUG,Chlorhexidine Gluconate,,Chlorhexidine Gluconate,RINSE,ORAL,20120418,,ANDA,ANDA077789,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,1.2,mg/mL,Decreased Cell Wall Integrity [PE],,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0116-6720,HUMAN PRESCRIPTION DRUG,Acclean Chlorhexidine Gluconate 0.12% Oral Rinse,,Chlorhexidine Gluconate 0.12% Oral Rinse,LIQUID,ORAL,20130201,,ANDA,ANDA077789,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,1.2,mg/mL,Decreased Cell Wall Integrity [PE],,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0116-8500,HUMAN OTC DRUG,Provon Antimicrobial Foam Handwash,,Chlorhexidine Gluconate 2%,SOLUTION,TOPICAL,20160701,,NDA,NDA019422,"Xttrium Laboratories, Inc.",CHLORHEXIDINE GLUCONATE,20,mg/mL,Decreased Cell Wall Integrity [PE],,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0121-0431,HUMAN OTC DRUG,Milk of Magnesia,,Magnesium Hydroxide,SUSPENSION,ORAL,19790904,,OTC MONOGRAPH DRUG,M007,"PAI Holdings, LLC",MAGNESIUM HYDROXIDE,400,mg/5mL,"Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0489,HUMAN PRESCRIPTION DRUG,DIPHENHYDRAMINE HYDROCHLORIDE,,DIPHENHYDRAMINE HYDROCHLORIDE,SOLUTION,ORAL,19820210,,ANDA,ANDA087513,"PAI Holdings, LLC dba PAI Pharma",DIPHENHYDRAMINE HYDROCHLORIDE,12.5,mg/5mL,"Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0531,HUMAN PRESCRIPTION DRUG,Phenobarbital,,Phenobarbital,SOLUTION,ORAL,20070219,,UNAPPROVED DRUG OTHER,,"Pharmaceutical Associates, Inc.",PHENOBARBITAL,20,mg/5mL,,CIV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0576,HUMAN PRESCRIPTION DRUG,Metoclopramide,,metoclopramide hydrochloride,SOLUTION,ORAL,19910601,,ANDA,ANDA072744,"PAI Holdings, LLC dba PAI Pharma",METOCLOPRAMIDE HYDROCHLORIDE,5,mg/5mL,"Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0577,HUMAN PRESCRIPTION DRUG,LACTULOSE,,LACTULOSE,SOLUTION,ORAL,19660730,,ANDA,ANDA074623,"PAI Holdings, LLC dba PAI Pharma",LACTULOSE,10,g/15mL,"Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0581,HUMAN PRESCRIPTION DRUG,Haloperidol,,Haloperidol,SOLUTION,ORAL,20091110,,ANDA,ANDA073037,"PAI Holdings, LLC dba PAI Pharma",HALOPERIDOL,2,mg/mL,Typical Antipsychotic [EPC],,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0595,HUMAN PRESCRIPTION DRUG,Sodium Citrate and Citric Acid,,SODIUM CITRATE and CITRIC ACID MONOHYDRATE,SOLUTION,ORAL,19690101,,UNAPPROVED DRUG OTHER,,"Pharmaceutical Associates, Inc.",ANHYDROUS CITRIC ACID; SODIUM CITRATE,334; 500,mg/5mL; mg/5mL,"Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0638,HUMAN OTC DRUG,GUAIFENESIN DM,,GUAIFENESIN and DEXTROMETHORPHAN,SYRUP,ORAL,19920701,,OTC MONOGRAPH DRUG,M012,"PAI Holdings, LLC dba PAI Pharma",DEXTROMETHORPHAN; GUAIFENESIN,10; 100,mg/5mL; mg/5mL,"Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0646,HUMAN PRESCRIPTION DRUG,AMANTADINE HYDROCHLORIDE,,AMANTADINE HYDROCHLORIDE,SOLUTION,ORAL,19950717,,ANDA,ANDA074509,"PAI Holdings, LLC dba PAI Pharma",AMANTADINE HYDROCHLORIDE,50,mg/5mL,"Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0653,HUMAN PRESCRIPTION DRUG,Fluphenazine Hydrochloride,,Fluphenazine Hydrochloride,"SOLUTION, CONCENTRATE",ORAL,20100901,,ANDA,ANDA074725,"PAI Holdings, LLC dba PAI Pharma",FLUPHENAZINE HYDROCHLORIDE,5,mg/mL,"Phenothiazine [EPC], Phenothiazines [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0654,HUMAN PRESCRIPTION DRUG,Fluphenazine Hydrochloride,,Fluphenazine Hydrochloride,ELIXIR,ORAL,20100831,,ANDA,ANDA040146,"PAI Holdings, LLC dba PAI Pharma",FLUPHENAZINE HYDROCHLORIDE,0.5,mg/mL,"Phenothiazine [EPC], Phenothiazines [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0657,HUMAN OTC DRUG,Acetaminophen,,Acetaminophen,SOLUTION,ORAL,20070801,,OTC MONOGRAPH DRUG,M013,"PAI Holdings, LLC dba PAI Pharma",ACETAMINOPHEN,160,mg/5mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0658,HUMAN PRESCRIPTION DRUG,Trihexyphenidyl Hydrochloride,,Trihexyphenidyl Hydrochloride,SOLUTION,ORAL,19970515,,ANDA,ANDA040177,"PAI Holdings, LLC dba PAI Pharma",TRIHEXYPHENIDYL HYDROCHLORIDE,2,mg/5mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0670,HUMAN PRESCRIPTION DRUG,ETHOSUXIMIDE,,ETHOSUXIMIDE,SOLUTION,ORAL,20001122,,ANDA,ANDA040253,"PAI Holdings, LLC dba PAI Pharma",ETHOSUXIMIDE,250,mg/5mL,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0675,HUMAN PRESCRIPTION DRUG,VALPROIC ACID,,VALPROIC ACID,SOLUTION,ORAL,20050411,,ANDA,ANDA075379,"PAI Holdings, LLC dba PAI Pharma",VALPROIC ACID,250,mg/5mL,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0676,HUMAN PRESCRIPTION DRUG,Potassium Citrate and Citric Acid,,Potassium Citrate and Citric Acid Monohydrate,SOLUTION,ORAL,19971007,,UNAPPROVED DRUG OTHER,,"PAI Holdings, LLC dba PAI Pharma",CITRIC ACID MONOHYDRATE; POTASSIUM CITRATE,334; 1100,mg/5mL; mg/5mL,"Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0677,HUMAN PRESCRIPTION DRUG,TRICITRATES,,"POTASSIUM CITRATE, SODIUM CITRATE, and CITRIC ACID MONOHYDRATE",SOLUTION,ORAL,20050525,,UNAPPROVED DRUG OTHER,,"PAI Holdings, LLC dba PAI Pharma",CITRIC ACID MONOHYDRATE; POTASSIUM CITRATE; SODIUM CITRATE,334; 550; 500,mg/5mL; mg/5mL; mg/5mL,"Acidifying Activity [MoA], Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0678,HUMAN PRESCRIPTION DRUG,Nortriptyline Hydrochloride,,Nortriptyline Hydrochloride,SOLUTION,ORAL,20000823,,ANDA,ANDA075606,"PAI Holdings, LLC dba PAI Pharma",NORTRIPTYLINE HYDROCHLORIDE,10,mg/5mL,Tricyclic Antidepressant [EPC],,N,20251231,F32.9,"[{""icd10_code"":""F32.9"",""description"":""Major depressive disorder, single episode, unspecified"",""confidence"":0.5,""context"":""depression""},{""icd10_code"":""F33.9"",""description"":""Major depressive disorder, recurrent, unspecified"",""confidence"":0.25,""context"":""recurrent depression""},{""icd10_code"":""F41.9"",""description"":""Anxiety disorder, unspecified"",""confidence"":0.15,""context"":""anxiety/panic""},{""icd10_code"":""F43.10"",""description"":""Post-traumatic stress disorder, unspecified"",""confidence"":0.05,""context"":""PTSD""},{""icd10_code"":""F50.00"",""description"":""Anorexia nervosa, unspecified"",""confidence"":0.05,""context"":""eating disorders""}]",0.50
0121-0721,HUMAN PRESCRIPTION DRUG,Fluoxetine,,FLUOXETINE HYDROCHLORIDE,SOLUTION,ORAL,20020130,,ANDA,ANDA076015,"PAI Holdings, LLC dba PAI Pharma",FLUOXETINE HYDROCHLORIDE,20,mg/5mL,"Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0727,HUMAN PRESCRIPTION DRUG,Ranitidine,,RANITIDINE,SYRUP,ORAL,20101101,,ANDA,ANDA077405,"Pharmaceutical Associates, Inc.",RANITIDINE,15,mg/mL,"Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0744,HUMAN OTC DRUG,GUAIFENESIN,,GUAIFENESIN,SOLUTION,ORAL,20020901,,OTC MONOGRAPH DRUG,M012,"PAI Holdings, LLC dba PAI Pharma",GUAIFENESIN,100,mg/5mL,"Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0759,HUMAN PRESCRIPTION DRUG,Prednisolone Sodium Phosphate,,Prednisolone Sodium Phosphate,SOLUTION,ORAL,20050425,,ANDA,ANDA076913,"PAI Holdings, LLC dba PAI Pharma",PREDNISOLONE SODIUM PHOSPHATE,15,mg/5mL,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0766,HUMAN OTC DRUG,Calcium Carbonate,,Calcium Carbonate,SUSPENSION,ORAL,20041201,,OTC MONOGRAPH DRUG,M001,"PAI Holdings, LLC dba PAI Pharma",CALCIUM CARBONATE,1250,mg/5mL,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0770,HUMAN PRESCRIPTION DRUG,Lorazepam,,Lorazepam,LIQUID,ORAL,20101101,,ANDA,ANDA090260,"Pharmaceutical Associates, Inc.",LORAZEPAM,2,mg/mL,"Benzodiazepine [EPC], Benzodiazepines [CS]",CIV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0773,HUMAN PRESCRIPTION DRUG,Prednisolone Sodium Phosphate,,Prednisolone Sodium Phosphate,SOLUTION,ORAL,20170131,,ANDA,ANDA078465,"PAI Holdings, LLC dba PAI Pharma",PREDNISOLONE SODIUM PHOSPHATE,10,mg/5mL,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0775,HUMAN OTC DRUG,Guaifenesin and Codeine Phosphate,,Guaifenesin and Codeine Phosphate,SOLUTION,ORAL,20061001,,OTC MONOGRAPH DRUG,M012,"PAI Holdings, LLC",CODEINE PHOSPHATE; GUAIFENESIN,10; 100,mg/5mL; mg/5mL,"Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]",CV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0777,HUMAN PRESCRIPTION DRUG,Prednisolone Sodium Phosphate,,Prednisolone Sodium Phosphate,SOLUTION,ORAL,20170131,,ANDA,ANDA078988,"PAI Holdings, LLC dba PAI Pharma",PREDNISOLONE SODIUM PHOSPHATE,20,mg/5mL,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0799,HUMAN PRESCRIPTION DRUG,Levetiracetam,,LEVETIRACETAM,SOLUTION,ORAL,20150604,,ANDA,ANDA201157,"PAI Holdings, LLC dba PAI Pharma",LEVETIRACETAM,100,mg/mL,Decreased Central Nervous System Disorganized Electrical Activity [PE],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0810,HUMAN PRESCRIPTION DRUG,Nystatin,,NYSTATIN,SUSPENSION,ORAL,20160201,,ANDA,ANDA203621,"Pharmaceutical Associates, Inc.",NYSTATIN,100000,[USP'U]/mL,"Polyene Antifungal [EPC], Polyenes [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0820,HUMAN PRESCRIPTION DRUG,THEOPHYLLINE,,THEOPHYLLINE,SOLUTION,ORAL,20161216,,ANDA,ANDA206344,"PAI Holdings, LLC dba PAI Pharma",THEOPHYLLINE,80,mg/15mL,"Methylxanthine [EPC], Xanthines [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0825,HUMAN PRESCRIPTION DRUG,Morphine Sulfate,,MORPHINE SULFATE,SOLUTION,ORAL,20161114,,ANDA,ANDA206573,"PAI Holdings, LLC dba PAI Pharma",MORPHINE SULFATE,100,mg/5mL,"Full Opioid Agonists [MoA], Opioid Agonist [EPC]",CII,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0826,HUMAN PRESCRIPTION DRUG,OXYCODONE HYDROCHLORIDE,,OXYCODONE HYDROCHLORIDE,SOLUTION,ORAL,20180604,,ANDA,ANDA206822,"PAI Holdings, LLC dba PAI Pharma",OXYCODONE HYDROCHLORIDE,100,mg/5mL,"Full Opioid Agonists [MoA], Opioid Agonist [EPC]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0827,HUMAN PRESCRIPTION DRUG,OXYCODONE HYDROCHLORIDE,,OXYCODONE HYDROCHLORIDE,SOLUTION,ORAL,20190408,,ANDA,ANDA206914,"PAI Holdings, LLC dba PAI Pharma",OXYCODONE HYDROCHLORIDE,5,mg/5mL,"Full Opioid Agonists [MoA], Opioid Agonist [EPC]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0833,HUMAN OTC DRUG,Childrens Ibuprofen Oral Suspension,,Ibuprofen,SUSPENSION,ORAL,20250507,,ANDA,ANDA214789,"PAI Holdings, LLC dba PAI Pharma",IBUPROFEN,100,mg/5mL,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20251231,M79.3,"[{""icd10_code"":""M79.3"",""description"":""Panniculitis, unspecified"",""confidence"":0.3,""context"":""general pain/inflammation""},{""icd10_code"":""M25.50"",""description"":""Pain in unspecified joint"",""confidence"":0.25,""context"":""joint pain""},{""icd10_code"":""R50.9"",""description"":""Fever, unspecified"",""confidence"":0.2,""context"":""fever reduction""},{""icd10_code"":""G43.909"",""description"":""Migraine, unspecified, not intractable, without status migrainosus"",""confidence"":0.15,""context"":""headache""},{""icd10_code"":""M79.1"",""description"":""Myalgia"",""confidence"":0.1,""context"":""muscle pain""}]",0.30
0121-0853,HUMAN PRESCRIPTION DRUG,Sulfamethoxazole and Trimethoprim,,Sulfamethoxazole and Trimethoprim,SUSPENSION,ORAL,20240805,,NDA,NDA018615,"PAI Holdings, LLC dba PAI Pharma",SULFAMETHOXAZOLE; TRIMETHOPRIM,200; 40,mg/5mL; mg/5mL,"Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0854,HUMAN PRESCRIPTION DRUG,SULFATRIM,,Sulfamethoxazole and Trimethoprim,SUSPENSION,ORAL,19830703,,NDA,NDA018615,"PAI Holdings, LLC dba PAI Pharma",SULFAMETHOXAZOLE; TRIMETHOPRIM,200; 40,mg/5mL; mg/5mL,"Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0865,HUMAN OTC DRUG,Diphenhydramine HCl,,diphenhydramine hydrochloride,SOLUTION,ORAL,20200618,,OTC MONOGRAPH DRUG,M012,"PAI Holdings, LLC dba PAI Pharma",DIPHENHYDRAMINE HYDROCHLORIDE,12.5,mg/5mL,"Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0867,HUMAN PRESCRIPTION DRUG,VANCOMYCIN HYDROCHLORIDE,,VANCOMYCIN HYDROCHLORIDE,CAPSULE,ORAL,20190725,20250731,ANDA,ANDA210729,"PAI Holdings, LLC dba PAI Pharma",VANCOMYCIN HYDROCHLORIDE,125,mg/1,"Glycopeptide Antibacterial [EPC], Glycopeptides [CS]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0868,HUMAN PRESCRIPTION DRUG,Nystatin,,NYSTATIN,SUSPENSION,ORAL,20200717,,ANDA,ANDA203621,"PAI Holdings, LLC dba PAI Pharma",NYSTATIN,100000,[USP'U]/mL,"Polyene Antifungal [EPC], Polyenes [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0873,HUMAN PRESCRIPTION DRUG,LACTULOSE,,Lactulose,SOLUTION,ORAL,20191203,,ANDA,ANDA074623,"PAI Holdings, LLC dba PAI Pharma",LACTULOSE,10,g/15mL,"Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0874,HUMAN PRESCRIPTION DRUG,Cetirizine Hydrochloride,,Cetirizine Hydrochloride,SOLUTION,ORAL,20240212,,ANDA,ANDA078412,"PAI Holdings, LLC dba PAI Pharma",CETIRIZINE HYDROCHLORIDE,1,mg/mL,"Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0885,HUMAN PRESCRIPTION DRUG,Prednisolone,,Prednisolone,SOLUTION,ORAL,20230912,,ANDA,ANDA040571,"PAI Holdings, LLC dba PAI Pharma",PREDNISOLONE,15,mg/5mL,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0892,HUMAN PRESCRIPTION DRUG,Phenytoin,,Phenytoin,SUSPENSION,ORAL,20040408,,ANDA,ANDA040521,"PAI Holdings, LLC dba PAI Pharma",PHENYTOIN,125,mg/5mL,"Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0893,HUMAN PRESCRIPTION DRUG,CHLORHEXIDINE GLUCONATE,,CHLORHEXIDINE GLUCONATE,RINSE,ORAL,19951215,,ANDA,ANDA074522,"PAI Holdings, LLC dba PAI Pharma",CHLORHEXIDINE GLUCONATE,1.2,mg/mL,Decreased Cell Wall Integrity [PE],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0903,HUMAN PRESCRIPTION DRUG,Lidocaine Viscous,,Lidocaine Hydrochloride,SOLUTION,ORAL,19850426,,ANDA,ANDA088802,"Pharmaceutical Associates, Inc.",LIDOCAINE HYDROCHLORIDE,20,mg/mL,"Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0904,HUMAN PRESCRIPTION DRUG,Morphine Sulfate,,Morphine Sulfate,SOLUTION,ORAL,20170317,,NDA,NDA022195,"PAI Holdings, LLC dba PAI Pharma",MORPHINE SULFATE,10,mg/5mL,"Full Opioid Agonists [MoA], Opioid Agonist [EPC]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0905,HUMAN PRESCRIPTION DRUG,Diazepam,,Diazepam,SOLUTION,ORAL,19870403,,ANDA,ANDA070928,"Pharmaceutical Associates, Inc.",DIAZEPAM,5,mg/5mL,"Benzodiazepine [EPC], Benzodiazepines [CS]",CIV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0908,HUMAN PRESCRIPTION DRUG,Propranolol Hydrochloride,,Propranolol Hydrochloride,SOLUTION,ORAL,20210903,,ANDA,ANDA070979,"Pharmaceutical Associates, Inc.",PROPRANOLOL HYDROCHLORIDE,20,mg/5mL,"Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0914,HUMAN OTC DRUG,Childrens Ibuprofen Oral Suspension,,Ibuprofen,SUSPENSION,ORAL,19990430,,ANDA,ANDA074916,"Pharmaceutical Associates, Inc.",IBUPROFEN,100,mg/5mL,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20251231,M79.3,"[{""icd10_code"":""M79.3"",""description"":""Panniculitis, unspecified"",""confidence"":0.3,""context"":""general pain/inflammation""},{""icd10_code"":""M25.50"",""description"":""Pain in unspecified joint"",""confidence"":0.25,""context"":""joint pain""},{""icd10_code"":""R50.9"",""description"":""Fever, unspecified"",""confidence"":0.2,""context"":""fever reduction""},{""icd10_code"":""G43.909"",""description"":""Migraine, unspecified, not intractable, without status migrainosus"",""confidence"":0.15,""context"":""headache""},{""icd10_code"":""M79.1"",""description"":""Myalgia"",""confidence"":0.1,""context"":""muscle pain""}]",0.30
0121-0925,HUMAN PRESCRIPTION DRUG,Promethazine VC with Codeine Oral Solution,,Promethazine and Phenylephrine Hydrochloride and Codeine Phosphate,SOLUTION,ORAL,20210318,,ANDA,ANDA040660,"PAI Holdings, LLC",CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE,10; 5; 6.25,mg/5mL; mg/5mL; mg/5mL,"Adrenergic alpha1-Agonists [MoA], Full Opioid Agonists [MoA], Opioid Agonist [EPC], Phenothiazine [EPC], Phenothiazines [CS], alpha-1 Adrenergic Agonist [EPC]",CV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0933,HUMAN PRESCRIPTION DRUG,"Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide",,"Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide",SOLUTION,ORAL,20220303,,ANDA,ANDA202940,"PAI Holdings, LLC dba PAI Pharma",BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE,2; 10; 30,mg/5mL; mg/5mL; mg/5mL,"Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0935,HUMAN OTC DRUG,Docusate Sodium,,Docusate Sodium,LIQUID,ORAL,20210816,,OTC MONOGRAPH DRUG,M007,"PAI Holdings, LLC dba PAI Pharma",DOCUSATE SODIUM,50,mg/5mL,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0940,HUMAN OTC DRUG,Milk of Magnesia Concentrate,,MAGNESIUM HYDROXIDE,SUSPENSION,ORAL,20220118,,OTC MONOGRAPH DRUG,M007,"PAI Holdings, LLC dba PAI Pharma",MAGNESIUM HYDROXIDE,2400,mg/10mL,"Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0941,HUMAN OTC DRUG,Acetaminophen,,Acetaminophen,SUSPENSION,ORAL,20210903,,OTC MONOGRAPH DRUG,M013,"PAI Holdings, LLC dba PAI Pharma",ACETAMINOPHEN,160,mg/5mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0942,HUMAN PRESCRIPTION DRUG,Phenobarbital Oral Solution,,Phenobarbital Oral,SOLUTION,ORAL,20210820,,UNAPPROVED DRUG OTHER,,"PAI Holdings, LLC dba PAI Pharma",PHENOBARBITAL,20,mg/5mL,,CIV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0945,HUMAN PRESCRIPTION DRUG,Megestrol Acetate,,Megestrol Acetate,SUSPENSION,ORAL,20010725,,ANDA,ANDA075671,"PAI Holdings, LLC dba PAI Pharma",MEGESTROL ACETATE,400,mg/10mL,"Progesterone Congeners [CS], Progestin [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0948,HUMAN PRESCRIPTION DRUG,Potassium Chloride,,POTASSIUM CHLORIDE,SOLUTION,ORAL,20230327,,ANDA,ANDA210766,"PAI Holdings, LLC dba PAI Pharma",POTASSIUM CHLORIDE,20,meq/15mL,"Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0950,HUMAN PRESCRIPTION DRUG,Lidocaine Hydrochloride,,Lidocaine Hydrochloride,SOLUTION,ORAL,20240220,,ANDA,ANDA218138,"PAI Holdings, LLC dba PAI Pharma",LIDOCAINE HYDROCHLORIDE,20,mg/mL,"Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0956,HUMAN PRESCRIPTION DRUG,Atovaquone,,Atovaquone,SUSPENSION,ORAL,20250404,,ANDA,ANDA214272,"PAI Holdings, LLC dba PAI Pharma",ATOVAQUONE,750,mg/5mL,"Antimalarial [EPC], Antiprotozoal [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0965,HUMAN PRESCRIPTION DRUG,Lactulose,,Lactulose,"POWDER, FOR SOLUTION",ORAL,20250317,,ANDA,ANDA217914,"PAI Holdings, LLC dba PAI Pharma",LACTULOSE,10,g/10g,"Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0966,HUMAN OTC DRUG,Dye Free Childrens Acetaminophen,,Acetaminophen,SUSPENSION,ORAL,20220309,,OTC MONOGRAPH DRUG,M013,"PAI Holdings, LLC dba PAI Pharma",ACETAMINOPHEN,160,mg/5mL,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0970,HUMAN OTC DRUG,Lidocaine Pain Relief,,Lidocaine Pain Relief,PATCH,TOPICAL,20230403,,OTC MONOGRAPH DRUG,M017,"PAI Holdings, LLC dba PAI Pharma",LIDOCAINE,560,mg/1,"Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]",,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0121-0972,HUMAN PRESCRIPTION DRUG,Lidocaine Hydrochloride,,Lidocaine Hydrochloride,SOLUTION,TOPICAL,20230731,,ANDA,ANDA204494,"PAI Holdings, LLC dba PAI Pharma",LIDOCAINE HYDROCHLORIDE,40,mg/mL,"Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0121-0974,HUMAN PRESCRIPTION DRUG,Sucralfate,,Sucralfate,SUSPENSION,ORAL,20220315,,ANDA,ANDA211884,"PAI Holdings, LLC dba PAI Pharma",SUCRALFATE,1,g/10mL,"Aluminum Complex [EPC], Organometallic Compounds [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0976,HUMAN PRESCRIPTION DRUG,Cefotan,,Cefotetan,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20240408,,NDA,NDA050588,"PAI Holdings, LLC dba PAI Pharma",CEFOTETAN DISODIUM,1,g/10mL,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0977,HUMAN PRESCRIPTION DRUG,Cefotan,,Cefotetan,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20240408,,NDA,NDA050588,"PAI Holdings, LLC dba PAI Pharma",CEFOTETAN DISODIUM,2,g/20mL,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-0978,HUMAN PRESCRIPTION DRUG,DIPHENHYDRAMINE HYDROCHLORIDE,,DIPHENHYDRAMINE HYDROCHLORIDE,SOLUTION,ORAL,19820210,,ANDA,ANDA087513,"PAI Holdings, LLC dba PAI Pharma",DIPHENHYDRAMINE HYDROCHLORIDE,25,mg/10mL,"Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1002,HUMAN PRESCRIPTION DRUG,Lidocaine and Prilocaine,,Lidocaine and Prilocaine,CREAM,TOPICAL,20250206,,ANDA,ANDA205887,"PAI Holdings, LLC dba PAI Pharma",LIDOCAINE; PRILOCAINE,25; 25,mg/g; mg/g,"Amide Local Anesthetic [EPC], Amide Local Anesthetic [EPC], Amides [CS], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Local Anesthesia [PE]",,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0121-1008,HUMAN PRESCRIPTION DRUG,Acetaminophen and Codeine Phosphate,,ACETAMINOPHEN and CODEINE PHOSPHATE,SOLUTION,ORAL,19810821,,ANDA,ANDA087508,"PAI Holdings, LLC dba PAI Pharma",ACETAMINOPHEN; CODEINE PHOSPHATE,300; 30,mg/12.5mL; mg/12.5mL,"Full Opioid Agonists [MoA], Opioid Agonist [EPC]",CV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1012,HUMAN PRESCRIPTION DRUG,Lacosamide,,Lacosamide,SOLUTION,ORAL,20220826,,ANDA,ANDA216151,"PAI Holdings, LLC dba PAI Pharma",LACOSAMIDE,50,mg/5mL,Decreased Central Nervous System Disorganized Electrical Activity [PE],CV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1016,HUMAN PRESCRIPTION DRUG,Atovaquone,,Atovaquone,SUSPENSION,ORAL,20240110,,ANDA,ANDA214272,"PAI Holdings, LLC",ATOVAQUONE,750,mg/5mL,"Antimalarial [EPC], Antiprotozoal [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1018,HUMAN PRESCRIPTION DRUG,Buprenorphine and Naloxone,,buprenorphine hydrochloride and naloxone hydrochloride,TABLET,SUBLINGUAL,20230905,,ANDA,ANDA204431,"PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma",BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE,2; .5,mg/1; mg/1,"Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]",CIII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1019,HUMAN PRESCRIPTION DRUG,buprenorphine hydrochloride,,buprenorphine hydrochloride,TABLET,SUBLINGUAL,20231012,,ANDA,ANDA090622,"PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma",BUPRENORPHINE HYDROCHLORIDE,2,mg/1,"Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]",CIII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1022,HUMAN OTC DRUG,Dye Free Childrens Ibuprofen,,Ibuprofen,SUSPENSION,ORAL,20231103,,ANDA,ANDA210602,"PAI Holdings, LLC dba PAI Pharma",IBUPROFEN,100,mg/5mL,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20261231,M79.3,"[{""icd10_code"":""M79.3"",""description"":""Panniculitis, unspecified"",""confidence"":0.3,""context"":""general pain/inflammation""},{""icd10_code"":""M25.50"",""description"":""Pain in unspecified joint"",""confidence"":0.25,""context"":""joint pain""},{""icd10_code"":""R50.9"",""description"":""Fever, unspecified"",""confidence"":0.2,""context"":""fever reduction""},{""icd10_code"":""G43.909"",""description"":""Migraine, unspecified, not intractable, without status migrainosus"",""confidence"":0.15,""context"":""headache""},{""icd10_code"":""M79.1"",""description"":""Myalgia"",""confidence"":0.1,""context"":""muscle pain""}]",0.30
0121-1025,HUMAN PRESCRIPTION DRUG,Cimetidine Hydrochloride,,Cimetidine Hydrochloride,SOLUTION,ORAL,20250109,,ANDA,ANDA074664,"PAI Holdings, LLC dba PAI Pharma",CIMETIDINE HYDROCHLORIDE,300,mg/5mL,"Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1034,HUMAN PRESCRIPTION DRUG,Hydroxyzine Hydrochloride,,hydroxyzine hydrochloride,SOLUTION,ORAL,20020410,,ANDA,ANDA040391,"PAI Holdings, LLC dba PAI Pharma",HYDROXYZINE DIHYDROCHLORIDE,10,mg/5mL,"Antihistamine [EPC], Histamine Receptor Antagonists [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1035,HUMAN PRESCRIPTION DRUG,Lincomycin,,Lincomycin Hydrochloride,INJECTION,INTRAMUSCULAR; INTRAVENOUS,20241007,,ANDA,ANDA212770,"PAI Holdings, LLC dba PAI Pharma",LINCOMYCIN HYDROCHLORIDE,3000,mg/10mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1036,HUMAN PRESCRIPTION DRUG,Hydrocodone Bitartrate and Homatropine Methylbromide,,Hydrocodone Bitartrate and Homatropine Methylbromide,SOLUTION,ORAL,20240805,,NDA AUTHORIZED GENERIC,NDA005213,"PAI Holdings, LLC dba PAI Pharma",HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE,1.5; 5,mg/5mL; mg/5mL,"Opioid Agonist [EPC], Opioid Agonists [MoA]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1045,HUMAN PRESCRIPTION DRUG,Nystatin,,NYSTATIN,SUSPENSION,ORAL,20240621,,ANDA,ANDA203621,"PAI Holdings, LLC dba PAI Pharma",NYSTATIN,100000,[USP'U]/mL,"Polyene Antifungal [EPC], Polyenes [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1070,HUMAN PRESCRIPTION DRUG,Promethazine DM,,Promethazine Hydrochloride and Dextromethorphan Hydrobromide,SOLUTION,ORAL,20250604,,ANDA,ANDA040649,"PAI Holdings, LLC dba PAI Pharma",DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE,15; 6.25,mg/5mL; mg/5mL,"Phenothiazine [EPC], Phenothiazines [CS], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1154,HUMAN PRESCRIPTION DRUG,LACTULOSE,,LACTULOSE,SOLUTION,ORAL,19660730,,ANDA,ANDA074623,"PAI Holdings, LLC dba PAI Pharma",LACTULOSE,20,g/30mL,"Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1190,HUMAN PRESCRIPTION DRUG,Sodium Citrate and Citric Acid,,SODIUM CITRATE and CITRIC ACID MONOHYDRATE,SOLUTION,ORAL,19690101,,UNAPPROVED DRUG OTHER,,"Pharmaceutical Associates, Inc.",ANHYDROUS CITRIC ACID; SODIUM CITRATE,334; 500,mg/5mL; mg/5mL,"Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1276,HUMAN OTC DRUG,GUAIFENESIN DM,,GUAIFENESIN and DEXTROMETHORPHAN,SYRUP,ORAL,19920701,,OTC MONOGRAPH DRUG,M012,"PAI Holdings, LLC dba PAI Pharma",DEXTROMETHORPHAN; GUAIFENESIN,20; 200,mg/10mL; mg/10mL,"Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1314,HUMAN OTC DRUG,Acetaminophen,,Acetaminophen,SOLUTION,ORAL,20070801,,OTC MONOGRAPH DRUG,M013,"PAI Holdings, LLC dba PAI Pharma",ACETAMINOPHEN,325,mg/10.15mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1350,HUMAN PRESCRIPTION DRUG,VALPROIC ACID,,VALPROIC ACID,SOLUTION,ORAL,20050411,,ANDA,ANDA075379,"PAI Holdings, LLC dba PAI Pharma",VALPROIC ACID,500,mg/10mL,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1488,HUMAN OTC DRUG,GUAIFENESIN,,GUAIFENESIN,SOLUTION,ORAL,20020901,,OTC MONOGRAPH DRUG,M012,"PAI Holdings, LLC dba PAI Pharma",GUAIFENESIN,200,mg/10mL,"Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1544,HUMAN PRESCRIPTION DRUG,Hydrocodone Bitartrate and Acetaminophen,,HYDROCODONE BITARTRATE and ACETAMINOPHEN,SOLUTION,ORAL,20130729,,ANDA,ANDA040838,"PAI Holdings, LLC dba PAI Pharma",ACETAMINOPHEN; HYDROCODONE BITARTRATE,217; 5,mg/10mL; mg/10mL,"Opioid Agonist [EPC], Opioid Agonists [MoA]",CII,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1550,HUMAN OTC DRUG,Guaifenesin and Codeine Phosphate,,Guaifenesin and Codeine Phosphate,SOLUTION,ORAL,20061001,,OTC MONOGRAPH DRUG,M012,"PAI Holdings, LLC",CODEINE PHOSPHATE; GUAIFENESIN,20; 200,mg/10mL; mg/10mL,"Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]",CV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1576,HUMAN PRESCRIPTION DRUG,Metoclopramide,,metoclopramide hydrochloride,SOLUTION,ORAL,19910601,,ANDA,ANDA072744,"PAI Holdings, LLC dba PAI Pharma",METOCLOPRAMIDE HYDROCHLORIDE,5,mg/5mL,"Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1598,HUMAN PRESCRIPTION DRUG,Levetiracetam,,LEVETIRACETAM,SOLUTION,ORAL,20150604,,ANDA,ANDA201157,"PAI Holdings, LLC dba PAI Pharma",LEVETIRACETAM,1000,mg/10mL,Decreased Central Nervous System Disorganized Electrical Activity [PE],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1666,HUMAN OTC DRUG,Childrens Ibuprofen Oral Suspension,,Ibuprofen,SUSPENSION,ORAL,20250507,,ANDA,ANDA214789,"PAI Holdings, LLC dba PAI Pharma",IBUPROFEN,200,mg/10mL,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20251231,M79.3,"[{""icd10_code"":""M79.3"",""description"":""Panniculitis, unspecified"",""confidence"":0.3,""context"":""general pain/inflammation""},{""icd10_code"":""M25.50"",""description"":""Pain in unspecified joint"",""confidence"":0.25,""context"":""joint pain""},{""icd10_code"":""R50.9"",""description"":""Fever, unspecified"",""confidence"":0.2,""context"":""fever reduction""},{""icd10_code"":""G43.909"",""description"":""Migraine, unspecified, not intractable, without status migrainosus"",""confidence"":0.15,""context"":""headache""},{""icd10_code"":""M79.1"",""description"":""Myalgia"",""confidence"":0.1,""context"":""muscle pain""}]",0.30
0121-1730,HUMAN OTC DRUG,Diphenhydramine HCl,,diphenhydramine hydrochloride,SOLUTION,ORAL,20200618,,OTC MONOGRAPH DRUG,M012,"PAI Holdings, LLC dba PAI Pharma",DIPHENHYDRAMINE HYDROCHLORIDE,25,mg/10mL,"Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1744,HUMAN OTC DRUG,GUAIFENESIN,,GUAIFENESIN,SOLUTION,ORAL,20020901,,OTC MONOGRAPH DRUG,M012,"PAI Holdings, LLC dba PAI Pharma",GUAIFENESIN,100,mg/5mL,"Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1746,HUMAN PRESCRIPTION DRUG,LACTULOSE,,LACTULOSE,SOLUTION,ORAL,20191203,,ANDA,ANDA074623,"PAI Holdings, LLC dba PAI Pharma",LACTULOSE,20,g/30mL,"Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1760,HUMAN OTC DRUG,Mag-AL Liquid,,Aluminum Hydroxide and Magnesium Hydroxide,SUSPENSION,ORAL,20040114,,OTC MONOGRAPH DRUG,M001,"PAI Holdings, LLC",ALUMINUM HYDROXIDE; MAGNESIUM HYDROXIDE,200; 200,mg/5mL; mg/5mL,"Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1761,HUMAN OTC DRUG,Mag-AL Plus,,"Aluminum Hydroxide, Magnesium Hydroxide, and Simethicone",SUSPENSION,ORAL,20040114,,OTC MONOGRAPH DRUG,M001,"PAI Holdings, LLC dba PAI Pharma",ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE,200; 20; 200,mg/5mL; mg/5mL; mg/5mL,"Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1762,HUMAN OTC DRUG,Mag-AL Plus,XS,"Aluminum Hydroxide, Magnesium Hydroxide, and Dimethicone",SUSPENSION,ORAL,20040114,,OTC MONOGRAPH DRUG,M002,"PAI Holdings, LLC dba PAI Pharma",ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE,400; 40; 400,mg/5mL; mg/5mL; mg/5mL,"Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1775,HUMAN OTC DRUG,Guaifenesin and Codeine Phosphate,,Guaifenesin and Codeine Phosphate,SOLUTION,ORAL,20061001,,OTC MONOGRAPH DRUG,M012,"PAI Holdings, LLC",CODEINE PHOSPHATE; GUAIFENESIN,10; 100,mg/5mL; mg/5mL,"Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]",CV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1781,HUMAN OTC DRUG,Childrens Acetaminophen,,Acetaminophen,SUSPENSION,ORAL,20070917,,OTC MONOGRAPH DRUG,M013,"PAI Holdings, LLC dba PAI Pharma",ACETAMINOPHEN,160,mg/5mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1796,HUMAN PRESCRIPTION DRUG,Atovaquone,,Atovaquone,SUSPENSION,ORAL,20181011,,ANDA,ANDA210692,"PAI Holdings, LLC dba PAI Pharma",ATOVAQUONE,1500,mg/10mL,"Antimalarial [EPC], Antiprotozoal [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1828,HUMAN OTC DRUG,Childrens Ibuprofen Oral Suspension,,Ibuprofen,SUSPENSION,ORAL,19990430,,ANDA,ANDA074916,"Pharmaceutical Associates, Inc.",IBUPROFEN,100,mg/10mL,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20251231,M79.3,"[{""icd10_code"":""M79.3"",""description"":""Panniculitis, unspecified"",""confidence"":0.3,""context"":""general pain/inflammation""},{""icd10_code"":""M25.50"",""description"":""Pain in unspecified joint"",""confidence"":0.25,""context"":""joint pain""},{""icd10_code"":""R50.9"",""description"":""Fever, unspecified"",""confidence"":0.2,""context"":""fever reduction""},{""icd10_code"":""G43.909"",""description"":""Migraine, unspecified, not intractable, without status migrainosus"",""confidence"":0.15,""context"":""headache""},{""icd10_code"":""M79.1"",""description"":""Myalgia"",""confidence"":0.1,""context"":""muscle pain""}]",0.30
0121-1870,HUMAN OTC DRUG,Docusate Sodium,,Docusate Sodium,LIQUID,ORAL,20210816,,OTC MONOGRAPH DRUG,M007,"PAI Holdings, LLC dba PAI Pharma",DOCUSATE SODIUM,100,mg/10mL,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1882,HUMAN OTC DRUG,Acetaminophen,,Acetaminophen,SUSPENSION,ORAL,20210903,,OTC MONOGRAPH DRUG,M013,"PAI Holdings, LLC dba PAI Pharma",ACETAMINOPHEN,325,mg/10.15mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1884,HUMAN PRESCRIPTION DRUG,Phenobarbital Oral Solution,,Phenobarbital Oral,SOLUTION,ORAL,20210820,,UNAPPROVED DRUG OTHER,,"PAI Holdings, LLC dba PAI Pharma",PHENOBARBITAL,30,mg/7.5mL,,CIV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1896,HUMAN PRESCRIPTION DRUG,Potassium Chloride,,POTASSIUM CHLORIDE,SOLUTION,ORAL,20230327,,ANDA,ANDA210766,"PAI Holdings, LLC dba PAI Pharma",POTASSIUM CHLORIDE,20,meq/30mL,"Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1930,HUMAN PRESCRIPTION DRUG,Lactulose,,Lactulose,"POWDER, FOR SOLUTION",ORAL,20250317,,ANDA,ANDA217914,"PAI Holdings, LLC dba PAI Pharma",LACTULOSE,20,g/20g,"Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1971,HUMAN OTC DRUG,Acetaminophen,,Acetaminophen,SOLUTION,ORAL,20070801,,OTC MONOGRAPH DRUG,M013,"PAI Holdings, LLC dba PAI Pharma",ACETAMINOPHEN,650,mg/20.3mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-1996,HUMAN PRESCRIPTION DRUG,Nitrofurantoin Oral Suspension,,Nitrofurantoin Oral Suspension,SUSPENSION,ORAL,20240610,,ANDA,ANDA201355,"PAI Holdings, LLC dba PAI Pharma",NITROFURANTOIN,25,mg/5mL,"Nitrofuran Antibacterial [EPC], Nitrofurans [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-2024,HUMAN PRESCRIPTION DRUG,Lacosamide,,Lacosamide,SOLUTION,ORAL,20220826,,ANDA,ANDA216151,"PAI Holdings, LLC dba PAI Pharma",LACOSAMIDE,100,mg/10mL,Decreased Central Nervous System Disorganized Electrical Activity [PE],CV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-2036,HUMAN PRESCRIPTION DRUG,Buprenorphine and Naloxone,,buprenorphine hydrochloride and naloxone hydrochloride,TABLET,SUBLINGUAL,20230905,,ANDA,ANDA204431,"PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma",BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE,8; 2,mg/1; mg/1,"Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]",CIII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-2038,HUMAN PRESCRIPTION DRUG,buprenorphine hydrochloride,,buprenorphine hydrochloride,TABLET,SUBLINGUAL,20231012,,ANDA,ANDA090622,"PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma",BUPRENORPHINE HYDROCHLORIDE,8,mg/1,"Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]",CIII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-2044,HUMAN OTC DRUG,Dye Free Childrens Ibuprofen,,Ibuprofen,SUSPENSION,ORAL,20231103,,ANDA,ANDA210602,"PAI Holdings, LLC dba PAI Pharma",IBUPROFEN,200,mg/10mL,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20261231,M79.3,"[{""icd10_code"":""M79.3"",""description"":""Panniculitis, unspecified"",""confidence"":0.3,""context"":""general pain/inflammation""},{""icd10_code"":""M25.50"",""description"":""Pain in unspecified joint"",""confidence"":0.25,""context"":""joint pain""},{""icd10_code"":""R50.9"",""description"":""Fever, unspecified"",""confidence"":0.2,""context"":""fever reduction""},{""icd10_code"":""G43.909"",""description"":""Migraine, unspecified, not intractable, without status migrainosus"",""confidence"":0.15,""context"":""headache""},{""icd10_code"":""M79.1"",""description"":""Myalgia"",""confidence"":0.1,""context"":""muscle pain""}]",0.30
0121-2106,HUMAN PRESCRIPTION DRUG,leuprolide acetate,,leuprolide acetate,KIT,SUBCUTANEOUS,20250201,,ANDA,ANDA217957,"PAI Holdings, LLC dba PAI Pharma",,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-2232,HUMAN OTC DRUG,GUAIFENESIN,,GUAIFENESIN,SOLUTION,ORAL,20020901,,OTC MONOGRAPH DRUG,M012,"PAI Holdings, LLC dba PAI Pharma",GUAIFENESIN,300,mg/15mL,"Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-2316,HUMAN PRESCRIPTION DRUG,Hydrocodone Bitartrate and Acetaminophen,,HYDROCODONE BITARTRATE and ACETAMINOPHEN,SOLUTION,ORAL,20130729,,ANDA,ANDA040838,"PAI Holdings, LLC dba PAI Pharma",ACETAMINOPHEN; HYDROCODONE BITARTRATE,325; 7.5,mg/15mL; mg/15mL,"Opioid Agonist [EPC], Opioid Agonists [MoA]",CII,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-2397,HUMAN PRESCRIPTION DRUG,Levetiracetam,,LEVETIRACETAM,SOLUTION,ORAL,20150604,,ANDA,ANDA201157,"PAI Holdings, LLC dba PAI Pharma",LEVETIRACETAM,1500,mg/15mL,Decreased Central Nervous System Disorganized Electrical Activity [PE],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-2823,HUMAN OTC DRUG,Acetaminophen,,Acetaminophen,SUSPENSION,ORAL,20210903,,OTC MONOGRAPH DRUG,M013,"PAI Holdings, LLC dba PAI Pharma",ACETAMINOPHEN,650,mg/20.3mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-2826,HUMAN PRESCRIPTION DRUG,Phenobarbital Oral Solution,,Phenobarbital Oral,SOLUTION,ORAL,20210820,,UNAPPROVED DRUG OTHER,,"PAI Holdings, LLC dba PAI Pharma",PHENOBARBITAL,60,mg/15mL,,CIV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-2847,HUMAN PRESCRIPTION DRUG,Potassium Chloride,,POTASSIUM CHLORIDE,SOLUTION,ORAL,20230327,,ANDA,ANDA210766,"PAI Holdings, LLC dba PAI Pharma",POTASSIUM CHLORIDE,40,meq/15mL,"Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-3036,HUMAN PRESCRIPTION DRUG,Lacosamide,,Lacosamide,SOLUTION,ORAL,20220826,,ANDA,ANDA216151,"PAI Holdings, LLC dba PAI Pharma",LACOSAMIDE,150,mg/15mL,Decreased Central Nervous System Disorganized Electrical Activity [PE],CV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-4048,HUMAN PRESCRIPTION DRUG,Lacosamide,,Lacosamide,SOLUTION,ORAL,20220826,,ANDA,ANDA216151,"PAI Holdings, LLC dba PAI Pharma",LACOSAMIDE,200,mg/20mL,Decreased Central Nervous System Disorganized Electrical Activity [PE],CV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-4577,HUMAN PRESCRIPTION DRUG,LACTULOSE,,LACTULOSE,SOLUTION,ORAL,19660730,,ANDA,ANDA074623,"PAI Holdings, LLC dba PAI Pharma",LACTULOSE,10,g/15mL,"Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-4675,HUMAN PRESCRIPTION DRUG,VALPROIC ACID,,VALPROIC ACID,SOLUTION,ORAL,20050411,,ANDA,ANDA075379,"PAI Holdings, LLC dba PAI Pharma",VALPROIC ACID,250,mg/5mL,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-4721,HUMAN PRESCRIPTION DRUG,Fluoxetine,,FLUOXETINE HYDROCHLORIDE,SOLUTION,ORAL,20020201,,ANDA,ANDA076015,"PAI Holdings, LLC dba PAI Pharma",FLUOXETINE HYDROCHLORIDE,20,mg/5mL,"Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-4727,HUMAN PRESCRIPTION DRUG,Ranitidine,,RANITIDINE,SYRUP,ORAL,20101101,,ANDA,ANDA077405,"Pharmaceutical Associates, Inc.",RANITIDINE,15,mg/mL,"Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-4759,HUMAN PRESCRIPTION DRUG,Prednisolone Sodium Phosphate,,Prednisolone Sodium Phosphate,SOLUTION,ORAL,20240322,,ANDA,ANDA076913,"PAI Holdings, LLC dba PAI Pharma",PREDNISOLONE SODIUM PHOSPHATE,15,mg/5mL,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-4766,HUMAN OTC DRUG,Calcium Carbonate,,Calcium Carbonate,SUSPENSION,ORAL,20041201,,OTC MONOGRAPH DRUG,M001,"PAI Holdings, LLC dba PAI Pharma",CALCIUM CARBONATE,1250,mg/5mL,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-4772,HUMAN PRESCRIPTION DRUG,Hydrocodone Bitartrate and Acetaminophen,,HYDROCODONE BITARTRATE and ACETAMINOPHEN,SOLUTION,ORAL,20130729,,ANDA,ANDA040838,"PAI Holdings, LLC dba PAI Pharma",ACETAMINOPHEN; HYDROCODONE BITARTRATE,108; 2.5,mg/5mL; mg/5mL,"Opioid Agonist [EPC], Opioid Agonists [MoA]",CII,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-4799,HUMAN PRESCRIPTION DRUG,Levetiracetam,,LEVETIRACETAM,SOLUTION,ORAL,20150604,,ANDA,ANDA201157,"PAI Holdings, LLC dba PAI Pharma",LEVETIRACETAM,500,mg/5mL,Decreased Central Nervous System Disorganized Electrical Activity [PE],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-4810,HUMAN PRESCRIPTION DRUG,Nystatin,,NYSTATIN,SUSPENSION,ORAL,20160201,,ANDA,ANDA203621,"Pharmaceutical Associates, Inc.",NYSTATIN,100000,[USP'U]/mL,"Polyene Antifungal [EPC], Polyenes [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-4820,HUMAN PRESCRIPTION DRUG,THEOPHYLLINE,,THEOPHYLLINE,SOLUTION,ORAL,20161216,,ANDA,ANDA206344,"PAI Holdings, LLC dba PAI Pharma",THEOPHYLLINE,80,mg/15mL,"Methylxanthine [EPC], Xanthines [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-4827,HUMAN PRESCRIPTION DRUG,OXYCODONE HYDROCHLORIDE,,OXYCODONE HYDROCHLORIDE,SOLUTION,ORAL,20190408,,ANDA,ANDA206914,"PAI Holdings, LLC dba PAI Pharma",OXYCODONE HYDROCHLORIDE,5,mg/5mL,"Full Opioid Agonists [MoA], Opioid Agonist [EPC]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-4948,HUMAN PRESCRIPTION DRUG,Potassium Chloride,,POTASSIUM CHLORIDE,SOLUTION,ORAL,20230327,,ANDA,ANDA210766,"PAI Holdings, LLC dba PAI Pharma",POTASSIUM CHLORIDE,20,meq/15mL,"Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-4950,HUMAN PRESCRIPTION DRUG,Lidocaine Hydrochloride,,Lidocaine Hydrochloride,SOLUTION,ORAL,20240220,,ANDA,ANDA218138,"PAI Holdings, LLC dba PAI Pharma",LIDOCAINE HYDROCHLORIDE,20,mg/mL,"Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0121-4967,HUMAN OTC DRUG,Senna,,sennosides,LIQUID,ORAL,20220322,,OTC MONOGRAPH DRUG,M007,"PAI Holdings, LLC dba PAI Pharma",SENNOSIDES,8.8,mg/5mL,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0126-0016,HUMAN PRESCRIPTION DRUG,PreviDent,5000 Dry Mouth,Sodium fluoride,"GEL, DENTIFRICE",DENTAL,20090706,,UNAPPROVED DRUG OTHER,,"Colgate Oral Pharmaceuticals, Inc.",SODIUM FLUORIDE,6.1,mg/mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0126-0022,HUMAN PRESCRIPTION DRUG,PreviDent 5000 Enamel Protect,,SODIUM FLUORIDE and POTASSIUM NITRATE,"GEL, DENTIFRICE",DENTAL,20110330,,UNAPPROVED DRUG OTHER,,"Colgate Oral Pharmaceuticals, Inc.",POTASSIUM NITRATE; SODIUM FLUORIDE,57.5; 5.8,mg/mL; mg/mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0126-0032,HUMAN OTC DRUG,Colgate Phos-Flur Ortho Defense Alcohol Free Anticavity Mint Fluoride,,SODIUM FLUORIDE,RINSE,DENTAL,20110112,,OTC MONOGRAPH DRUG,M021,"Colgate Oral Pharmaceuticals, Inc.",SODIUM FLUORIDE,2,mg/10mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0126-0033,HUMAN PRESCRIPTION DRUG,PreviDent Alcohol Free,,Sodium Fluoride,MOUTHWASH,DENTAL,20160613,,UNAPPROVED DRUG OTHER,,"Colgate Oral Pharmaceuticals, Inc.",SODIUM FLUORIDE,0.9,mg/mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0126-0034,HUMAN OTC DRUG,Colgate Phos-Flur Ortho Defense Alcohol Free Anticavity Gushing Grape Fluoride,,SODIUM FLUORIDE,RINSE,DENTAL,20110215,,OTC MONOGRAPH DRUG,M021,"Colgate Oral Pharmaceuticals, Inc.",SODIUM FLUORIDE,2,mg/10mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0126-0070,HUMAN PRESCRIPTION DRUG,PreviDent,5000 Sensitive,Sodium fluoride and Potassium nitrate,"GEL, DENTIFRICE",DENTAL,20090706,,UNAPPROVED DRUG OTHER,,"Colgate Oral Pharmaceuticals, Inc.",POTASSIUM NITRATE; SODIUM FLUORIDE,57.5; 5.8,mg/mL; mg/mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0126-0072,HUMAN PRESCRIPTION DRUG,PreviDent 5000 Booster Plus Fruitastic,,Sodium Fluoride,"PASTE, DENTIFRICE",DENTAL,20150301,,UNAPPROVED DRUG OTHER,,"Colgate Oral Pharmaceuticals, Inc.",SODIUM FLUORIDE,6,mg/mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0126-0074,HUMAN PRESCRIPTION DRUG,PreviDent 5000 Booster Plus Spearmint,,Sodium Fluoride,"PASTE, DENTIFRICE",DENTAL,20150301,,UNAPPROVED DRUG OTHER,,"Colgate Oral Pharmaceuticals, Inc.",SODIUM FLUORIDE,6,mg/mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0126-0083,HUMAN OTC DRUG,Peroxyl Mouth Sore Mild Mint,,Hydrogen Peroxide,RINSE,BUCCAL,20090101,,OTC MONOGRAPH DRUG,M022,Colgate Oral Pharmaceuticals Inc.,HYDROGEN PEROXIDE,15,mg/mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0126-0088,HUMAN PRESCRIPTION DRUG,PreviDent Fresh Mint,,Sodium Fluoride,"GEL, DENTIFRICE",DENTAL,20120829,,UNAPPROVED DRUG OTHER,,"Colgate Oral Pharmaceuticals, Inc.",SODIUM FLUORIDE,5,mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0126-0165,HUMAN OTC DRUG,Gel-Kam Fruit and Berry,,Stannous Fluoride,"GEL, DENTIFRICE",DENTAL,19900101,,OTC MONOGRAPH DRUG,M021,"Colgate Oral Pharmaceuticals, Inc.",STANNOUS FLUORIDE,1,mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0126-0192,HUMAN OTC DRUG,Gel-Kam Mint,,Stannous Fluoride,"GEL, DENTIFRICE",DENTAL,19900101,,OTC MONOGRAPH DRUG,M021,"Colgate Oral Pharmaceuticals, Inc.",STANNOUS FLUORIDE,1,mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0126-0272,HUMAN PRESCRIPTION DRUG,Periogard Alcohol Free,,Chlorhexidine Gluconate,RINSE,BUCCAL,20201118,,ANDA,ANDA203212,"Colgate Oral Pharmaceuticals, Inc.",CHLORHEXIDINE GLUCONATE,1.2,mg/mL,Decreased Cell Wall Integrity [PE],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0126-0282,HUMAN PRESCRIPTION DRUG,Periogard Alcohol Free,,Chlorhexidine Gluconate,RINSE,BUCCAL,20211004,,ANDA,ANDA203212,"Colgate Oral Pharmaceuticals, Inc.",CHLORHEXIDINE GLUCONATE,1.2,mg/mL,Decreased Cell Wall Integrity [PE],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0126-0286,HUMAN PRESCRIPTION DRUG,PreviDent,5000 Plus Fruitastic,Sodium Fluoride,"PASTE, DENTIFRICE",DENTAL,20120829,,UNAPPROVED DRUG OTHER,,"Colgate Oral Pharmaceuticals, Inc.",SODIUM FLUORIDE,11,mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0126-0287,HUMAN PRESCRIPTION DRUG,PreviDent,5000 Plus Spearmint,Sodium Fluoride,"PASTE, DENTIFRICE",DENTAL,20120829,,UNAPPROVED DRUG OTHER,,"Colgate Oral Pharmaceuticals, Inc.",SODIUM FLUORIDE,11,mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0126-0288,HUMAN PRESCRIPTION DRUG,PreviDent Very Berry,,Sodium Fluoride,"GEL, DENTIFRICE",DENTAL,20120829,,UNAPPROVED DRUG OTHER,,"Colgate Oral Pharmaceuticals, Inc.",SODIUM FLUORIDE,5,mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0126-0289,HUMAN PRESCRIPTION DRUG,PreviDent OrthoDefense,,SODIUM FLUORIDE,"PASTE, DENTIFRICE",DENTAL,20190304,,UNAPPROVED DRUG OTHER,,"Colgate Oral Pharmaceuticals, Inc.",SODIUM FLUORIDE,6,mg/mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0126-0311,HUMAN PRESCRIPTION DRUG,PreviDent 5000 Kids,,Sodium Fluoride,"PASTE, DENTIFRICE",DENTAL,20230701,,UNAPPROVED DRUG OTHER,,"Colgate Oral Pharmaceuticals, Inc.",SODIUM FLUORIDE,6,mg/mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0131-1810,HUMAN PRESCRIPTION DRUG,Vimpat,,lacosamide,INJECTION,INTRAVENOUS,20090526,,NDA,NDA022254,"UCB, Inc.",LACOSAMIDE,10,mg/mL,Decreased Central Nervous System Disorganized Electrical Activity [PE],CV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0131-2477,HUMAN PRESCRIPTION DRUG,Vimpat,,lacosamide,"TABLET, FILM COATED",ORAL,20090526,,NDA,NDA022253,"UCB, Inc.",LACOSAMIDE,50,mg/1,Decreased Central Nervous System Disorganized Electrical Activity [PE],CV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0131-2478,HUMAN PRESCRIPTION DRUG,Vimpat,,lacosamide,"TABLET, FILM COATED",ORAL,20090526,,NDA,NDA022253,"UCB, Inc.",LACOSAMIDE,100,mg/1,Decreased Central Nervous System Disorganized Electrical Activity [PE],CV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0131-2479,HUMAN PRESCRIPTION DRUG,Vimpat,,lacosamide,"TABLET, FILM COATED",ORAL,20090526,,NDA,NDA022253,"UCB, Inc.",LACOSAMIDE,150,mg/1,Decreased Central Nervous System Disorganized Electrical Activity [PE],CV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0131-2480,HUMAN PRESCRIPTION DRUG,Vimpat,,lacosamide,"TABLET, FILM COATED",ORAL,20090526,,NDA,NDA022253,"UCB, Inc.",LACOSAMIDE,200,mg/1,Decreased Central Nervous System Disorganized Electrical Activity [PE],CV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0131-5410,HUMAN PRESCRIPTION DRUG,Vimpat,,lacosamide,SOLUTION,ORAL,20100420,,NDA,NDA022255,"UCB, Inc.",LACOSAMIDE,10,mg/mL,Decreased Central Nervous System Disorganized Electrical Activity [PE],CV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0132-0075,HUMAN OTC DRUG,Fleet,,Glycerin,SUPPOSITORY,RECTAL,19841101,,OTC MONOGRAPH DRUG,M007,"C.B. Fleet Company, Inc.",GLYCERIN,2,g/1,"Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0132-0078,HUMAN OTC DRUG,Fleet,,"sodium phosphate, dibasic and sodium phosphate, monobasic",ENEMA,RECTAL,20040625,,OTC MONOGRAPH DRUG,M007,"C.B. Fleet Company, Inc.","SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC",7; 19,g/230mL; g/230mL,"Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0132-0113,HUMAN OTC DRUG,Pedia-Lax,,Docusate Sodium,LIQUID,ORAL,20230228,,OTC MONOGRAPH DRUG,M007,"C.B. Fleet Company, Inc.",DOCUSATE SODIUM,50,mg/15mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0132-0185,HUMAN OTC DRUG,Fleet,,glycerin,LIQUID,RECTAL,20020603,,OTC MONOGRAPH DRUG,M007,"C.B. Fleet Company, Inc.",GLYCERIN,5.4,g/1,"Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0132-0190,HUMAN OTC DRUG,Pedia-Lax,,Glycerin,LIQUID,RECTAL,20080301,,OTC MONOGRAPH DRUG,M007,"C.B. Fleet Company, Inc.",GLYCERIN,2.8,g/2.7mL,"Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0132-0194,HUMAN OTC DRUG,Boudreauxs,,Zinc Oxide,PASTE,TOPICAL,20161001,,OTC MONOGRAPH DRUG,M016,"C.B. Fleet Company, Inc.",ZINC OXIDE,40,g/100g,"Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0132-0195,HUMAN OTC DRUG,Pedia-Lax,,Glycerin,LIQUID,RECTAL,20190201,,OTC MONOGRAPH DRUG,M007,"C.B. Fleet Company, Inc.",GLYCERIN,2.8,g/4mL,"Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0132-0201,HUMAN OTC DRUG,Fleet,,"sodium phosphate, dibasic and sodium phosphate, monobasic",ENEMA,RECTAL,19530310,,OTC MONOGRAPH DRUG,M007,"C.B. Fleet Company, Inc.","SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC",7; 19,g/118mL; g/118mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0132-0202,HUMAN OTC DRUG,Pedia-Lax,,"sodium phosphate, dibasic and sodium phosphate, monobasic",ENEMA,RECTAL,20020510,,OTC MONOGRAPH DRUG,M007,"C.B. Fleet Company, Inc.","SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC",3.5; 9.5,g/66mL; g/66mL,"Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0132-0208,HUMAN OTC DRUG,PHAZYME,,Simethicone,"CAPSULE, GELATIN COATED",ORAL,20120201,,OTC MONOGRAPH DRUG,M002,"C.B. Fleet Company, Inc.",DIMETHICONE,180,mg/1,Skin Barrier Activity [PE],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0132-0211,HUMAN OTC DRUG,PHAZYME,,Simethicone,"CAPSULE, GELATIN COATED",ORAL,20140401,,OTC MONOGRAPH DRUG,M002,"C.B. Fleet Company, Inc.",DIMETHICONE,250,mg/1,Skin Barrier Activity [PE],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0132-0217,HUMAN OTC DRUG,PHAZYME ULTIMATE,,SIMETHICONE,"CAPSULE, LIQUID FILLED",ORAL,20210215,20250731,OTC MONOGRAPH DRUG,M002,"C.B. Fleet Company, Inc.",DIMETHICONE,500,mg/1,Skin Barrier Activity [PE],,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0132-0222,HUMAN OTC DRUG,Phazyme Ultimate,,SIMETHICONE,"CAPSULE, LIQUID FILLED",ORAL,20240201,,OTC MONOGRAPH DRUG,M002,"C.B. Fleet Company, Inc.",DIMETHICONE,500,mg/1,Skin Barrier Activity [PE],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0132-0301,HUMAN OTC DRUG,FLEET,,Mineral Oil,ENEMA,RECTAL,20020501,,OTC MONOGRAPH DRUG,M007,"C.B. Fleet Company, Inc.",MINERAL OIL,100,g/100mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0132-0323,HUMAN OTC DRUG,Boudreauxs,,Zinc Oxide,CREAM,TOPICAL,20120201,,OTC MONOGRAPH DRUG,M016,"C.B. Fleet Company, Inc.",ZINC OXIDE,40,g/113g,,,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0132-0324,HUMAN OTC DRUG,Boudreauxs,,Zinc Oxide,OINTMENT,TOPICAL,20191202,,OTC MONOGRAPH DRUG,M016,"C.B. Fleet Company, Inc.",ZINC OXIDE,16,g/113g,"Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]",,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0132-0325,HUMAN OTC DRUG,Boudreauxs Rash Kicking Kit,,Zinc oxide,KIT,TOPICAL,20180525,,OTC MONOGRAPH DRUG,M016,"C.B. Fleet Company, Inc.",,,,,,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0132-0326,HUMAN OTC DRUG,Boudreauxs Butt Barrier,,Dimethicone,OINTMENT,TOPICAL,20220301,,OTC MONOGRAPH DRUG,M016,"C.B. Fleet Company, Inc.",DIMETHICONE,1,g/113g,Skin Barrier Activity [PE],,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0132-0327,HUMAN OTC DRUG,Boudreauxs Baby Shower Bundle,,Zinc oxide,KIT,,20240201,,OTC MONOGRAPH DRUG,M016,"C.B. Fleet Company, Inc.",,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0132-0333,HUMAN OTC DRUG,Boudreauxs,,Zinc Oxide,CREAM,TOPICAL,20120201,,OTC MONOGRAPH DRUG,M016,"C.B. Fleet Company, Inc.",ZINC OXIDE,16,g/113g,,,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0132-0334,HUMAN OTC DRUG,Boudreauxs,,Zinc Oxide,CREAM,TOPICAL,20120201,,OTC MONOGRAPH DRUG,M016,"C.B. Fleet Company, Inc.",ZINC OXIDE,16,g/113g,,,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0132-0400,HUMAN OTC DRUG,FLEET,,Mineral Oil,LIQUID,ORAL,20240401,,OTC MONOGRAPH DRUG,M007,"C.B. Fleet Company, Inc.",MINERAL OIL,2.5,g/5mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0132-0401,HUMAN OTC DRUG,Fleet,,bisacodyl,"TABLET, COATED",ORAL,20240621,,OTC MONOGRAPH DRUG,M007,"C.B. Fleet Company, Inc.",BISACODYL,5,mg/1,"Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0132-0402,HUMAN OTC DRUG,Fleet,,docusate sodium,"CAPSULE, LIQUID FILLED",ORAL,20240621,,OTC MONOGRAPH DRUG,M007,"C.B. Fleet Company, Inc.",DOCUSATE SODIUM,100,mg/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0132-0507,HUMAN OTC DRUG,PHAZYME,,Simethicone and Calcium Carbonate,"TABLET, CHEWABLE",ORAL,20160301,20251231,OTC MONOGRAPH DRUG,M002,"C.B. Fleet Company, Inc.",CALCIUM CARBONATE; DIMETHICONE,750; 250,mg/241; mg/241,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0132-0655,HUMAN OTC DRUG,Pedia-Lax,,Magnesium hydroxide,"TABLET, CHEWABLE",ORAL,20080301,,OTC MONOGRAPH DRUG,M007,"C.B. Fleet Company, Inc.",MAGNESIUM HYDROXIDE,400,mg/1,"Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0132-0703,HUMAN OTC DRUG,Fleet,,Bisacodyl,ENEMA,RECTAL,20020510,,OTC MONOGRAPH DRUG,M007,"C.B. Fleet Company, Inc.",BISACODYL,10,mg/30mL,"Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0070,HUMAN OTC DRUG,TUMS,,calcium carbonate,TABLET,ORAL,20100310,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,500,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0071,HUMAN OTC DRUG,TUMS,,calcium carbonate,TABLET,ORAL,20100310,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,500,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0074,HUMAN OTC DRUG,TUMS,EX,calcium carbonate,TABLET,ORAL,20100118,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,750,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0076,HUMAN OTC DRUG,TUMS,EX,calcium carbonate,TABLET,ORAL,20100118,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,750,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0089,HUMAN OTC DRUG,CITRUCEL,,methylcellulose,"POWDER, FOR SOLUTION",ORAL,20100916,,OTC MONOGRAPH DRUG,M007,Haleon US Holdings LLC,METHYLCELLULOSE (4000 MPA.S),2,g/19g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0090,HUMAN OTC DRUG,CITRUCEL,,methylcellulose,"POWDER, FOR SOLUTION",ORAL,20100916,,OTC MONOGRAPH DRUG,M007,Haleon US Holdings LLC,METHYLCELLULOSE (4000 MPA.S),2,g/10.2g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0094,HUMAN OTC DRUG,GAVISCON,,aluminum hydroxide and magnesium carbonate,LIQUID,ORAL,20110114,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE,95; 358,mg/15mL; mg/15mL,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0095,HUMAN OTC DRUG,GAVISCON,,aluminum hydroxide and magnesium carbonate,LIQUID,ORAL,20110114,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE,254; 237.5,mg/5mL; mg/5mL,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0098,HUMAN OTC DRUG,Gaviscon,Extra Strength,aluminum hydroxide and magnesium carbonate,"TABLET, CHEWABLE",ORAL,20110613,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE,160; 105,mg/1; mg/1,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0118,HUMAN OTC DRUG,TUMS,ULTRA,calcium carbonate,"TABLET, CHEWABLE",ORAL,20100212,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,1000,mg/1,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0138,HUMAN OTC DRUG,Tums Chewy Bites,Mixed Fruit,calcium carbonate,"TABLET, CHEWABLE",ORAL,20220626,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,1000,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0140,HUMAN OTC DRUG,TUMS,EX,calcium carbonate,TABLET,ORAL,20100118,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,750,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0154,HUMAN OTC DRUG,TUMS,EX,calcium carbonate,TABLET,ORAL,20100118,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,750,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0155,HUMAN OTC DRUG,TUMS,Extra Strength Sugar-Free,calcium carbonate,"TABLET, CHEWABLE",ORAL,20180318,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,750,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0157,HUMAN OTC DRUG,Nicorette,Original,nicotine polacrilex,"GUM, CHEWING",ORAL,20090629,,NDA,NDA018612,Haleon US Holdings LLC,NICOTINE,2,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0158,HUMAN OTC DRUG,Nicorette,Original,nicotine polacrilex,"GUM, CHEWING",ORAL,20090629,,NDA,NDA020066,Haleon US Holdings LLC,NICOTINE,4,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0178,HUMAN OTC DRUG,TUMS,EX,calcium carbonate,TABLET,ORAL,20100118,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,750,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0180,HUMAN OTC DRUG,TUMS,ULTRA,calcium carbonate,"TABLET, CHEWABLE",ORAL,20100212,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,1000,mg/1,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0181,HUMAN OTC DRUG,TUMS,ULTRA,calcium carbonate,"TABLET, CHEWABLE",ORAL,20100212,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,1000,mg/1,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0183,HUMAN OTC DRUG,Tums Chewy Bites,,calcium carbonate,"TABLET, CHEWABLE",ORAL,20190301,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,1000,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0184,HUMAN OTC DRUG,Tums Chewy Bites,Berry Shake,calcium carbonate,"TABLET, CHEWABLE",ORAL,20210305,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,750,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0185,HUMAN OTC DRUG,Tums Chewy Bites,Tropical Fruit Smoothie,calcium carbonate,"TABLET, CHEWABLE",ORAL,20240401,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,750,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0194,HUMAN OTC DRUG,NICODERM,CQ,nicotine,"PATCH, EXTENDED RELEASE",TRANSDERMAL,20110512,,NDA,NDA020165,Haleon US Holdings LLC,NICOTINE,21,mg/24h,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0195,HUMAN OTC DRUG,NICODERM,CQ,nicotine,"PATCH, EXTENDED RELEASE",TRANSDERMAL,20110512,,NDA,NDA020165,Haleon US Holdings LLC,NICOTINE,14,mg/24h,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0196,HUMAN OTC DRUG,NICODERM,CQ,nicotine,"PATCH, EXTENDED RELEASE",TRANSDERMAL,20110512,,NDA,NDA020165,Haleon US Holdings LLC,NICOTINE,7,mg/24h,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0199,HUMAN OTC DRUG,CITRUCEL,,methylcellulose,TABLET,ORAL,20100201,,OTC MONOGRAPH DRUG,M007,Haleon US Holdings LLC,METHYLCELLULOSE (4000 MPA.S),500,mg/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0200,HUMAN OTC DRUG,ABREVA,,docosanol,CREAM,TOPICAL,20100319,,NDA,NDA020941,Haleon US Holdings LLC,DOCOSANOL,100,mg/g,,,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0135-0227,HUMAN OTC DRUG,TUMS,Smoothies,calcium carbonate,"TABLET, CHEWABLE",ORAL,20191007,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,750,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0228,HUMAN OTC DRUG,TUMS,ULTRA,calcium carbonate,"TABLET, CHEWABLE",ORAL,20100212,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,1000,mg/1,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0229,HUMAN OTC DRUG,Nicorette,Mint,nicotine polacrilex,"GUM, CHEWING",ORAL,20090629,,NDA,NDA018612,Haleon US Holdings LLC,NICOTINE,2,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0230,HUMAN OTC DRUG,Nicorette,Mint,nicotine polacrilex,"GUM, CHEWING",ORAL,20090629,,NDA,NDA020066,Haleon US Holdings LLC,NICOTINE,4,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0234,HUMAN OTC DRUG,AQUAFRESH,EXTREME CLEAN WHITENING ACTION,sodium fluoride,PASTE,DENTAL,20110325,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,SODIUM FLUORIDE,1.13,mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0235,HUMAN OTC DRUG,TUMS,ULTRA,calcium carbonate,"TABLET, CHEWABLE",ORAL,20210621,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,1000,mg/1,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0241,HUMAN OTC DRUG,Nicorette,Fruit Chill,nicotine polacrilex,"GUM, CHEWING",ORAL,20090914,,NDA,NDA018612,Haleon US Holdings LLC,NICOTINE,2,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0242,HUMAN OTC DRUG,Nicorette,Fruit Chill,nicotine polacrilex,"GUM, CHEWING",ORAL,20090914,,NDA,NDA020066,Haleon US Holdings LLC,NICOTINE,4,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0243,HUMAN OTC DRUG,TUMS,Smoothies,calcium carbonate,"TABLET, CHEWABLE",ORAL,20100324,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,750,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0245,HUMAN OTC DRUG,TUMS,Smoothies,calcium carbonate,"TABLET, CHEWABLE",ORAL,20100324,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,750,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0246,HUMAN OTC DRUG,TUMS,Smoothies,calcium carbonate,"TABLET, CHEWABLE",ORAL,20100324,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,750,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0300,HUMAN OTC DRUG,ABREVA,,docosanol,CREAM,TOPICAL,20220325,,ANDA,ANDA208754,Haleon US Holdings LLC,DOCOSANOL,100,mg/g,,,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0135-0355,HUMAN OTC DRUG,Nicorette,Spearmint Burst,nicotine polacrilex,"GUM, CHEWING",ORAL,20170913,,NDA,NDA020066,Haleon US Holdings LLC,NICOTINE,4,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0400,HUMAN OTC DRUG,ABREVA,Rapid Pain Relief,"glycerin, lidocaine",GEL,TOPICAL,20230601,,OTC MONOGRAPH DRUG,M017,Haleon US Holdings LLC,GLYCERIN; LIDOCAINE HYDROCHLORIDE,200; 40,mg/g; mg/g,"Allergens [CS], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Local Anesthesia [PE], Non-Standardized Chemical Allergen [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0135-0430,HUMAN OTC DRUG,Gaviscon,Extra Strength,aluminum hydroxide and magnesium carbonate,"TABLET, CHEWABLE",ORAL,20110613,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE,160; 105,mg/1; mg/1,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0449,HUMAN OTC DRUG,SENSODYNE PRONAMEL,Intensive Enamel Repair Clean Mint,sodium fluoride,LIQUID,ORAL,20240102,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,SODIUM FLUORIDE,0.5,mg/mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0450,HUMAN OTC DRUG,SENSODYNE PRONAMEL,mineral BOOST refreshing peppermint,potassium nitrate and sodium fluoride,PASTE,ORAL,20210104,,OTC MONOGRAPH DRUG,M021,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.15,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0451,HUMAN OTC DRUG,SENSODYNE PRONAMEL,Intensive Enamel Repair Extra Fresh,sodium fluoride,LIQUID,ORAL,20240102,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,SODIUM FLUORIDE,0.5,mg/mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0456,HUMAN OTC DRUG,TUMS,Smoothies,calcium carbonate,"TABLET, CHEWABLE",ORAL,20100324,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,750,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0460,HUMAN OTC DRUG,SENSODYNE PRONAMEL,Daily Protection,potassium nitrate and sodium fluoride,PASTE,ORAL,20101018,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.15,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0461,HUMAN OTC DRUG,ALLI,,orlistat,CAPSULE,ORAL,20070207,,NDA,NDA021887,Haleon US Holdings LLC,ORLISTAT,60,mg/1,"Intestinal Lipase Inhibitor [EPC], Lipase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0466,HUMAN OTC DRUG,Nicorette,Cinnamon Surge,nicotine polacrilex,"GUM, CHEWING",ORAL,20090629,,NDA,NDA018612,Haleon US Holdings LLC,NICOTINE,2,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0467,HUMAN OTC DRUG,Nicorette,Cinnamon Surge,nicotine polacrilex,"GUM, CHEWING",ORAL,20090629,,NDA,NDA020066,Haleon US Holdings LLC,NICOTINE,4,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0474,HUMAN OTC DRUG,Nicorette,White Ice Mint,nicotine polacrilex,"GUM, CHEWING",ORAL,20090629,,NDA,NDA018612,Haleon US Holdings LLC,NICOTINE,2,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0475,HUMAN OTC DRUG,Nicorette,White Ice Mint,nicotine polacrilex,"GUM, CHEWING",ORAL,20090629,,NDA,NDA020066,Haleon US Holdings LLC,NICOTINE,4,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0479,HUMAN OTC DRUG,SENSODYNE,Advanced Whitening,potassium nitrate,PASTE,ORAL,20201016,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.15,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0480,HUMAN OTC DRUG,SENSODYNE PRONAMEL,mineral BOOST whitening action,potassium nitrate and sodium fluoride,PASTE,ORAL,20210104,,OTC MONOGRAPH DRUG,M021,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.15,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0481,HUMAN OTC DRUG,SENSODYNE PRONAMEL,Intensive Enamel Repair Whitening,potassium nitrate and sodium fluoride,PASTE,ORAL,20200106,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.15,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0484,HUMAN OTC DRUG,SENSODYNE PRONAMEL,Gentle Whitening,potassium nitrate and sodium fluoride,PASTE,ORAL,20101018,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.15,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0486,HUMAN OTC DRUG,SENSODYNE PRONAMEL,Intensive Enamel Repair Extra Fresh,potassium nitrate and sodium fluoride,PASTE,ORAL,20181129,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.15,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0492,HUMAN OTC DRUG,SENSODYNE PRONAMEL,Intensive Enamel Repair Clean Mint,potassium nitrate and sodium fluoride,PASTE,ORAL,20181129,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.15,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0508,HUMAN OTC DRUG,NICORETTE,,nicotine polacrilex,LOZENGE,ORAL,20100301,,NDA,NDA022360,Haleon US Holdings LLC,NICOTINE,2,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0510,HUMAN OTC DRUG,NICORETTE,,nicotine polacrilex,LOZENGE,ORAL,20101019,,NDA,NDA021330,Haleon US Holdings LLC,NICOTINE,2,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0511,HUMAN OTC DRUG,NICORETTE,,nicotine polacrilex,LOZENGE,ORAL,20101019,,NDA,NDA021330,Haleon US Holdings LLC,NICOTINE,4,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0520,HUMAN OTC DRUG,SENSODYNE PRONAMEL,Fresh Breath,potassium nitrate and sodium fluoride,PASTE,ORAL,20110414,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.15,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0521,HUMAN OTC DRUG,TUMS,EX,calcium carbonate,TABLET,ORAL,20110323,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,750,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0525,HUMAN OTC DRUG,Sensodyne,Extra Whitening,potassium nitrate and sodium fluoride,PASTE,DENTAL,19900930,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.11,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0529,HUMAN OTC DRUG,Sensodyne,Fresh Mint,potassium nitrate and sodium fluoride,PASTE,DENTAL,19900930,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.15,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0532,HUMAN OTC DRUG,Nicorette,Spearmint Burst,nicotine polacrilex,"GUM, CHEWING",ORAL,20170913,,NDA,NDA018612,Haleon US Holdings LLC,NICOTINE,2,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0533,HUMAN OTC DRUG,Nicorette,Spearmint Burst,nicotine polacrilex,"GUM, CHEWING",ORAL,20170913,,NDA,NDA020066,Haleon US Holdings LLC,NICOTINE,4,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0537,HUMAN OTC DRUG,PANADOL,,acetaminophen,SUSPENSION,ORAL,20121015,,OTC MONOGRAPH DRUG,M013,Haleon US Holdings LLC,ACETAMINOPHEN,160,mg/5mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0539,HUMAN OTC DRUG,PANADOL,,acetaminophen,SUSPENSION,ORAL,20121015,,OTC MONOGRAPH DRUG,M013,Haleon US Holdings LLC,ACETAMINOPHEN,160,mg/5mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0540,HUMAN OTC DRUG,TUMS,ULTRA,calcium carbonate,"TABLET, CHEWABLE",ORAL,20100212,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,1000,mg/1,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0547,HUMAN OTC DRUG,SENSODYNE,Repair and Protect Extra Fresh,stannous fluoride,PASTE,ORAL,20210628,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,STANNOUS FLUORIDE,1.1,mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0548,HUMAN OTC DRUG,SENSODYNE,Repair and Protect,stannous fluoride,PASTE,ORAL,20210628,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,STANNOUS FLUORIDE,1.1,mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0550,HUMAN OTC DRUG,Sensodyne,,potassium nitrate and sodium fluoride,PASTE,DENTAL,20040217,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.1,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0553,HUMAN OTC DRUG,Tums,Ultra,Calcium carbonate,"TABLET, CHEWABLE",ORAL,20230301,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,1000,mg/1,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0557,HUMAN OTC DRUG,BIOTENE,Fresh Mint Original,sodium fluoride,PASTE,ORAL,20130715,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,SODIUM FLUORIDE,1.5,mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0558,HUMAN OTC DRUG,BIOTENE,Gentle Mint,sodium fluoride,PASTE,ORAL,20130715,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,SODIUM FLUORIDE,1.5,mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0560,HUMAN OTC DRUG,Tums,Chewy Delights,calcium carbonate,"BAR, CHEWABLE",ORAL,20130801,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,1177,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0561,HUMAN OTC DRUG,Tums,Chewy Delights,calcium carbonate,"BAR, CHEWABLE",ORAL,20130801,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,1177,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0568,HUMAN OTC DRUG,SENSODYNE PRONAMEL,Multi Action,potassium nitrate and sodium fluoride,PASTE,ORAL,20131209,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.15,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0569,HUMAN OTC DRUG,Tums,Chewy Delights,calcium carbonate,"BAR, CHEWABLE",ORAL,20140815,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,1177,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0572,HUMAN OTC DRUG,Sensodyne Complete Protection,Extra Fresh,stannous fluoride,PASTE,DENTAL,20140714,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,STANNOUS FLUORIDE,1.1,mg/g,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0573,HUMAN OTC DRUG,Sensodyne Complete Protection,,stannous fluoride,PASTE,DENTAL,20140714,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,STANNOUS FLUORIDE,1.1,mg/g,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0574,HUMAN OTC DRUG,GAVISCON,,aluminum hydroxide and magnesium carbonate,LIQUID,ORAL,20140801,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE,254; 237.5,mg/5mL; mg/5mL,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0575,HUMAN OTC DRUG,SENSODYNE,Repair and Protect Whitening,stannous fluoride,PASTE,ORAL,20210628,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,STANNOUS FLUORIDE,1.1,mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0576,HUMAN OTC DRUG,FLONASE,ALLERGY RELIEF,fluticasone propionate,"SPRAY, METERED",NASAL,20141204,,NDA,NDA205434,Haleon US Holdings LLC,FLUTICASONE PROPIONATE,50,ug/1,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0577,HUMAN OTC DRUG,biotene,,sodium monofluorophosphate,PASTE,ORAL,20160901,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,SODIUM MONOFLUOROPHOSPHATE,1.4,mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0578,HUMAN OTC DRUG,FLONASE,Headache and Allergy Relief,"acetaminophen, chlorpheniramine maleate, phenylephrine hcl",TABLET,ORAL,20220310,,OTC MONOGRAPH DRUG,M012,Haleon US Holdings LLC,ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE,325; 2; 5,mg/1; mg/1; mg/1,"Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0579,HUMAN OTC DRUG,Sensodyne,True white,potassium nitrate and sodium fluoride,PASTE,DENTAL,20151221,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.15,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0580,HUMAN OTC DRUG,Sensodyne Pronamel,Gentle Whitening Advanced,potassium nitrate and sodium fluoride,PASTE,DENTAL,20210315,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.15,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0581,HUMAN OTC DRUG,Sensodyne,True white,potassium nitrate and sodium fluoride,PASTE,DENTAL,20151221,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.15,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0582,HUMAN OTC DRUG,CHILDRENS FLONASE,ALLERGY RELIEF,fluticasone propionate,"SPRAY, METERED",NASAL,20160229,,NDA,NDA205434,Haleon US Holdings LLC,FLUTICASONE PROPIONATE,50,ug/1,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0582,HUMAN OTC DRUG,CHILDRENS FLONASE,ALLERGY RELIEF,fluticasone propionate,"SPRAY, METERED",NASAL,20160229,,NDA,NDA205434,Haleon US Holdings LLC,FLUTICASONE PROPIONATE,50,ug/1,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0590,HUMAN OTC DRUG,AQUAFRESH,CAVITY PROTECTION,sodium fluoride,PASTE,DENTAL,20161001,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,SODIUM FLUORIDE,1.15,mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0591,HUMAN OTC DRUG,AQUAFRESH,EXTRA FRESH PLUS WHITENING,sodium fluoride,PASTE,DENTAL,20140509,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,SODIUM FLUORIDE,1.15,mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0593,HUMAN OTC DRUG,sensodyne,,potassium nitrate and sodium fluoride,PASTE,DENTAL,20161219,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.15,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0598,HUMAN OTC DRUG,parodontax,,stannous fluoride,PASTE,DENTAL,20161219,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,STANNOUS FLUORIDE,1.1,mg/g,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0601,HUMAN OTC DRUG,parodontax,,stannous fluoride,PASTE,DENTAL,20161219,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,STANNOUS FLUORIDE,1.1,mg/g,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0602,HUMAN OTC DRUG,Sensodyne Pronamel,Strong and Bright Enamel Mint,potassium nitrate and sodium fluoride,PASTE,ORAL,20161219,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.15,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0603,HUMAN OTC DRUG,Sensodyne Pronamel,Strong and Bright Enamel Extra Fresh,potassium nitrate and sodium fluoride,PASTE,ORAL,20161219,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.15,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0604,HUMAN OTC DRUG,Aquafresh,Extreme Clean Pure Breath Action,sodium fluoride,PASTE,DENTAL,20160601,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,SODIUM FLUORIDE,1.15,mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0605,HUMAN OTC DRUG,AQUAFRESH,SENSITIVE MAXIMUM STRENGTH,potassium nitrate and sodium fluoride,PASTE,DENTAL,20170217,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.1,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0606,HUMAN OTC DRUG,Tums Chewy Bites,,calcium carbonate,"TABLET, CHEWABLE",ORAL,20170301,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,750,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0607,HUMAN OTC DRUG,Panadol,Cold and Flu NonDrowsy,acetaminophen and phenyleprine HCl,"TABLET, FILM COATED",ORAL,20170601,,OTC MONOGRAPH DRUG,M013,Haleon US Holdings LLC,ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE,325; 5,mg/1; mg/1,"Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0608,HUMAN OTC DRUG,PANADOL,PM,acetaminophen and diphenhydramine HCl,"TABLET, FILM COATED",ORAL,20161201,,OTC MONOGRAPH DRUG,M013,Haleon US Holdings LLC,ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE,500; 25,mg/1; mg/1,"Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0609,HUMAN OTC DRUG,PANADOL,Extra Strength,acetaminophen,"TABLET, FILM COATED",ORAL,20170315,,OTC MONOGRAPH DRUG,M013,Haleon US Holdings LLC,ACETAMINOPHEN,500,mg/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0611,HUMAN OTC DRUG,Tums,Regular Strength,calcium carbonate,"TABLET, CHEWABLE",ORAL,20160901,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,500,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0615,HUMAN OTC DRUG,FLONASE SENSIMIST,ALLERGY RELIEF,fluticasone furoate,"SPRAY, METERED",NASAL,20170201,,NDA,NDA022051,Haleon US Holdings LLC,FLUTICASONE FUROATE,27.5,ug/1,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0616,HUMAN OTC DRUG,FLONASE SENSIMIST,ALLERGY RELIEF,fluticasone furoate,"SPRAY, METERED",NASAL,20170701,,NDA,NDA022051,Haleon US Holdings LLC,FLUTICASONE FUROATE,27.5,ug/1,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0618,HUMAN OTC DRUG,Tums Chewy Bites,,calcium carbonate,"TABLET, CHEWABLE",ORAL,20170518,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,750,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0620,HUMAN OTC DRUG,PANADOL,Extra,acetaminophen and caffeine,"TABLET, FILM COATED",ORAL,20170301,,OTC MONOGRAPH DRUG,M013,Haleon US Holdings LLC,ACETAMINOPHEN; CAFFEINE,500; 65,mg/1; mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0621,HUMAN OTC DRUG,SENSODYNE,Rapid Relief,stannous fluoride,PASTE,ORAL,20180108,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,STANNOUS FLUORIDE,1.1,mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0622,HUMAN OTC DRUG,SENSODYNE,Rapid Relief,stannous fluoride,PASTE,ORAL,20180108,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,STANNOUS FLUORIDE,1.1,mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0623,HUMAN OTC DRUG,Tums,Chewy Bites Peppermint,Calcium Carbonate,"TABLET, CHEWABLE",ORAL,20170801,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,750,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0624,HUMAN OTC DRUG,Tums Chewy Bites with Gas Relief,,calcium carbonate and simethicone,"TABLET, CHEWABLE",ORAL,20180301,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE; DIMETHICONE,750; 80,mg/1; mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0625,HUMAN OTC DRUG,NICORETTE,,nicotine polacrilex,LOZENGE,ORAL,20190411,,NDA,NDA021330,Haleon US Holdings LLC,NICOTINE,2,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0626,HUMAN OTC DRUG,NICORETTE,,nicotine polacrilex,LOZENGE,ORAL,20190411,,NDA,NDA021330,Haleon US Holdings LLC,NICOTINE,4,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0627,HUMAN OTC DRUG,parodontax,Complete Protection,stannous fluoride,PASTE,DENTAL,20181101,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,STANNOUS FLUORIDE,1.1,mg/g,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0630,HUMAN OTC DRUG,Tums Chewy Bites,,calcium carbonate,"TABLET, CHEWABLE",ORAL,20190301,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,750,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0631,HUMAN OTC DRUG,Tums Chewy Bites,,calcium carbonate,"TABLET, CHEWABLE",ORAL,20190301,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,750,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0632,HUMAN OTC DRUG,SENSODYNE,Rapid Relief,stannous fluoride,PASTE,ORAL,20190708,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,STANNOUS FLUORIDE,1.1,mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0633,HUMAN OTC DRUG,Tums Chewy Bites,,calcium carbonate,"TABLET, CHEWABLE",ORAL,20190928,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,750,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0634,HUMAN OTC DRUG,parodontax,Complete Protection,stannous fluoride,PASTE,DENTAL,20200106,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,STANNOUS FLUORIDE,1.1,mg/g,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0635,HUMAN OTC DRUG,NICORETTE,,nicotine polacrilex,LOZENGE,ORAL,20220601,,ANDA,ANDA077007,Haleon US Holdings LLC,NICOTINE,2,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0636,HUMAN OTC DRUG,NICORETTE,,nicotine polacrilex,LOZENGE,ORAL,20220601,,ANDA,ANDA077007,Haleon US Holdings LLC,NICOTINE,4,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0637,HUMAN OTC DRUG,parodontax,Active Gum Repair,stannous fluoride,PASTE,DENTAL,20210104,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,STANNOUS FLUORIDE,1.1,mg/g,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0638,HUMAN OTC DRUG,parodontax,Active Gum Repair Whitening,stannous fluoride,PASTE,DENTAL,20220103,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,STANNOUS FLUORIDE,1.1,mg/g,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0641,HUMAN OTC DRUG,Tums Chewy Bites,Mixed Fruit,calcium carbonate,"TABLET, CHEWABLE",ORAL,20210115,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,1000,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0642,HUMAN OTC DRUG,Tums Chewy Bites,Orange and Cream ES,calcium carbonate,"TABLET, CHEWABLE",ORAL,20210305,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,750,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0643,HUMAN OTC DRUG,Sensodyne,Extra Whitening Cool Mint,potassium nitrate and sodium fluoride,PASTE,DENTAL,20230403,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.15,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0644,HUMAN OTC DRUG,Sensodyne Pronamel,Gentle Whitening Fresh Mint,potassium nitrate and sodium fluoride,PASTE,DENTAL,20230403,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.15,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0650,HUMAN OTC DRUG,Parodontax,Active Gum Health Clear Mint,cetylpyridinium chloride,MOUTHWASH,ORAL,20220103,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,CETYLPYRIDINIUM CHLORIDE,0.7,mg/mL,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0651,HUMAN OTC DRUG,Parodontax,Active Gum Health Mint,cetylpyridinium chloride,MOUTHWASH,ORAL,20220103,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,CETYLPYRIDINIUM CHLORIDE,70,mg/mL,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0652,HUMAN OTC DRUG,Parodontax,Active Gum Health Daily Mouthwash Breath Freshener,Cetylpyridinium chloride,LIQUID,ORAL,20240102,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,CETYLPYRIDINIUM CHLORIDE,70,mg/mL,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0700,HUMAN OTC DRUG,SENSODYNE PRONAMEL,Active Shield Fresh Mint,potassium nitrate and sodium fluoride,PASTE,ORAL,20230102,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.15,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0701,HUMAN OTC DRUG,SENSODYNE PRONAMEL,Active Shield Cool Mint,potassium nitrate and sodium fluoride,PASTE,ORAL,20230102,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.15,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0702,HUMAN OTC DRUG,Sensodyne,Clinical White Stain Protector,"Potassium nitrate, Sodium fluoride",PASTE,ORAL,20240102,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 2.5,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0703,HUMAN OTC DRUG,Sensodyne,Clinical White Enamel Strengthening,"Potassium nitrate, Sodium fluoride",PASTE,ORAL,20240102,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 2.5,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0710,HUMAN OTC DRUG,Polident,ProPartial,stannous fluoride,PASTE,DENTAL,20210104,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,STANNOUS FLUORIDE,1.5,mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0737,HUMAN OTC DRUG,parodontax,Active Gum Repair Breath Freshener,stannous fluoride,PASTE,DENTAL,20240102,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,STANNOUS FLUORIDE,1.1,mg/g,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0808,HUMAN OTC DRUG,Sensodyne Pronamel,Kids Bubble Twist,sodium fluoride,PASTE,DENTAL,20250106,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,SODIUM FLUORIDE,1.1,mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0809,HUMAN OTC DRUG,Sensodyne Pronamel,Kids Berry Twist,sodium fluoride,PASTE,DENTAL,20250106,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,SODIUM FLUORIDE,1.1,mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0810,HUMAN OTC DRUG,Sensodyne Pronamel,Clinical Enamel Strength Deep Clean,"potassium nitrate, sodium fluoride",PASTE,ORAL,20250106,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.15,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-0811,HUMAN OTC DRUG,Sensodyne Pronamel,Clinical Enamel Strength Whitening Action,"potassium nitrate, sodium fluoride",PASTE,ORAL,20250106,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.15,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-1000,HUMAN OTC DRUG,TUMS,,calcium carbonate,TABLET,ORAL,20211008,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,750,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-1001,HUMAN OTC DRUG,TUMS,,calcium carbonate,TABLET,ORAL,20211008,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,750,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-1002,HUMAN OTC DRUG,TUMS,"extra strength, smoothies",calcium carbonate,"TABLET, CHEWABLE",ORAL,20211129,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,750,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-1200,HUMAN OTC DRUG,NATEAN,Clean and Whiten,sodium fluoride,PASTE,ORAL,20220103,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,SODIUM FLUORIDE,1.5,mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-1250,HUMAN OTC DRUG,NATEAN,Clean plus Sensitivity Relief,"potassium nitrate, sodium fluoride",PASTE,ORAL,20220103,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.5,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-1326,HUMAN OTC DRUG,Tums,Naturals,calcium carbonate,"TABLET, CHEWABLE",ORAL,20201015,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,1000,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-1328,HUMAN OTC DRUG,Tums,Naturals,calcium carbonate,"TABLET, CHEWABLE",ORAL,20201015,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,1000,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-1329,HUMAN OTC DRUG,FLONASE,Nighttime Allergy Relief,triprolidine hcl,TABLET,ORAL,20221215,20260228,OTC MONOGRAPH DRUG,M012,Haleon US Holdings LLC,TRIPROLIDINE HYDROCHLORIDE,2.5,mg/1,,,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-1500,HUMAN OTC DRUG,NICORETTE,,nicotine polacrilex,LOZENGE,ORAL,20220601,,NDA,NDA022360,Haleon US Holdings LLC,NICOTINE,4,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-2029,HUMAN OTC DRUG,Chapstick,12 Days of Christmas,white petrolatum,KIT,,20210930,,OTC MONOGRAPH DRUG,M016,Haleon US Holdings LLC,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-2800,HUMAN OTC DRUG,NICORETTE,,nicotine polacrilex,LOZENGE,ORAL,20220601,,NDA,NDA022360,Haleon US Holdings LLC,NICOTINE,2,mg/1,"Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-5022,HUMAN OTC DRUG,SENSODYNE,Sensitivity Gum and Enamel Mint,stannous fluoride,PASTE,ORAL,20230102,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,STANNOUS FLUORIDE,1.1,mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-5023,HUMAN OTC DRUG,SENSODYNE,Sensitivity and Gum Mint,stannous fluoride,PASTE,ORAL,20200106,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,STANNOUS FLUORIDE,1.1,mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-5024,HUMAN OTC DRUG,SENSODYNE,Sensitivity and Gum Whitening,stannous fluoride,PASTE,ORAL,20200106,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,STANNOUS FLUORIDE,1.1,mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-5025,HUMAN OTC DRUG,SENSODYNE,SENSITIVITY AND GUM CLEAN AND FRESH,stannous fluoride,PASTE,ORAL,20210106,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,STANNOUS FLUORIDE,1.1,mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-5026,HUMAN OTC DRUG,Sensodyne,Nourish Gently Soothing,potassium nitrate and sodium fluoride,PASTE,DENTAL,20220103,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.15,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-5027,HUMAN OTC DRUG,Sensodyne,Nourish Healthy White,potassium nitrate and sodium fluoride,PASTE,DENTAL,20220103,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.15,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-5028,HUMAN OTC DRUG,Sensodyne,Natural white,potassium nitrate and sodium fluoride,PASTE,DENTAL,20220124,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.15,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-5029,HUMAN OTC DRUG,SENSODYNE,Advanced Whitening Plus,potassium nitrate,PASTE,ORAL,20240712,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.11,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-5030,HUMAN OTC DRUG,Sensodyne,Pronamel Gentle Whitening Advanced Plus,"potassium nitrate, sodium fluoride",PASTE,ORAL,20241001,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.11,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-5468,HUMAN OTC DRUG,Sensodyne,Clinical White Intensive Clean,"potassium nitrate, sodium fluoride",PASTE,ORAL,20241231,,OTC MONOGRAPH DRUG,M022,Haleon US Holdings LLC,POTASSIUM NITRATE; SODIUM FLUORIDE,50; 1.1,mg/g; mg/g,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-5969,HUMAN OTC DRUG,Tums Chewy Bites,Strawberries and Cream,calcium carbonate,"TABLET, CHEWABLE",ORAL,20250601,,OTC MONOGRAPH DRUG,M001,Haleon US Holdings LLC,CALCIUM CARBONATE,750,mg/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-7011,HUMAN OTC DRUG,PANADOL,Extra Strength,acetaminophen,"TABLET, FILM COATED",ORAL,20210215,,OTC MONOGRAPH DRUG,M013,Haleon US Holdings LLC,ACETAMINOPHEN,500,mg/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-7021,HUMAN OTC DRUG,PANADOL,PM,acetaminophen and diphenhydramine HCl,"TABLET, FILM COATED",ORAL,20210625,,OTC MONOGRAPH DRUG,M013,Haleon US Holdings LLC,ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE,500; 25,mg/1; mg/1,"Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0135-7031,HUMAN OTC DRUG,Panadol,Cold and Flu NonDrowsy,acetaminophen and phenyleprine HCl,"TABLET, FILM COATED",ORAL,20221220,,OTC MONOGRAPH DRUG,M013,Haleon US Holdings LLC,ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE,325; 5,mg/1; mg/1,"Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0140-0004,HUMAN PRESCRIPTION DRUG,Valium,,diazepam,TABLET,ORAL,19631115,20270810,NDA,NDA013263,Roche Laboratories Inc.,DIAZEPAM,2,mg/1,"Benzodiazepine [EPC], Benzodiazepines [CS]",CIV,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-1171,HUMAN PRESCRIPTION DRUG,Captopril,,Captopril,TABLET,ORAL,19960213,,ANDA,ANDA074505,Hikma Pharmaceuticals USA Inc.,CAPTOPRIL,12.5,mg/1,"Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-1172,HUMAN PRESCRIPTION DRUG,Captopril,,Captopril,TABLET,ORAL,19960213,,ANDA,ANDA074505,Hikma Pharmaceuticals USA Inc.,CAPTOPRIL,25,mg/1,"Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-1173,HUMAN PRESCRIPTION DRUG,Captopril,,Captopril,TABLET,ORAL,19960213,,ANDA,ANDA074505,Hikma Pharmaceuticals USA Inc.,CAPTOPRIL,50,mg/1,"Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-1174,HUMAN PRESCRIPTION DRUG,Captopril,,Captopril,TABLET,ORAL,19960213,,ANDA,ANDA074505,Hikma Pharmaceuticals USA Inc.,CAPTOPRIL,100,mg/1,"Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-1227,HUMAN PRESCRIPTION DRUG,Dicyclomine,,Dicyclomine hydrochloride,TABLET,ORAL,19961001,,ANDA,ANDA040161,Hikma Pharmaceuticals USA Inc.,DICYCLOMINE HYDROCHLORIDE,20,mg/1,"Anticholinergic [EPC], Cholinergic Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-1240,HUMAN PRESCRIPTION DRUG,Digoxin,,Digoxin,TABLET,ORAL,20071030,,ANDA,ANDA077002,Hikma Pharmaceuticals USA Inc.,DIGOXIN,125,ug/1,"Cardiac Glycoside [EPC], Cardiac Glycosides [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-1241,HUMAN PRESCRIPTION DRUG,Digoxin,,Digoxin,TABLET,ORAL,20071030,,ANDA,ANDA077002,Hikma Pharmaceuticals USA Inc.,DIGOXIN,250,ug/1,"Cardiac Glycoside [EPC], Cardiac Glycosides [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-1455,HUMAN PRESCRIPTION DRUG,Phenobarbital,,Phenobarbital,TABLET,ORAL,19990111,,UNAPPROVED DRUG OTHER,,Hikma Pharmaceuticals USA Inc.,PHENOBARBITAL,60,mg/1,,CIV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-1458,HUMAN PRESCRIPTION DRUG,Phenobarbital,,Phenobarbital,TABLET,ORAL,20000107,,UNAPPROVED DRUG OTHER,,Hikma Pharmaceuticals USA Inc.,PHENOBARBITAL,100,mg/1,,CIV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-1495,HUMAN PRESCRIPTION DRUG,Phenobarbital,,Phenobarbital,TABLET,ORAL,20200305,,UNAPPROVED DRUG OTHER,,Hikma Pharmaceuticals USA Inc.,PHENOBARBITAL,15,mg/1,,CIV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-1500,HUMAN PRESCRIPTION DRUG,Phenobarbital,,Phenobarbital,TABLET,ORAL,20200305,,UNAPPROVED DRUG OTHER,,Hikma Pharmaceuticals USA Inc.,PHENOBARBITAL,30,mg/1,,CIV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-1769,HUMAN PRESCRIPTION DRUG,Isosorbide Dinitrate,,Isosorbide Dinitrate,TABLET,ORAL,19781201,,ANDA,ANDA086067,Hikma Pharmaceuticals USA Inc.,ISOSORBIDE DINITRATE,5,mg/1,"Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-1771,HUMAN PRESCRIPTION DRUG,Isosorbide Dinitrate,,Isosorbide Dinitrate,TABLET,ORAL,19781201,,ANDA,ANDA086066,Hikma Pharmaceuticals USA Inc.,ISOSORBIDE DINITRATE,10,mg/1,"Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-1772,HUMAN PRESCRIPTION DRUG,Isosorbide Dinitrate,,Isosorbide Dinitrate,TABLET,ORAL,19830426,,ANDA,ANDA088088,Hikma Pharmaceuticals USA Inc.,ISOSORBIDE DINITRATE,20,mg/1,"Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-2112,HUMAN PRESCRIPTION DRUG,Doxycycline Hyclate,,Doxycycline Hyclate,"TABLET, COATED",ORAL,20030702,,ANDA,ANDA065095,Hikma Pharmaceuticals USA Inc.,DOXYCYCLINE HYCLATE,100,mg/1,"Tetracycline-class Drug [EPC], Tetracyclines [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-3018,HUMAN PRESCRIPTION DRUG,Colchicine,,Colchicine,CAPSULE,ORAL,20141001,,NDA,NDA204820,Hikma Pharmaceuticals USA Inc.,COLCHICINE,0.6,mg/1,"Alkaloid [EPC], Alkaloids [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9005,HUMAN PRESCRIPTION DRUG,Testosterone Cypionate,,Testosterone Cypionate,INJECTION,INTRAMUSCULAR,20211122,,ANDA,ANDA091244,Hikma Pharmaceuticals USA Inc.,TESTOSTERONE CYPIONATE,200,mg/mL,"Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]",CIII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9006,HUMAN PRESCRIPTION DRUG,AcetaZOLAMIDE,,Acetazolamide,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,19960501,,ANDA,ANDA040089,Hikma Pharmaceuticals USA Inc.,ACETAZOLAMIDE SODIUM,500,mg/1,"Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9022,HUMAN PRESCRIPTION DRUG,Fulvestrant,,Fulvestrant,INJECTION,INTRAMUSCULAR,20220210,,ANDA,ANDA214682,Hikma Pharmaceuticals USA Inc.,FULVESTRANT,50,mg/mL,"Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9084,HUMAN PRESCRIPTION DRUG,Doxorubicin Hydrochloride,,Doxorubicin Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,19960501,,ANDA,ANDA062975,Hikma Pharmaceuticals USA Inc.,DOXORUBICIN HYDROCHLORIDE,2,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9085,HUMAN PRESCRIPTION DRUG,Doxorubicin Hydrochloride,,Doxorubicin Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,19960501,,ANDA,ANDA062975,Hikma Pharmaceuticals USA Inc.,DOXORUBICIN HYDROCHLORIDE,2,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9086,HUMAN PRESCRIPTION DRUG,Doxorubicin Hydrochloride,,Doxorubicin Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,19960501,,ANDA,ANDA062975,Hikma Pharmaceuticals USA Inc.,DOXORUBICIN HYDROCHLORIDE,2,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9087,HUMAN PRESCRIPTION DRUG,Doxorubicin Hydrochloride,,Doxorubicin Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,19960501,,ANDA,ANDA064097,Hikma Pharmaceuticals USA Inc.,DOXORUBICIN HYDROCHLORIDE,2,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9088,HUMAN PRESCRIPTION DRUG,Doxorubicin Hydrochloride,,Doxorubicin Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,19960501,,ANDA,ANDA062975,Hikma Pharmaceuticals USA Inc.,DOXORUBICIN HYDROCHLORIDE,2,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9089,HUMAN PRESCRIPTION DRUG,Doxorubicin Hydrochloride,,Doxorubicin Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,19960501,,ANDA,ANDA062975,Hikma Pharmaceuticals USA Inc.,DOXORUBICIN HYDROCHLORIDE,2,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9090,HUMAN PRESCRIPTION DRUG,Doxorubicin Hydrochloride,,Doxorubicin Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,19960501,,ANDA,ANDA062975,Hikma Pharmaceuticals USA Inc.,DOXORUBICIN HYDROCHLORIDE,2,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9091,HUMAN PRESCRIPTION DRUG,Doxorubicin Hydrochloride,,Doxorubicin Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,19960501,,ANDA,ANDA064097,Hikma Pharmaceuticals USA Inc.,DOXORUBICIN HYDROCHLORIDE,2,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9092,HUMAN PRESCRIPTION DRUG,Doxorubicin Hydrochloride,,Doxorubicin Hydrochloride,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20180119,,ANDA,ANDA062921,Hikma Pharmaceuticals USA Inc.,DOXORUBICIN HYDROCHLORIDE,2,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9093,HUMAN PRESCRIPTION DRUG,Doxorubicin Hydrochloride,,Doxorubicin Hydrochloride,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20180119,,ANDA,ANDA062921,Hikma Pharmaceuticals USA Inc.,DOXORUBICIN HYDROCHLORIDE,2,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9098,HUMAN PRESCRIPTION DRUG,bortezomib,,bortezomib,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS; SUBCUTANEOUS,20220727,,ANDA,ANDA215011,Hikma Pharmaceuticals USA Inc.,BORTEZOMIB,3.5,mg/1,"Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9128,HUMAN PRESCRIPTION DRUG,Gentamicin,,Gentamicin,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20220215,,ANDA,ANDA062251,Hikma Pharmaceuticals USA Inc.,GENTAMICIN SULFATE,40,mg/mL,"Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9129,HUMAN PRESCRIPTION DRUG,Gentamicin,,Gentamicin,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20220215,,ANDA,ANDA062251,Hikma Pharmaceuticals USA Inc.,GENTAMICIN SULFATE,40,mg/mL,"Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9135,HUMAN PRESCRIPTION DRUG,Mitomycin,,Mitomycin,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20221001,,ANDA,ANDA064117,Hikma Pharmaceuticals USA Inc.,MITOMYCIN,20,mg/1,"Alkylating Activity [MoA], Alkylating Drug [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9136,HUMAN PRESCRIPTION DRUG,Mitomycin,,Mitomycin,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20221001,,ANDA,ANDA064117,Hikma Pharmaceuticals USA Inc.,MITOMYCIN,40,mg/1,"Alkylating Activity [MoA], Alkylating Drug [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9139,HUMAN PRESCRIPTION DRUG,Cefazolin,,Cefazolin,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,20230301,,NDA,NDA216109,Hikma Pharmaceuticals USA Inc.,CEFAZOLIN SODIUM,2,g/1,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9140,HUMAN PRESCRIPTION DRUG,Cefazolin,,Cefazolin,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,20230301,,NDA,NDA216109,Hikma Pharmaceuticals USA Inc.,CEFAZOLIN SODIUM,3,g/1,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9141,HUMAN PRESCRIPTION DRUG,Dobutamine,,Dobutamine,"INJECTION, SOLUTION",INTRAVENOUS,20230503,,ANDA,ANDA074277,Hikma Pharmaceuticals USA Inc.,DOBUTAMINE HYDROCHLORIDE,12.5,mg/mL,"Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9144,HUMAN PRESCRIPTION DRUG,Liraglutide,,liraglutide,INJECTION,SUBCUTANEOUS,20241224,,ANDA,ANDA215503,Hikma Pharmaceuticals USA Inc.,LIRAGLUTIDE,6,mg/mL,"GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9150,HUMAN PRESCRIPTION DRUG,COMBOGESIC IV,,acetaminophen and ibuprofen injection,INJECTION,INTRAVENOUS,20240205,,NDA,NDA215320,Hikma Pharmaceuticals USA Inc.,ACETAMINOPHEN; IBUPROFEN,1000; 300,mg/100mL; mg/100mL,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20251231,M79.3,"[{""icd10_code"":""M79.3"",""description"":""Panniculitis, unspecified"",""confidence"":0.3,""context"":""general pain/inflammation""},{""icd10_code"":""M25.50"",""description"":""Pain in unspecified joint"",""confidence"":0.25,""context"":""joint pain""},{""icd10_code"":""R50.9"",""description"":""Fever, unspecified"",""confidence"":0.2,""context"":""fever reduction""},{""icd10_code"":""G43.909"",""description"":""Migraine, unspecified, not intractable, without status migrainosus"",""confidence"":0.15,""context"":""headache""},{""icd10_code"":""M79.1"",""description"":""Myalgia"",""confidence"":0.1,""context"":""muscle pain""}]",0.30
0143-9151,HUMAN PRESCRIPTION DRUG,Dihydroergotamine Mesylate,,Dihydroergotamine Mesylate,INJECTION,INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,20230331,,ANDA,ANDA040453,Hikma Pharmaceuticals USA Inc.,DIHYDROERGOTAMINE MESYLATE,1,mg/mL,"Ergotamine Derivative [EPC], Ergotamines [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9152,HUMAN PRESCRIPTION DRUG,Vancomycin Hydrochloride,,Vancomycin Hydrochloride,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20230717,,ANDA,ANDA217489,Hikma Pharmaceuticals USA Inc.,VANCOMYCIN HYDROCHLORIDE,1.25,g/1,"Glycopeptide Antibacterial [EPC], Glycopeptides [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9153,HUMAN PRESCRIPTION DRUG,Vancomycin Hydrochloride,,Vancomycin Hydrochloride,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20230717,,ANDA,ANDA217489,Hikma Pharmaceuticals USA Inc.,VANCOMYCIN HYDROCHLORIDE,1.5,g/1,"Glycopeptide Antibacterial [EPC], Glycopeptides [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9155,HUMAN PRESCRIPTION DRUG,Furosemide,,Furosemide,INJECTION,INTRAMUSCULAR; INTRAVENOUS,20240531,,NDA,NDA018267,Hikma Pharmaceuticals USA Inc.,FUROSEMIDE,10,mg/mL,"Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9156,HUMAN PRESCRIPTION DRUG,Furosemide,,Furosemide,INJECTION,INTRAMUSCULAR; INTRAVENOUS,20240819,,NDA,NDA018267,Hikma Pharmaceuticals USA Inc.,FUROSEMIDE,10,mg/mL,"Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9157,HUMAN PRESCRIPTION DRUG,Furosemide,,Furosemide,INJECTION,INTRAMUSCULAR; INTRAVENOUS,20240819,,NDA,NDA018267,Hikma Pharmaceuticals USA Inc.,FUROSEMIDE,10,mg/mL,"Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9158,HUMAN PRESCRIPTION DRUG,Furosemide,,Furosemide,INJECTION,INTRAMUSCULAR; INTRAVENOUS,20240531,,NDA,NDA018267,Hikma Pharmaceuticals USA Inc.,FUROSEMIDE,10,mg/mL,"Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9159,HUMAN PRESCRIPTION DRUG,Furosemide,,Furosemide,INJECTION,INTRAMUSCULAR; INTRAVENOUS,20240531,,NDA,NDA018267,Hikma Pharmaceuticals USA Inc.,FUROSEMIDE,10,mg/mL,"Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9160,HUMAN PRESCRIPTION DRUG,Cisatracurium Besylate,,Cisatracurium Besylate,INJECTION,INTRAVENOUS,20250317,,ANDA,ANDA203078,Hikma Pharmaceuticals USA Inc.,CISATRACURIUM BESYLATE,10,mg/mL,"Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9161,HUMAN PRESCRIPTION DRUG,VANCOMYCIN HYDROCHLORIDE,,vancomycin hydrochloride,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS; ORAL,20230202,,NDA,NDA210274,HIKMA PHARMACEUTICALS USA INC.,VANCOMYCIN HYDROCHLORIDE,513,mg/mg,"Glycopeptide Antibacterial [EPC], Glycopeptides [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9162,HUMAN PRESCRIPTION DRUG,VANCOMYCIN HYDROCHLORIDE,,vancomycin hydrochloride,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS; ORAL,20230202,,NDA,NDA210274,HIKMA PHARMACEUTICALS USA INC.,VANCOMYCIN HYDROCHLORIDE,1025,mg/mg,"Glycopeptide Antibacterial [EPC], Glycopeptides [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9163,HUMAN PRESCRIPTION DRUG,VANCOMYCIN HYDROCHLORIDE,,vancomycin hydrochloride,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS; ORAL,20230203,,NDA,NDA210274,HIKMA PHARMACEUTICALS USA INC.,VANCOMYCIN HYDROCHLORIDE,5.13,g/g,"Glycopeptide Antibacterial [EPC], Glycopeptides [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9164,HUMAN PRESCRIPTION DRUG,VANCOMYCIN HYDROCHLORIDE,,vancomycin hydrochloride,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS; ORAL,20230202,,NDA,NDA210274,HIKMA PHARMACEUTICALS USA INC.,VANCOMYCIN HYDROCHLORIDE,10.25,g/g,"Glycopeptide Antibacterial [EPC], Glycopeptides [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9167,HUMAN PRESCRIPTION DRUG,ERIBULIN MESYLATE,,eribulin mesylate,INJECTION,INTRAVENOUS,20240628,,ANDA,ANDA218281,HIKMA PHARMACEUTICALS USA INC.,ERIBULIN MESYLATE,0.5,mg/mL,"Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9172,HUMAN PRESCRIPTION DRUG,Lidocaine,,Lidocaine Hydrochloride,"INJECTION, SOLUTION",INFILTRATION; PERINEURAL,20250520,,ANDA,ANDA080407,Hikma Pharmaceuticals USA Inc.,LIDOCAINE HYDROCHLORIDE,10,mg/mL,"Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9173,HUMAN PRESCRIPTION DRUG,Lidocaine,,Lidocaine Hydrochloride,"INJECTION, SOLUTION",INFILTRATION; PERINEURAL,20250520,,ANDA,ANDA080407,Hikma Pharmaceuticals USA Inc.,LIDOCAINE HYDROCHLORIDE,20,mg/mL,"Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9180,HUMAN PRESCRIPTION DRUG,calcium gluconate,,calcium gluconate,"INJECTION, SOLUTION",INTRAVENOUS,20231016,,ANDA,ANDA213071,Hikma Pharmaceuticals USA Inc.,CALCIUM GLUCONATE MONOHYDRATE,98,mg/mL,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9182,HUMAN PRESCRIPTION DRUG,Methylprednisolone Sodium Succinate,,Methylprednisolone Sodium Succinate,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20240115,,ANDA,ANDA202691,Hikma Pharmaceuticals USA Inc.,METHYLPREDNISOLONE SODIUM SUCCINATE,1,g/1,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9183,HUMAN PRESCRIPTION DRUG,Labetalol Hydrochloride,,Labetalol Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,20250131,,NDA,NDA213330,Hikma Pharmaceuticals USA Inc.,LABETALOL HYDROCHLORIDE,5,mg/mL,"Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9184,HUMAN PRESCRIPTION DRUG,calcium gluconate,,calcium gluconate,"INJECTION, SOLUTION",INTRAVENOUS,20231124,,ANDA,ANDA213071,Hikma Pharmaceuticals USA Inc.,CALCIUM GLUCONATE MONOHYDRATE,98,mg/mL,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9185,HUMAN PRESCRIPTION DRUG,calcium gluconate,,calcium gluconate,"INJECTION, SOLUTION",INTRAVENOUS,20240630,,ANDA,ANDA213071,Hikma Pharmaceuticals USA Inc.,CALCIUM GLUCONATE MONOHYDRATE,98,mg/mL,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9192,HUMAN PRESCRIPTION DRUG,Foscarnet Sodium,,foscarnet sodium,"INJECTION, SOLUTION",INTRAVENOUS,20231129,,ANDA,ANDA213987,Hikma Pharmaceuticals USA Inc.,FOSCARNET SODIUM,24,mg/mL,"Chelating Activity [MoA], DNA Polymerase Inhibitors [MoA], Pyrophosphate Analog DNA Polymerase Inhibitor [EPC], Pyrophosphate Analog [EXT]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9202,HUMAN PRESCRIPTION DRUG,Epirubicin Hydrochloride,,Epirubicin Hydrochloride,INJECTION,INTRAVENOUS,20070807,,ANDA,ANDA065289,Hikma Pharmaceuticals USA Inc.,EPIRUBICIN HYDROCHLORIDE,2,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9203,HUMAN PRESCRIPTION DRUG,Epirubicin Hydrochloride,,Epirubicin Hydrochloride,INJECTION,INTRAVENOUS,20070807,,ANDA,ANDA065289,Hikma Pharmaceuticals USA Inc.,EPIRUBICIN HYDROCHLORIDE,2,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9204,HUMAN PRESCRIPTION DRUG,Docetaxel,,Docetaxel,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,20210114,,ANDA,ANDA204490,Hikma Pharmaceuticals USA Inc.,DOCETAXEL,20,mg/mL,"Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9205,HUMAN PRESCRIPTION DRUG,Docetaxel,,Docetaxel,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,20210114,,ANDA,ANDA204490,Hikma Pharmaceuticals USA Inc.,DOCETAXEL,20,mg/mL,"Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9209,HUMAN PRESCRIPTION DRUG,Chloroprocaine Hydrochloride,,Chloroprocaine Hydrochloride,"INJECTION, SOLUTION",EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL,19981101,,ANDA,ANDA040273,Hikma Pharmaceuticals USA Inc.,CHLOROPROCAINE HYDROCHLORIDE,20,mg/mL,"Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9210,HUMAN PRESCRIPTION DRUG,Chloroprocaine Hydrochloride,,Chloroprocaine Hydrochloride,"INJECTION, SOLUTION",EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL,19981101,,ANDA,ANDA040273,Hikma Pharmaceuticals USA Inc.,CHLOROPROCAINE HYDROCHLORIDE,30,mg/mL,"Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9217,HUMAN PRESCRIPTION DRUG,Idarubicin Hydrochloride,,Idarubicin Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,20170130,,ANDA,ANDA065275,Hikma Pharmaceuticals USA Inc.,IDARUBICIN HYDROCHLORIDE,1,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9218,HUMAN PRESCRIPTION DRUG,Idarubicin Hydrochloride,,Idarubicin Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,20170130,,ANDA,ANDA065275,Hikma Pharmaceuticals USA Inc.,IDARUBICIN HYDROCHLORIDE,1,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9219,HUMAN PRESCRIPTION DRUG,Idarubicin Hydrochloride,,Idarubicin Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,20170130,,ANDA,ANDA065275,Hikma Pharmaceuticals USA Inc.,IDARUBICIN HYDROCHLORIDE,1,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9230,HUMAN PRESCRIPTION DRUG,Rifampin,,Rifampin,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20160303,,ANDA,ANDA205039,Hikma Pharmaceuticals USA Inc.,RIFAMPIN,600,mg/1,"Rifamycin Antibacterial [EPC], Rifamycins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9232,HUMAN PRESCRIPTION DRUG,Vecuronium Bromide,,Vecuronium Bromide,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,20190801,,ANDA,ANDA203725,Hikma Pharmaceuticals USA Inc.,VECURONIUM BROMIDE,20,mg/1,"Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9233,HUMAN PRESCRIPTION DRUG,Benztropine Mesylate,,Benztropine Mesylate,INJECTION,INTRAMUSCULAR; INTRAVENOUS,20211014,,ANDA,ANDA209442,Hikma Pharmaceuticals USA Inc.,BENZTROPINE MESYLATE,1,mg/mL,"Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9234,HUMAN PRESCRIPTION DRUG,Vecuronium Bromide,,Vecuronium Bromide,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,20190801,,ANDA,ANDA203725,Hikma Pharmaceuticals USA Inc.,VECURONIUM BROMIDE,10,mg/1,"Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9240,HUMAN PRESCRIPTION DRUG,Bleomycin,,Bleomycin,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS,20180109,,ANDA,ANDA065042,Hikma Pharmaceuticals USA Inc.,BLEOMYCIN SULFATE,15,[USP'U]/1,Cytoprotective Agent [EPC],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9241,HUMAN PRESCRIPTION DRUG,Bleomycin,,Bleomycin,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS,20180109,,ANDA,ANDA065042,Hikma Pharmaceuticals USA Inc.,BLEOMYCIN SULFATE,30,[USP'U]/1,Cytoprotective Agent [EPC],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9245,HUMAN PRESCRIPTION DRUG,Dacarbazine,,Dacarbazine,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20010808,,ANDA,ANDA075812,Hikma Pharmaceuticals USA Inc.,DACARBAZINE,10,mg/mL,"Alkylating Activity [MoA], Alkylating Drug [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9246,HUMAN PRESCRIPTION DRUG,Buprenorphine Hydrochloride,,Buprenorphine Hydrochloride,INJECTION,INTRAMUSCULAR; INTRAVENOUS,20050525,,ANDA,ANDA076931,Hikma Pharmaceuticals USA Inc.,BUPRENORPHINE HYDROCHLORIDE,0.324,mg/mL,"Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]",CIII,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9247,HUMAN PRESCRIPTION DRUG,Dexrazoxane,,Dexrazoxane,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20050331,,ANDA,ANDA076068,Hikma Pharmaceuticals USA Inc.,DEXRAZOXANE HYDROCHLORIDE,250,mg/1,Cytoprotective Agent [EPC],,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9248,HUMAN PRESCRIPTION DRUG,Dexrazoxane,,Dexrazoxane,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20050331,,ANDA,ANDA076068,Hikma Pharmaceuticals USA Inc.,DEXRAZOXANE HYDROCHLORIDE,500,mg/1,Cytoprotective Agent [EPC],,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9249,HUMAN PRESCRIPTION DRUG,Amoxicillin and Clavulanate Potassium,,Amoxicillin and Clavulanate Potassium,TABLET,ORAL,20160823,,ANDA,ANDA203824,Hikma Pharmaceuticals USA Inc.,AMOXICILLIN; CLAVULANATE POTASSIUM,875; 125,mg/1; mg/1,"Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9250,HUMAN PRESCRIPTION DRUG,Rocuronium Bromide,,Rocuronium Bromide,INJECTION,INTRAVENOUS,20170430,,ANDA,ANDA204679,Hikma Pharmaceuticals USA Inc.,ROCURONIUM BROMIDE,10,mg/mL,"Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9251,HUMAN PRESCRIPTION DRUG,Rocuronium Bromide,,Rocuronium Bromide,INJECTION,INTRAVENOUS,20170430,,ANDA,ANDA204679,Hikma Pharmaceuticals USA Inc.,ROCURONIUM BROMIDE,10,mg/mL,"Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9252,HUMAN PRESCRIPTION DRUG,Dopamine Hydrochloride,,Dopamine Hydrochloride,INJECTION,INTRAVENOUS,20180411,,ANDA,ANDA207707,Hikma Pharmaceuticals USA Inc.,DOPAMINE HYDROCHLORIDE,40,mg/mL,"Catecholamine [EPC], Catecholamines [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9253,HUMAN PRESCRIPTION DRUG,Dopamine Hydrochloride,,Dopamine Hydrochloride,INJECTION,INTRAVENOUS,20180411,,ANDA,ANDA207707,Hikma Pharmaceuticals USA Inc.,DOPAMINE HYDROCHLORIDE,80,mg/mL,"Catecholamine [EPC], Catecholamines [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9254,HUMAN PRESCRIPTION DRUG,Dopamine Hydrochloride,,Dopamine Hydrochloride,INJECTION,INTRAVENOUS,20180411,,ANDA,ANDA207707,Hikma Pharmaceuticals USA Inc.,DOPAMINE HYDROCHLORIDE,40,mg/mL,"Catecholamine [EPC], Catecholamines [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9255,HUMAN PRESCRIPTION DRUG,Dopamine Hydrochloride,,Dopamine Hydrochloride,INJECTION,INTRAVENOUS,20180411,,ANDA,ANDA207707,Hikma Pharmaceuticals USA Inc.,DOPAMINE HYDROCHLORIDE,80,mg/mL,"Catecholamine [EPC], Catecholamines [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9260,HUMAN PRESCRIPTION DRUG,mesna,,mesna,"INJECTION, SOLUTION",INTRAVENOUS,20040223,,ANDA,ANDA075739,Hikma Pharmaceuticals USA Inc.,MESNA,100,mg/mL,Cytoprotective Agent [EPC],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9261,HUMAN PRESCRIPTION DRUG,Cefazolin,,Cefazolin,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,20041018,,ANDA,ANDA065143,Hikma Pharmaceuticals USA Inc.,CEFAZOLIN SODIUM,10,g/1,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9262,HUMAN PRESCRIPTION DRUG,Cefazolin,,Cefazolin,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20010918,,ANDA,ANDA065047,Hikma Pharmaceuticals USA Inc.,CEFAZOLIN SODIUM,330,mg/mL,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9263,HUMAN PRESCRIPTION DRUG,Ropivacaine Hydrochloride,,Ropivacaine Hydrochloride,INJECTION,EPIDURAL; INFILTRATION,20200720,,ANDA,ANDA214074,Hikma Pharmaceuticals USA Inc.,ROPIVACAINE HYDROCHLORIDE,2,mg/mL,"Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9264,HUMAN PRESCRIPTION DRUG,Ropivacaine Hydrochloride,,Ropivacaine Hydrochloride,INJECTION,EPIDURAL; INFILTRATION,20200720,,ANDA,ANDA214074,Hikma Pharmaceuticals USA Inc.,ROPIVACAINE HYDROCHLORIDE,5,mg/mL,"Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9265,HUMAN PRESCRIPTION DRUG,Ropivacaine Hydrochloride,,Ropivacaine Hydrochloride,INJECTION,EPIDURAL,20200720,,ANDA,ANDA214074,Hikma Pharmaceuticals USA Inc.,ROPIVACAINE HYDROCHLORIDE,7.5,mg/mL,"Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9266,HUMAN PRESCRIPTION DRUG,Ropivacaine Hydrochloride,,Ropivacaine Hydrochloride,INJECTION,EPIDURAL,20200720,,ANDA,ANDA214074,Hikma Pharmaceuticals USA Inc.,ROPIVACAINE HYDROCHLORIDE,10,mg/mL,"Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9267,HUMAN PRESCRIPTION DRUG,Clindamycin in 5 percent Dextrose,,Clindamycin in percent Dextrose,"INJECTION, SOLUTION",INTRAVENOUS,20240612,,ANDA,ANDA214401,Hikma Pharmaceuticals USA Inc.,CLINDAMYCIN,6,mg/mL,"Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9268,HUMAN PRESCRIPTION DRUG,Clindamycin in 5 percent Dextrose,,Clindamycin in 5 percent Dextrose,"INJECTION, SOLUTION",INTRAVENOUS,20240612,,ANDA,ANDA214401,Hikma Pharmaceuticals USA Inc.,CLINDAMYCIN,12,mg/mL,"Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9269,HUMAN PRESCRIPTION DRUG,Clindamycin in 5 percent Dextrose,,Clindamycin in 5 percent Dextrose,"INJECTION, SOLUTION",INTRAVENOUS,20240612,,ANDA,ANDA214401,Hikma Pharmaceuticals USA Inc.,CLINDAMYCIN,18,mg/mL,"Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9270,HUMAN PRESCRIPTION DRUG,Floxuridine,,Floxuridine,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRA-ARTERIAL,20180215,,ANDA,ANDA075387,Hikma Pharmaceuticals USA Inc.,FLOXURIDINE,100,mg/mL,"Antimetabolite [EPC], Deoxyuridine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9273,HUMAN PRESCRIPTION DRUG,Dihydroergotamine Mesylate,,Dihydroergotamine Mesylate,INJECTION,INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,20170915,,ANDA,ANDA206621,Hikma Pharmaceuticals USA Inc.,DIHYDROERGOTAMINE MESYLATE,1,mg/mL,"Ergotamine Derivative [EPC], Ergotamines [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9275,HUMAN PRESCRIPTION DRUG,Adriamycin,,Doxorubicin Hydrochloride,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20180119,,ANDA,ANDA062921,Hikma Pharmaceuticals USA Inc.,DOXORUBICIN HYDROCHLORIDE,2,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9277,HUMAN PRESCRIPTION DRUG,Adriamycin,,Doxorubicin Hydrochloride,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20180119,,ANDA,ANDA062921,Hikma Pharmaceuticals USA Inc.,DOXORUBICIN HYDROCHLORIDE,2,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9279,HUMAN PRESCRIPTION DRUG,Mitomycin,,Mitomycin,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,19960501,,ANDA,ANDA064117,Hikma Pharmaceuticals USA Inc.,MITOMYCIN,20,mg/40mL,"Alkylating Activity [MoA], Alkylating Drug [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9280,HUMAN PRESCRIPTION DRUG,Mitomycin,,Mitomycin,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,19990901,,ANDA,ANDA064117,Hikma Pharmaceuticals USA Inc.,MITOMYCIN,40,mg/80mL,"Alkylating Activity [MoA], Alkylating Drug [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9281,HUMAN PRESCRIPTION DRUG,Levetiracetam in Sodium Chloride,,Levetiracetam in Sodium Chloride,INJECTION,INTRAVENOUS,20250208,,ANDA,ANDA211356,Hikma Pharmaceuticals USA Inc.,LEVETIRACETAM,5,mg/mL,Decreased Central Nervous System Disorganized Electrical Activity [PE],,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9282,HUMAN PRESCRIPTION DRUG,Levetiracetam in Sodium Chloride,,Levetiracetam in Sodium Chloride,INJECTION,INTRAVENOUS,20250208,,ANDA,ANDA211356,Hikma Pharmaceuticals USA Inc.,LEVETIRACETAM,10,mg/mL,Decreased Central Nervous System Disorganized Electrical Activity [PE],,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9283,HUMAN PRESCRIPTION DRUG,Levetiracetam in Sodium Chloride,,Levetiracetam in Sodium Chloride,INJECTION,INTRAVENOUS,20250208,,ANDA,ANDA211356,Hikma Pharmaceuticals USA Inc.,LEVETIRACETAM,15,mg/mL,Decreased Central Nervous System Disorganized Electrical Activity [PE],,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9284,HUMAN PRESCRIPTION DRUG,Pantoprazole Sodium,,Pantoprazole Sodium,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20170922,,NDA,NDA209463,Hikma Pharmaceuticals USA Inc.,PANTOPRAZOLE SODIUM,40,mg/1,"Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9285,HUMAN PRESCRIPTION DRUG,Amoxicillin,,Amoxicillin,"TABLET, COATED",ORAL,20060329,,ANDA,ANDA065255,Hikma Pharmaceuticals USA Inc.,AMOXICILLIN,875,mg/1,"Penicillin-class Antibacterial [EPC], Penicillins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9288,HUMAN PRESCRIPTION DRUG,Argatroban,,Argatroban,INJECTION,INTRAVENOUS,20120105,,NDA,NDA203049,Hikma Pharmaceuticals USA Inc.,ARGATROBAN,250,mg/2.5mL,"Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9289,HUMAN PRESCRIPTION DRUG,Estradiol Valerate,,Estradiol Valerate,INJECTION,INTRAMUSCULAR,20200421,,ANDA,ANDA203723,Hikma Pharmaceuticals USA Inc.,ESTRADIOL VALERATE,10,mg/mL,"Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9290,HUMAN PRESCRIPTION DRUG,Estradiol Valerate,,Estradiol Valerate,INJECTION,INTRAMUSCULAR,20200421,,ANDA,ANDA203723,Hikma Pharmaceuticals USA Inc.,ESTRADIOL VALERATE,20,mg/mL,"Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9291,HUMAN PRESCRIPTION DRUG,Estradiol Valerate,,Estradiol Valerate,INJECTION,INTRAMUSCULAR,20200421,,ANDA,ANDA203723,Hikma Pharmaceuticals USA Inc.,ESTRADIOL VALERATE,40,mg/mL,"Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9292,HUMAN PRESCRIPTION DRUG,Thiotepa,,Thiotepa,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRACAVITARY; INTRAVENOUS; INTRAVESICAL,20230929,,ANDA,ANDA211755,Hikma Pharmaceuticals USA Inc.,THIOTEPA,100,mg/1,"Alkylating Activity [MoA], Alkylating Drug [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9295,HUMAN PRESCRIPTION DRUG,Haloperidol Decanoate,,Haloperidol Decanoate,INJECTION,INTRAMUSCULAR,19981001,,ANDA,ANDA075305,Hikma Pharmaceuticals USA Inc.,HALOPERIDOL DECANOATE,100,mg/mL,Typical Antipsychotic [EPC],,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9296,HUMAN PRESCRIPTION DRUG,Haloperidol Decanoate,,Haloperidol Decanoate,INJECTION,INTRAMUSCULAR,19981001,,ANDA,ANDA075305,Hikma Pharmaceuticals USA Inc.,HALOPERIDOL DECANOATE,100,mg/mL,Typical Antipsychotic [EPC],,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9297,HUMAN PRESCRIPTION DRUG,Dantrolene,,Dantrolene,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,20170619,,ANDA,ANDA204762,Hikma Pharmaceuticals USA Inc.,DANTROLENE SODIUM,20,mg/1,"Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9298,HUMAN PRESCRIPTION DRUG,Sodium Ferric Gluconate Complex in Sucrose,,Sodium Ferric Gluconate Complex in Sucrose,INJECTION,INTRAVENOUS,20110331,,ANDA,ANDA078215,Hikma Pharmaceuticals USA Inc.,SODIUM FERRIC GLUCONATE COMPLEX,12.5,mg/mL,"Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9299,HUMAN PRESCRIPTION DRUG,Ganciclovir,,Ganciclovir sodium,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20210617,,ANDA,ANDA076222,Hikma Pharmaceuticals USA Inc.,GANCICLOVIR SODIUM,50,mg/mL,"Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9300,HUMAN PRESCRIPTION DRUG,Pantoprazole Sodium,,Pantoprazole Sodium,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20170922,,NDA,NDA209463,Hikma Pharmaceuticals USA Inc.,PANTOPRAZOLE SODIUM,40,mg/1,"Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9306,HUMAN PRESCRIPTION DRUG,Idarubicin Hydrochloride,,Idarubicin Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,20180112,,ANDA,ANDA065275,Hikma Pharmaceuticals USA Inc.,IDARUBICIN HYDROCHLORIDE,1,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9307,HUMAN PRESCRIPTION DRUG,Idarubicin Hydrochloride,,Idarubicin Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,20180112,,ANDA,ANDA065275,Hikma Pharmaceuticals USA Inc.,IDARUBICIN HYDROCHLORIDE,1,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9308,HUMAN PRESCRIPTION DRUG,Idarubicin Hydrochloride,,Idarubicin Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,20180112,,ANDA,ANDA065275,Hikma Pharmaceuticals USA Inc.,IDARUBICIN HYDROCHLORIDE,1,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9309,HUMAN PRESCRIPTION DRUG,Thiotepa,,Thiotepa,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRACAVITARY; INTRAVENOUS; INTRAVESICAL,20010601,,ANDA,ANDA075547,Hikma Pharmaceuticals USA Inc.,THIOTEPA,15,mg/1.5mL,"Alkylating Activity [MoA], Alkylating Drug [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9310,HUMAN PRESCRIPTION DRUG,Etomidate,,Etomidate,INJECTION,INTRAVENOUS,20160225,,ANDA,ANDA202354,Hikma Pharmaceuticals USA Inc.,ETOMIDATE,2,mg/mL,"General Anesthesia [PE], General Anesthetic [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9311,HUMAN PRESCRIPTION DRUG,Etomidate,,Etomidate,INJECTION,INTRAVENOUS,20160225,,ANDA,ANDA202354,Hikma Pharmaceuticals USA Inc.,ETOMIDATE,2,mg/mL,"General Anesthesia [PE], General Anesthetic [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9315,HUMAN PRESCRIPTION DRUG,Levofloxacin,,Levofloxacin,"INJECTION, SOLUTION",INTRAVENOUS,20110916,,ANDA,ANDA091375,Hikma Pharmaceuticals USA Inc.,LEVOFLOXACIN,250,mg/50mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9316,HUMAN PRESCRIPTION DRUG,Levofloxacin,,Levofloxacin,"INJECTION, SOLUTION",INTRAVENOUS,20110916,,ANDA,ANDA091375,Hikma Pharmaceuticals USA Inc.,LEVOFLOXACIN,500,mg/100mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9317,HUMAN PRESCRIPTION DRUG,Levofloxacin,,Levofloxacin,"INJECTION, SOLUTION",INTRAVENOUS,20110916,,ANDA,ANDA091375,Hikma Pharmaceuticals USA Inc.,LEVOFLOXACIN,750,mg/150mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9318,HUMAN PRESCRIPTION DRUG,Norepinephrine Bitartrate,,Norepinephrine Bitartrate,INJECTION,INTRAVENOUS,20180801,,ANDA,ANDA203662,Hikma Pharmaceuticals USA Inc.,NOREPINEPHRINE BITARTRATE,1,mg/mL,"Catecholamine [EPC], Catecholamines [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9319,HUMAN PRESCRIPTION DRUG,Haloperidol,,Haloperidol lactate,INJECTION,INTRAMUSCULAR,20180914,,ANDA,ANDA075858,Hikma Pharmaceuticals USA Inc.,HALOPERIDOL LACTATE,5,mg/mL,Typical Antipsychotic [EPC],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9320,HUMAN PRESCRIPTION DRUG,Labetalol Hydrochloride,,Labetalol Hydrochloride,INJECTION,INTRAVENOUS,19991129,,ANDA,ANDA075303,Hikma Pharmaceuticals USA Inc.,LABETALOL HYDROCHLORIDE,5,mg/mL,"Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9326,HUMAN PRESCRIPTION DRUG,Milrinone Lactate,,Milrinone Lactate,"INJECTION, SOLUTION",INTRAVENOUS,20101203,,ANDA,ANDA077966,Hikma Pharmaceuticals USA Inc.,MILRINONE LACTATE,1,mg/mL,"Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9328,HUMAN PRESCRIPTION DRUG,Bupivacaine Hydrochloride,,Bupivacaine Hydrochloride,"INJECTION, SOLUTION",INFILTRATION; PERINEURAL,20210211,,ANDA,ANDA205141,Hikma Pharmaceuticals USA Inc.,BUPIVACAINE HYDROCHLORIDE,2.5,mg/mL,"Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9329,HUMAN PRESCRIPTION DRUG,Bupivacaine Hydrochloride,,Bupivacaine Hydrochloride,"INJECTION, SOLUTION",PERINEURAL,20210211,,ANDA,ANDA205141,Hikma Pharmaceuticals USA Inc.,BUPIVACAINE HYDROCHLORIDE,5,mg/mL,"Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9330,HUMAN PRESCRIPTION DRUG,Bupivacaine Hydrochloride,,Bupivacaine Hydrochloride,"INJECTION, SOLUTION",EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL,20210211,,ANDA,ANDA204842,Hikma Pharmaceuticals USA Inc.,BUPIVACAINE HYDROCHLORIDE,2.5,mg/mL,"Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9331,HUMAN PRESCRIPTION DRUG,Bupivacaine Hydrochloride,,Bupivacaine Hydrochloride,"INJECTION, SOLUTION",EPIDURAL; INTRACAUDAL; PERINEURAL,20210211,,ANDA,ANDA204842,Hikma Pharmaceuticals USA Inc.,BUPIVACAINE HYDROCHLORIDE,5,mg/mL,"Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9332,HUMAN PRESCRIPTION DRUG,Bupivacaine Hydrochloride,,Bupivacaine Hydrochloride,"INJECTION, SOLUTION",EPIDURAL; RETROBULBAR,20210211,,ANDA,ANDA204842,Hikma Pharmaceuticals USA Inc.,BUPIVACAINE HYDROCHLORIDE,7.5,mg/mL,"Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9333,HUMAN PRESCRIPTION DRUG,Bupivacaine Hydrochloride,,Bupivacaine Hydrochloride,"INJECTION, SOLUTION",EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL,20210211,,ANDA,ANDA204842,Hikma Pharmaceuticals USA Inc.,BUPIVACAINE HYDROCHLORIDE,2.5,mg/mL,"Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9334,HUMAN PRESCRIPTION DRUG,Bupivacaine Hydrochloride,,Bupivacaine Hydrochloride,"INJECTION, SOLUTION",EPIDURAL; INTRACAUDAL; PERINEURAL,20210211,,ANDA,ANDA204842,Hikma Pharmaceuticals USA Inc.,BUPIVACAINE HYDROCHLORIDE,5,mg/mL,"Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9335,HUMAN PRESCRIPTION DRUG,Bupivacaine Hydrochloride,,Bupivacaine Hydrochloride,"INJECTION, SOLUTION",EPIDURAL; RETROBULBAR,20210211,,ANDA,ANDA204842,Hikma Pharmaceuticals USA Inc.,BUPIVACAINE HYDROCHLORIDE,7.5,mg/mL,"Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9338,HUMAN PRESCRIPTION DRUG,Succinylcholine Chloride,,Succinylcholine Chloride,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20210426,,ANDA,ANDA213229,Hikma Pharmaceuticals USA Inc.,SUCCINYLCHOLINE CHLORIDE DIHYDRATE,20,mg/mL,"Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9339,HUMAN PRESCRIPTION DRUG,Sterile Water,,Sterile Water,"INJECTION, SOLUTION",INTRAVENOUS,20230505,,ANDA,ANDA212735,Hikma Pharmaceuticals USA Inc.,WATER,1,mL/mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9355,HUMAN PRESCRIPTION DRUG,Vancomycin Hydrochloride,,Vancomycin Hydrochloride,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20181003,,ANDA,ANDA206616,Hikma Pharmaceuticals USA Inc.,VANCOMYCIN,750,mg/1,"Glycopeptide Antibacterial [EPC], Glycopeptides [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9356,HUMAN PRESCRIPTION DRUG,Vancomycin Hydrochloride,,Vancomycin Hydrochloride,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20200811,,ANDA,ANDA203300,Hikma Pharmaceuticals USA Inc.,VANCOMYCIN HYDROCHLORIDE,500,mg/1,"Glycopeptide Antibacterial [EPC], Glycopeptides [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9357,HUMAN PRESCRIPTION DRUG,Vancomycin Hydrochloride,,Vancomycin Hydrochloride,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20200811,,ANDA,ANDA203300,Hikma Pharmaceuticals USA Inc.,VANCOMYCIN HYDROCHLORIDE,1,g/1,"Glycopeptide Antibacterial [EPC], Glycopeptides [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9358,HUMAN PRESCRIPTION DRUG,Vancomycin Hydrochloride,,Vancomycin Hydrochloride,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,20181015,,ANDA,ANDA204360,Hikma Pharmaceuticals USA Inc.,VANCOMYCIN HYDROCHLORIDE,5,g/1,"Glycopeptide Antibacterial [EPC], Glycopeptides [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9359,HUMAN PRESCRIPTION DRUG,Vancomycin Hydrochloride,,Vancomycin Hydrochloride,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,20181015,,ANDA,ANDA204360,Hikma Pharmaceuticals USA Inc.,VANCOMYCIN HYDROCHLORIDE,10,g/1,"Glycopeptide Antibacterial [EPC], Glycopeptides [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9361,HUMAN PRESCRIPTION DRUG,Micafungin,,Micafungin sodium,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20210709,,ANDA,ANDA213261,Hikma Pharmaceuticals USA Inc.,MICAFUNGIN,50,mg/1,"Echinocandin Antifungal [EPC], Lipopeptides [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9362,HUMAN PRESCRIPTION DRUG,Micafungin,,Micafungin sodium,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20210709,,ANDA,ANDA213261,Hikma Pharmaceuticals USA Inc.,MICAFUNGIN,100,mg/1,"Echinocandin Antifungal [EPC], Lipopeptides [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9363,HUMAN PRESCRIPTION DRUG,Labetalol HCl in Sodium Chloride,,LABETALOL HYDROCHLORIDE,INJECTION,INTRAVENOUS,20201109,,NDA,NDA213330,Hikma Pharmaceuticals USA Inc.,LABETALOL HYDROCHLORIDE,1,mg/mL,"Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9364,HUMAN PRESCRIPTION DRUG,Labetalol HCl in Sodium Chloride,,LABETALOL HYDROCHLORIDE,INJECTION,INTRAVENOUS,20201109,,NDA,NDA213330,Hikma Pharmaceuticals USA Inc.,LABETALOL HYDROCHLORIDE,1,mg/mL,"Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9365,HUMAN PRESCRIPTION DRUG,Labetalol HCl in Sodium Chloride,,LABETALOL HYDROCHLORIDE,INJECTION,INTRAVENOUS,20201109,,NDA,NDA213330,Hikma Pharmaceuticals USA Inc.,LABETALOL HYDROCHLORIDE,1,mg/mL,"Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9366,HUMAN PRESCRIPTION DRUG,Labetalol HCl in Dextrose,,Labetalol Hydrochloride,INJECTION,INTRAVENOUS,20201109,,NDA,NDA213330,Hikma Pharmaceuticals USA Inc.,LABETALOL HYDROCHLORIDE,1,mg/mL,"Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9367,HUMAN PRESCRIPTION DRUG,Methotrexate,,Methotrexate,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS,20050906,,ANDA,ANDA040632,Hikma Pharmaceuticals USA Inc.,METHOTREXATE,1,g/1,"Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9368,HUMAN PRESCRIPTION DRUG,Leucovorin Calcium,,Leucovorin Calcium,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,19950523,,ANDA,ANDA040056,Hikma Pharmaceuticals USA Inc.,LEUCOVORIN CALCIUM,200,mg/20mL,"Folate Analog [EPC], Folic Acid [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9369,HUMAN PRESCRIPTION DRUG,Adriamycin,,Doxorubicin Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,19960501,,ANDA,ANDA062975,Hikma Pharmaceuticals USA Inc.,DOXORUBICIN HYDROCHLORIDE,2,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9370,HUMAN PRESCRIPTION DRUG,Adriamycin,,Doxorubicin Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,19960501,,ANDA,ANDA062975,Hikma Pharmaceuticals USA Inc.,DOXORUBICIN HYDROCHLORIDE,2,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9371,HUMAN PRESCRIPTION DRUG,Adriamycin,,Doxorubicin Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,19960501,,ANDA,ANDA062975,Hikma Pharmaceuticals USA Inc.,DOXORUBICIN HYDROCHLORIDE,2,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9372,HUMAN PRESCRIPTION DRUG,Adriamycin,,Doxorubicin Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,19960501,,ANDA,ANDA064097,Hikma Pharmaceuticals USA Inc.,DOXORUBICIN HYDROCHLORIDE,2,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9373,HUMAN PRESCRIPTION DRUG,Milrinone Lactate,,Milrinone Lactate,"INJECTION, SOLUTION",INTRAVENOUS,20101203,,ANDA,ANDA077966,Hikma Pharmaceuticals USA Inc.,MILRINONE LACTATE,1,mg/mL,"Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9374,HUMAN PRESCRIPTION DRUG,Milrinone Lactate,,Milrinone Lactate,"INJECTION, SOLUTION",INTRAVENOUS,20101203,,ANDA,ANDA077966,Hikma Pharmaceuticals USA Inc.,MILRINONE LACTATE,1,mg/mL,"Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9375,HUMAN PRESCRIPTION DRUG,Terbutaline Sulfate,,Terbutaline Sulfate,INJECTION,SUBCUTANEOUS,20090520,,ANDA,ANDA078630,Hikma Pharmaceuticals USA Inc.,TERBUTALINE SULFATE,1,mg/mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9376,HUMAN PRESCRIPTION DRUG,Etoposide,,Etoposide,INJECTION,INTRAVENOUS,19960501,,ANDA,ANDA074290,Hikma Pharmaceuticals USA Inc.,ETOPOSIDE,20,mg/mL,"Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9377,HUMAN PRESCRIPTION DRUG,Argatroban,,Argatroban,INJECTION,INTRAVENOUS,20200325,,NDA,NDA203049,Hikma Pharmaceuticals USA Inc.,ARGATROBAN,50,mg/50mL,"Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9378,HUMAN PRESCRIPTION DRUG,Daptomycin,,Daptomycin,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20200101,,ANDA,ANDA212022,Hikma Pharmaceuticals USA Inc.,DAPTOMYCIN,500,mg/10mL,"Lipopeptide Antibacterial [EPC], Lipopeptides [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9379,HUMAN PRESCRIPTION DRUG,Midazolam in Sodium Chloride,,Midazolam in Sodium Chloride,INJECTION,INTRAVENOUS,20230519,,ANDA,ANDA216159,Hikma Pharmaceuticals USA Inc.,MIDAZOLAM HYDROCHLORIDE,1,mg/mL,"Benzodiazepine [EPC], Benzodiazepines [CS]",CIV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9380,HUMAN PRESCRIPTION DRUG,Midazolam in Sodium Chloride,,Midazolam in Sodium Chloride,INJECTION,INTRAVENOUS,20230519,,ANDA,ANDA216159,Hikma Pharmaceuticals USA Inc.,MIDAZOLAM HYDROCHLORIDE,1,mg/mL,"Benzodiazepine [EPC], Benzodiazepines [CS]",CIV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9381,HUMAN PRESCRIPTION DRUG,Doxycycline,,Doxycycline,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,20210517,,ANDA,ANDA062992,Hikma Pharmaceuticals USA Inc.,DOXYCYCLINE HYCLATE,100,mg/1,"Tetracycline-class Drug [EPC], Tetracyclines [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9384,HUMAN PRESCRIPTION DRUG,FOSAPREPITANT DIMEGLUMINE,,FOSAPREPITANT DIMEGLUMINE,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20200908,,ANDA,ANDA213106,Hikma Pharmaceuticals USA Inc.,FOSAPREPITANT DIMEGLUMINE,150,mg/5mL,"Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9385,HUMAN PRESCRIPTION DRUG,decitabine,,decitabine,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20220415,,ANDA,ANDA213472,Hikma Pharmaceuticals USA Inc.,DECITABINE,50,mg/1,"Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9386,HUMAN PRESCRIPTION DRUG,Acetaminophen,,Acetaminophen,INJECTION,INTRAVENOUS,20220603,,NDA,NDA206968,Hikma Pharmaceuticals USA Inc.,ACETAMINOPHEN,1000,mg/100mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9387,HUMAN PRESCRIPTION DRUG,Triamcinolone Acetonide,,Triamcinolone Acetonide,"INJECTION, SUSPENSION",INTRA-ARTICULAR; INTRAMUSCULAR,20250303,,ANDA,ANDA215254,Hikma Pharmaceuticals USA Inc.,TRIAMCINOLONE ACETONIDE,40,mg/mL,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9391,HUMAN PRESCRIPTION DRUG,REMIFENTANIL HYDROCHLORIDE,,REMIFENTANIL HYDROCHLORIDE,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20210515,,ANDA,ANDA210594,Hikma Pharmaceuticals USA Inc.,REMIFENTANIL HYDROCHLORIDE,1,mg/mL,"Full Opioid Agonists [MoA], Opioid Agonist [EPC]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9392,HUMAN PRESCRIPTION DRUG,REMIFENTANIL HYDROCHLORIDE,,REMIFENTANIL HYDROCHLORIDE,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20210515,,ANDA,ANDA210594,Hikma Pharmaceuticals USA Inc.,REMIFENTANIL HYDROCHLORIDE,2,mg/2mL,"Full Opioid Agonists [MoA], Opioid Agonist [EPC]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9393,HUMAN PRESCRIPTION DRUG,REMIFENTANIL HYDROCHLORIDE,,REMIFENTANIL HYDROCHLORIDE,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20210515,,ANDA,ANDA210594,Hikma Pharmaceuticals USA Inc.,REMIFENTANIL HYDROCHLORIDE,5,mg/5mL,"Full Opioid Agonists [MoA], Opioid Agonist [EPC]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9396,HUMAN PRESCRIPTION DRUG,Cisatracurium Besylate,,Cisatracurium Besylate,INJECTION,INTRAVENOUS,20230531,,ANDA,ANDA203078,Hikma Pharmaceuticals USA Inc.,CISATRACURIUM BESYLATE,2,mg/mL,"Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9397,HUMAN PRESCRIPTION DRUG,Cisatracurium Besylate,,Cisatracurium Besylate,INJECTION,INTRAVENOUS,20250317,,ANDA,ANDA203079,Hikma Pharmaceuticals USA Inc.,CISATRACURIUM BESYLATE,2,mg/mL,"Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9398,HUMAN PRESCRIPTION DRUG,ertapenem sodium,,ertapenem sodium,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20210802,,ANDA,ANDA208790,"Hikma Pharmaceuticals USA, Inc.",ERTAPENEM SODIUM,1,g/1,"Carbapenems [CS], Penem Antibacterial [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9428,HUMAN PRESCRIPTION DRUG,FOSAPREPITANT DIMEGLUMINE,,FOSAPREPITANT DIMEGLUMINE,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20210501,,ANDA,ANDA213106,Hikma Pharmaceuticals USA Inc.,FOSAPREPITANT DIMEGLUMINE,150,mg/5mL,"Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9429,HUMAN PRESCRIPTION DRUG,Ertapenem,,ertapenem sodium,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20250228,,ANDA,ANDA218067,Hikma Pharmaceuticals USA Inc.,ERTAPENEM SODIUM,1,g/1,"Carbapenems [CS], Penem Antibacterial [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9430,HUMAN PRESCRIPTION DRUG,Meropenem,,Meropenem,INJECTION,INTRAVENOUS,20240901,,ANDA,ANDA216424,Hikma Pharmaceuticals USA Inc.,MEROPENEM,500,mg/20mL,"Carbapenems [CS], Penem Antibacterial [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9431,HUMAN PRESCRIPTION DRUG,Meropenem,,Meropenem,INJECTION,INTRAVENOUS,20240901,,ANDA,ANDA216424,Hikma Pharmaceuticals USA Inc.,MEROPENEM,1,g/30mL,"Carbapenems [CS], Penem Antibacterial [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9432,HUMAN PRESCRIPTION DRUG,Combogesic,,ACETAMINOPHEN and IBUPROFEN,"TABLET, FILM COATED",ORAL,20250106,,NDA,NDA209471,Hikma Pharmaceuticals USA Inc,ACETAMINOPHEN; IBUPROFEN,325; 97.5,mg/1; mg/1,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,20261231,M79.3,"[{""icd10_code"":""M79.3"",""description"":""Panniculitis, unspecified"",""confidence"":0.3,""context"":""general pain/inflammation""},{""icd10_code"":""M25.50"",""description"":""Pain in unspecified joint"",""confidence"":0.25,""context"":""joint pain""},{""icd10_code"":""R50.9"",""description"":""Fever, unspecified"",""confidence"":0.2,""context"":""fever reduction""},{""icd10_code"":""G43.909"",""description"":""Migraine, unspecified, not intractable, without status migrainosus"",""confidence"":0.15,""context"":""headache""},{""icd10_code"":""M79.1"",""description"":""Myalgia"",""confidence"":0.1,""context"":""muscle pain""}]",0.30
0143-9501,HUMAN PRESCRIPTION DRUG,Haloperidol,,Haloperidol lactate,INJECTION,INTRAMUSCULAR,20010619,,ANDA,ANDA075858,Hikma Pharmaceuticals USA Inc.,HALOPERIDOL LACTATE,5,mg/mL,Typical Antipsychotic [EPC],,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9502,HUMAN PRESCRIPTION DRUG,Haloperidol,,Haloperidol Lactate,INJECTION,INTRAMUSCULAR,20010619,,ANDA,ANDA075858,Hikma Pharmaceuticals USA Inc.,HALOPERIDOL LACTATE,5,mg/mL,Typical Antipsychotic [EPC],,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9503,HUMAN PRESCRIPTION DRUG,AcetaZOLAMIDE,,Acetazolamide,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,19960501,,ANDA,ANDA040089,Hikma Pharmaceuticals USA Inc.,ACETAZOLAMIDE SODIUM,500,mg/1,"Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9504,HUMAN PRESCRIPTION DRUG,CISplatin,,Cisplatin,INJECTION,INTRAVENOUS,20001107,,ANDA,ANDA075036,West-Ward Pharmaceuticals Corp,CISPLATIN,1,mg/mL,"Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9505,HUMAN PRESCRIPTION DRUG,CISplatin,,Cisplatin,INJECTION,INTRAVENOUS,20001107,,ANDA,ANDA075036,West-Ward Pharmaceuticals Corp,CISPLATIN,1,mg/mL,"Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9506,HUMAN PRESCRIPTION DRUG,Etomidate,,Etomidate,INJECTION,INTRAVENOUS,20160225,,ANDA,ANDA202354,Hikma Pharmaceuticals USA Inc.,ETOMIDATE,2,mg/mL,"General Anesthesia [PE], General Anesthetic [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9507,HUMAN PRESCRIPTION DRUG,Etomidate,,Etomidate,INJECTION,INTRAVENOUS,20160225,,ANDA,ANDA202354,Hikma Pharmaceuticals USA Inc.,ETOMIDATE,2,mg/mL,"General Anesthesia [PE], General Anesthetic [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9508,HUMAN PRESCRIPTION DRUG,Ketamine Hydrochloride,,Ketamine Hydrochloride,INJECTION,INTRAMUSCULAR; INTRAVENOUS,19960701,,ANDA,ANDA074524,Hikma Pharmaceuticals USA Inc.,KETAMINE HYDROCHLORIDE,50,mg/mL,"General Anesthesia [PE], General Anesthetic [EPC]",CIII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9509,HUMAN PRESCRIPTION DRUG,Ketamine Hydrochloride,,Ketamine Hydrochloride,INJECTION,INTRAMUSCULAR; INTRAVENOUS,19960701,,ANDA,ANDA074524,Hikma Pharmaceuticals USA Inc.,KETAMINE HYDROCHLORIDE,100,mg/mL,"General Anesthesia [PE], General Anesthetic [EPC]",CIII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9510,HUMAN PRESCRIPTION DRUG,Etoposide,,Etoposide,INJECTION,INTRAVENOUS,19960501,,ANDA,ANDA074290,Hikma Pharmaceuticals USA Inc.,ETOPOSIDE,20,mg/mL,"Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9511,HUMAN PRESCRIPTION DRUG,Etoposide,,Etoposide,INJECTION,INTRAVENOUS,19970201,,ANDA,ANDA074290,Hikma Pharmaceuticals USA Inc.,ETOPOSIDE,20,mg/mL,"Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9512,HUMAN PRESCRIPTION DRUG,Etoposide,,Etoposide,INJECTION,INTRAVENOUS,19970201,,ANDA,ANDA074290,Hikma Pharmaceuticals USA Inc.,ETOPOSIDE,20,mg/mL,"Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9513,HUMAN PRESCRIPTION DRUG,Palonosetron Hydrochloride,,Palonosetron Hydrochloride,INJECTION,INTRAVENOUS,20170901,,NDA,NDA207963,West-Ward Pharmaceuticals Corp,PALONOSETRON HYDROCHLORIDE,0.25,mg/2mL,"Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9514,HUMAN PRESCRIPTION DRUG,DROPERIDOL,,DROPERIDOL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20220601,,ANDA,ANDA208197,Hikma Pharmaceuticals USA Inc.,DROPERIDOL,2.5,mg/mL,"Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9515,HUMAN PRESCRIPTION DRUG,DROPERIDOL,,DROPERIDOL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20220601,,ANDA,ANDA208197,Hikma Pharmaceuticals USA Inc.,DROPERIDOL,2.5,mg/mL,"Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9516,HUMAN PRESCRIPTION DRUG,Methotrexate,,Methotrexate,SOLUTION,INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS,20180105,,ANDA,ANDA089343,Hikma Pharmaceuticals USA Inc.,METHOTREXATE,25,mg/mL,"Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9517,HUMAN PRESCRIPTION DRUG,Methotrexate,,Methotrexate,SOLUTION,INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS,20180105,,ANDA,ANDA089342,Hikma Pharmaceuticals USA Inc.,METHOTREXATE,25,mg/mL,"Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9518,HUMAN PRESCRIPTION DRUG,Methotrexate,,Methotrexate,SOLUTION,INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS,20180105,,ANDA,ANDA089341,Hikma Pharmaceuticals USA Inc.,METHOTREXATE,25,mg/mL,"Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9519,HUMAN PRESCRIPTION DRUG,Methotrexate,,Methotrexate,SOLUTION,INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS,20171010,,ANDA,ANDA089340,Hikma Pharmaceuticals USA Inc.,METHOTREXATE,25,mg/mL,"Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9525,HUMAN PRESCRIPTION DRUG,Dexmedetomidine Hydrochloride,,Dexmedetomidine Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,20200130,,ANDA,ANDA206407,Hikma Pharmaceuticals USA Inc.,DEXMEDETOMIDINE HYDROCHLORIDE,4,ug/mL,"Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9526,HUMAN PRESCRIPTION DRUG,Dexmedetomidine Hydrochloride,,Dexmedetomidine Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,20200130,,ANDA,ANDA206407,Hikma Pharmaceuticals USA Inc.,DEXMEDETOMIDINE HYDROCHLORIDE,4,ug/mL,"Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9529,HUMAN PRESCRIPTION DRUG,Fluphenazine Decanoate,,Fluphenazine Decanoate,INJECTION,INTRAMUSCULAR; SUBCUTANEOUS,19960830,,ANDA,ANDA074531,Hikma Pharmaceuticals USA Inc.,FLUPHENAZINE DECANOATE,25,mg/mL,"Phenothiazine [EPC], Phenothiazines [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9530,HUMAN PRESCRIPTION DRUG,Ifosfamide,,Ifosfamide,INJECTION,INTRAVENOUS,20170610,,ANDA,ANDA076619,Hikma Pharmaceuticals USA Inc.,IFOSFAMIDE,50,mg/mL,"Alkylating Activity [MoA], Alkylating Drug [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9531,HUMAN PRESCRIPTION DRUG,Ifosfamide,,Ifosfamide,INJECTION,INTRAVENOUS,20170610,,ANDA,ANDA076619,Hikma Pharmaceuticals USA Inc.,IFOSFAMIDE,50,mg/mL,"Alkylating Activity [MoA], Alkylating Drug [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9532,HUMAN PRESCRIPTION DRUG,Dexmedetomidine HCl,,Dexmedetomidine HCl,INJECTION,INTRAVENOUS,20170426,,ANDA,ANDA205046,Hikma Pharmaceuticals USA Inc.,DEXMEDETOMIDINE HYDROCHLORIDE,100,ug/mL,"Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9533,HUMAN PRESCRIPTION DRUG,Allopurinol sodium,,Allopurinol sodium,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20040901,,ANDA,ANDA076870,Hikma Pharmaceuticals USA Inc.,ALLOPURINOL SODIUM,500,mg/25mL,"Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9534,HUMAN PRESCRIPTION DRUG,Linezolid,,Linezolid,"INJECTION, SOLUTION",INTRAVENOUS,20221227,,ANDA,ANDA206454,Hikma Pharmaceuticals USA Inc.,LINEZOLID,600,mg/300mL,"Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9542,HUMAN PRESCRIPTION DRUG,Nicardipine Hydrochloride,,Nicardipine Hydrochloride,INJECTION,INTRAVENOUS,20120302,,NDA,NDA022276,Hikma Pharmaceuticals USA Inc.,NICARDIPINE HYDROCHLORIDE,2.5,mg/mL,"Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9546,HUMAN PRESCRIPTION DRUG,Adriamycin,,Doxorubicin Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,19960501,,ANDA,ANDA064097,Hikma Pharmaceuticals USA Inc.,DOXORUBICIN HYDROCHLORIDE,2,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9547,HUMAN PRESCRIPTION DRUG,Adriamycin,,Doxorubicin Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,19960501,,ANDA,ANDA062975,Hikma Pharmaceuticals USA Inc.,DOXORUBICIN HYDROCHLORIDE,2,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9548,HUMAN PRESCRIPTION DRUG,Adriamycin,,Doxorubicin Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,19960501,,ANDA,ANDA062975,Hikma Pharmaceuticals USA Inc.,DOXORUBICIN HYDROCHLORIDE,2,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9549,HUMAN PRESCRIPTION DRUG,Adriamycin,,Doxorubicin Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,19960501,,ANDA,ANDA062975,Hikma Pharmaceuticals USA Inc.,DOXORUBICIN HYDROCHLORIDE,2,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9550,HUMAN PRESCRIPTION DRUG,Daunorubicin Hydrochloride,,Daunorubicin Hydrochloride,INJECTION,INTRAVENOUS,20180102,,NDA,NDA050731,Hikma Pharmaceuticals USA Inc.,DAUNORUBICIN HYDROCHLORIDE,5,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9551,HUMAN PRESCRIPTION DRUG,Daunorubicin Hydrochloride,,Daunorubicin Hydrochloride,INJECTION,INTRAVENOUS,20180102,,NDA,NDA050731,Hikma Pharmaceuticals USA Inc.,DAUNORUBICIN HYDROCHLORIDE,5,mg/mL,"Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9552,HUMAN PRESCRIPTION DRUG,Leucovorin Calcium,,Leucovorin Calcium,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20000420,,ANDA,ANDA040335,Hikma Pharmaceuticals USA Inc.,LEUCOVORIN CALCIUM,350,mg/17.5mL,"Folate Analog [EPC], Folic Acid [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9553,HUMAN PRESCRIPTION DRUG,Leucovorin Calcium,,Leucovorin Calcium,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,19950523,,ANDA,ANDA040056,Hikma Pharmaceuticals USA Inc.,LEUCOVORIN CALCIUM,200,mg/20mL,"Folate Analog [EPC], Folic Acid [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9554,HUMAN PRESCRIPTION DRUG,Leucovorin Calcium,,Leucovorin Calcium,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,19880328,,ANDA,ANDA089717,Hikma Pharmaceuticals USA Inc.,LEUCOVORIN CALCIUM,100,mg/10mL,"Folate Analog [EPC], Folic Acid [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9555,HUMAN PRESCRIPTION DRUG,Leucovorin Calcium,,Leucovorin Calcium,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,19870914,,ANDA,ANDA089384,Hikma Pharmaceuticals USA Inc.,LEUCOVORIN CALCIUM,50,mg/5mL,"Folate Analog [EPC], Folic Acid [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9558,HUMAN PRESCRIPTION DRUG,Levoleucovorin,,Levoleucovorin,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20160707,,ANDA,ANDA206263,Hikma Pharmaceuticals USA Inc.,LEVOLEUCOVORIN CALCIUM,50,mg/5mL,"Folate Analog [EPC], Folic Acid [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9559,HUMAN PRESCRIPTION DRUG,Argatroban,,Argatroban,INJECTION,INTRAVENOUS,20161101,,NDA,NDA203049,Hikma Pharmaceuticals USA Inc.,ARGATROBAN,50,mg/50mL,"Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9564,HUMAN PRESCRIPTION DRUG,Phentolamine Mesylate,,Phentolamine Mesylate,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,19980515,,ANDA,ANDA040235,Hikma Pharmaceuticals USA Inc.,PHENTOLAMINE MESYLATE,5,mg/mL,"Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9565,HUMAN PRESCRIPTION DRUG,Thiotepa,,Thiotepa,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRACAVITARY; INTRAVENOUS; INTRAVESICAL,20010601,,ANDA,ANDA075547,Hikma Pharmaceuticals USA Inc.,THIOTEPA,15,mg/1.5mL,"Alkylating Activity [MoA], Alkylating Drug [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9566,HUMAN PRESCRIPTION DRUG,Azathioprine Sodium,,Azathioprine Sodium,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,19950501,,ANDA,ANDA074419,Hikma Pharmaceuticals USA Inc.,AZATHIOPRINE SODIUM,100,mg/10mL,"Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9567,HUMAN PRESCRIPTION DRUG,Cefuroxime,,Cefuroxime,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,20040109,,ANDA,ANDA065048,Hikma Pharmaceuticals USA Inc.,CEFUROXIME SODIUM,1.5,g/1,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9568,HUMAN PRESCRIPTION DRUG,Cefuroxime,,Cefuroxime,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20040109,,ANDA,ANDA065048,Hikma Pharmaceuticals USA Inc.,CEFUROXIME SODIUM,750,mg/1,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9569,HUMAN PRESCRIPTION DRUG,Cefuroxime,,Cefuroxime,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,20040109,,ANDA,ANDA065046,Hikma Pharmaceuticals USA Inc.,CEFUROXIME SODIUM,7.5,g/1,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9570,HUMAN PRESCRIPTION DRUG,Sodium Ferric Gluconate Complex in Sucrose,,Sodium Ferric Gluconate Complex in Sucrose,INJECTION,INTRAVENOUS,20110331,,ANDA,ANDA078215,Hikma Pharmaceuticals USA Inc.,SODIUM FERRIC GLUCONATE COMPLEX,12.5,mg/mL,"Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9574,HUMAN PRESCRIPTION DRUG,Levetiracetam,,Levetiracetam,INJECTION,INTRAVENOUS,20150601,,ANDA,ANDA090981,Hikma Pharmaceuticals USA Inc.,LEVETIRACETAM,100,mg/mL,Decreased Central Nervous System Disorganized Electrical Activity [PE],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9575,HUMAN PRESCRIPTION DRUG,Lidocaine,,Lidocaine Hydrochloride,"INJECTION, SOLUTION",INFILTRATION; PERINEURAL,19720214,,ANDA,ANDA080407,Hikma Pharmaceuticals USA Inc.,LIDOCAINE HYDROCHLORIDE,20,mg/mL,"Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9576,HUMAN PRESCRIPTION DRUG,Lidocaine,,Lidocaine Hydrochloride,"INJECTION, SOLUTION",INFILTRATION; PERINEURAL,19720214,,ANDA,ANDA080407,Hikma Pharmaceuticals USA Inc.,LIDOCAINE HYDROCHLORIDE,20,mg/mL,"Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9577,HUMAN PRESCRIPTION DRUG,Lidocaine,,Lidocaine Hydrochloride,"INJECTION, SOLUTION",INFILTRATION; PERINEURAL,19720214,,ANDA,ANDA080407,Hikma Pharmaceuticals USA Inc.,LIDOCAINE HYDROCHLORIDE,10,mg/mL,"Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9578,HUMAN PRESCRIPTION DRUG,Lidocaine,,Lidocaine Hydrochloride,"INJECTION, SOLUTION",INFILTRATION; PERINEURAL,19720214,,ANDA,ANDA080407,Hikma Pharmaceuticals USA Inc.,LIDOCAINE HYDROCHLORIDE,10,mg/mL,"Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9579,HUMAN PRESCRIPTION DRUG,Lidocaine,,LIDOCAINE HYDROCHLORIDE,"INJECTION, SOLUTION",INFILTRATION; PERINEURAL,19720214,,ANDA,ANDA080407,Hikma Pharmaceuticals USA Inc.,LIDOCAINE HYDROCHLORIDE,10,mg/mL,"Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9583,HUMAN PRESCRIPTION DRUG,Irinotecan Hydrochloride,,Irinotecan Hydrochloride,INJECTION,INTRAVENOUS,20101220,,ANDA,ANDA091032,Hikma Pharmaceuticals USA Inc.,IRINOTECAN HYDROCHLORIDE,20,mg/mL,"Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9584,HUMAN PRESCRIPTION DRUG,Glycopyrrolate,,Glycopyrrolate,INJECTION,INTRAMUSCULAR; INTRAVENOUS,20150601,,ANDA,ANDA090963,Hikma Pharmaceuticals USA Inc.,GLYCOPYRROLATE,0.2,mg/mL,"Anticholinergic [EPC], Cholinergic Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9585,HUMAN PRESCRIPTION DRUG,Glycopyrrolate,,Glycopyrrolate,INJECTION,INTRAMUSCULAR; INTRAVENOUS,20150601,,ANDA,ANDA090963,Hikma Pharmaceuticals USA Inc.,GLYCOPYRROLATE,0.2,mg/mL,"Anticholinergic [EPC], Cholinergic Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9586,HUMAN PRESCRIPTION DRUG,Glycopyrrolate,,Glycopyrrolate,INJECTION,INTRAMUSCULAR; INTRAVENOUS,20150601,,ANDA,ANDA090963,Hikma Pharmaceuticals USA Inc.,GLYCOPYRROLATE,0.2,mg/mL,"Anticholinergic [EPC], Cholinergic Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9587,HUMAN PRESCRIPTION DRUG,Glycopyrrolate,,Glycopyrrolate,INJECTION,INTRAMUSCULAR; INTRAVENOUS,20150601,,ANDA,ANDA090963,Hikma Pharmaceuticals USA Inc.,GLYCOPYRROLATE,0.2,mg/mL,"Anticholinergic [EPC], Cholinergic Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9593,HUMAN PRESCRIPTION DRUG,Nicardipine Hydrochloride,,Nicardipine Hydrochloride,INJECTION,INTRAVENOUS,20120302,,NDA,NDA022276,West-Ward Pharmaceuticals Corp,NICARDIPINE HYDROCHLORIDE,2.5,mg/mL,"Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9594,HUMAN PRESCRIPTION DRUG,Lidocaine Hydrochloride,,Lidocaine Hydrochloride,"INJECTION, SOLUTION",EPIDURAL; INFILTRATION; INTRACAUDAL,19750616,,ANDA,ANDA084625,Hikma Pharmaceuticals USA Inc.,LIDOCAINE HYDROCHLORIDE,20,mg/mL,"Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9595,HUMAN PRESCRIPTION DRUG,Lidocaine Hydrochloride,,LIDOCAINE HYDROCHLORIDE,"INJECTION, SOLUTION",EPIDURAL; INFILTRATION; INTRACAUDAL,19750616,,ANDA,ANDA084625,Hikma Pharmaceuticals USA Inc.,LIDOCAINE HYDROCHLORIDE,10,mg/mL,"Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9596,HUMAN PRESCRIPTION DRUG,Paricalcitol,,Paricalcitol,INJECTION,INTRAVENOUS,20141118,,NDA,NDA205917,West-Ward Pharmaceuticals Corp,PARICALCITOL,5,ug/mL,"Cholecalciferol [CS], Vitamin D3 Analog [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9597,HUMAN PRESCRIPTION DRUG,Abiraterone,,Abiraterone acetate,TABLET,ORAL,20181123,,ANDA,ANDA208339,Hikma Pharmaceuticals USA Inc.,ABIRATERONE ACETATE,250,mg/1,"Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9606,HUMAN PRESCRIPTION DRUG,Azacitidine,,Azacitidine,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS; SUBCUTANEOUS,20200608,,ANDA,ANDA209337,Hikma Pharmaceuticals USA Inc.,AZACITIDINE,100,mg/1,"Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9619,HUMAN PRESCRIPTION DRUG,Cyanocobalamin,,cyanocobalamin,INJECTION,INTRAMUSCULAR; SUBCUTANEOUS,19711020,,ANDA,ANDA080515,Hikma Pharmaceuticals USA Inc.,CYANOCOBALAMIN,1000,ug/mL,"Vitamin B 12 [CS], Vitamin B12 [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9620,HUMAN PRESCRIPTION DRUG,Cyanocobalamin,,cyanocobalamin,INJECTION,INTRAMUSCULAR; SUBCUTANEOUS,19711020,,ANDA,ANDA080515,Hikma Pharmaceuticals USA Inc.,CYANOCOBALAMIN,1000,ug/mL,"Vitamin B 12 [CS], Vitamin B12 [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9621,HUMAN PRESCRIPTION DRUG,Cyanocobalamin,,cyanocobalamin,INJECTION,INTRAMUSCULAR; SUBCUTANEOUS,19711020,,ANDA,ANDA080515,Hikma Pharmaceuticals USA Inc.,CYANOCOBALAMIN,1000,ug/mL,"Vitamin B 12 [CS], Vitamin B12 [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9622,HUMAN PRESCRIPTION DRUG,Labetalol Hydrochloride,,Labetalol Hydrochloride,INJECTION,INTRAVENOUS,19991129,,ANDA,ANDA075303,Hikma Pharmaceuticals USA Inc.,LABETALOL HYDROCHLORIDE,5,mg/mL,"Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9623,HUMAN PRESCRIPTION DRUG,Labetalol Hydrochloride,,Labetalol Hydrochloride,INJECTION,INTRAVENOUS,19991129,,ANDA,ANDA075303,Hikma Pharmaceuticals USA Inc.,LABETALOL HYDROCHLORIDE,5,mg/mL,"Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9624,HUMAN PRESCRIPTION DRUG,Paricalcitol,,Paricalcitol,INJECTION,INTRAVENOUS,20141118,,NDA,NDA205917,West-Ward Pharmaceuticals Corp,PARICALCITOL,5,ug/mL,"Cholecalciferol [CS], Vitamin D3 Analog [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9625,HUMAN PRESCRIPTION DRUG,Paricalcitol,,Paricalcitol,INJECTION,INTRAVENOUS,20141118,,NDA,NDA205917,West-Ward Pharmaceuticals Corp,PARICALCITOL,2,ug/mL,"Cholecalciferol [CS], Vitamin D3 Analog [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9633,HUMAN PRESCRIPTION DRUG,Nicardipine Hydrochloride,,Nicardipine Hydrochloride,INJECTION,INTRAVENOUS,20160407,,NDA,NDA022276,Hikma Pharmaceuticals USA Inc.,NICARDIPINE HYDROCHLORIDE,0.2,mg/mL,"Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9634,HUMAN PRESCRIPTION DRUG,Nicardipine Hydrochloride,,Nicardipine Hydrochloride,INJECTION,INTRAVENOUS,20160407,,NDA,NDA022276,Hikma Pharmaceuticals USA Inc.,NICARDIPINE HYDROCHLORIDE,0.1,mg/mL,"Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9637,HUMAN PRESCRIPTION DRUG,Valproate Sodium,,Valproate Sodium,INJECTION,INTRAVENOUS,20130415,,ANDA,ANDA078523,Hikma Pharmaceuticals USA Inc.,VALPROATE SODIUM,100,mg/mL,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9638,HUMAN PRESCRIPTION DRUG,SUMATRIPTAN,,sumatriptan,INJECTION,SUBCUTANEOUS,20130916,,ANDA,ANDA200183,Hikma Pharmaceuticals USA Inc.,SUMATRIPTAN SUCCINATE,6,mg/.5mL,"Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9642,HUMAN PRESCRIPTION DRUG,Zoledronic Acid,,zoledronic acid,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,20130603,,ANDA,ANDA202182,Hikma Pharmaceuticals USA Inc.,ZOLEDRONIC ACID,4,mg/5mL,"Bisphosphonate [EPC], Diphosphonates [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9657,HUMAN PRESCRIPTION DRUG,Acyclovir,,Acyclovir,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20160229,,ANDA,ANDA205771,Hikma Pharmaceuticals USA Inc.,ACYCLOVIR SODIUM,500,mg/1,"DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9658,HUMAN PRESCRIPTION DRUG,Acyclovir,,Acyclovir,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20160229,,ANDA,ANDA205771,Hikma Pharmaceuticals USA Inc.,ACYCLOVIR SODIUM,1,g/1,"DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9659,HUMAN PRESCRIPTION DRUG,Testosterone Cypionate,,Testosterone Cypionate,INJECTION,INTRAMUSCULAR,20120501,,ANDA,ANDA091244,Hikma Pharmaceuticals USA Inc.,TESTOSTERONE CYPIONATE,200,mg/mL,"Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]",CIII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9660,HUMAN PRESCRIPTION DRUG,Metoprolol Tartrate,,Metoroprolol Tartrate,"INJECTION, SOLUTION",INTRAVENOUS,20070530,,ANDA,ANDA077761,Hikma Pharmaceuticals USA Inc.,METOPROLOL TARTRATE,5,mg/5mL,"Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9665,HUMAN PRESCRIPTION DRUG,Cefazolin,,Cefazolin,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,20041018,,ANDA,ANDA065143,Hikma Pharmaceuticals USA Inc.,CEFAZOLIN SODIUM,20,g/1,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9666,HUMAN PRESCRIPTION DRUG,Fluconazole,,Fluconazole,INJECTION,INTRAVENOUS,20120130,,ANDA,ANDA078764,Hikma Pharmaceuticals USA Inc.,FLUCONAZOLE,2,mg/mL,"Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9667,HUMAN PRESCRIPTION DRUG,Fluconazole,,Fluconazole,INJECTION,INTRAVENOUS,20120130,,ANDA,ANDA078764,Hikma Pharmaceuticals USA Inc.,FLUCONAZOLE,2,mg/mL,"Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9668,HUMAN PRESCRIPTION DRUG,Fluconazole,,Fluconazole,INJECTION,INTRAVENOUS,20120130,,ANDA,ANDA078698,Hikma Pharmaceuticals USA Inc.,FLUCONAZOLE,2,mg/mL,"Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9669,HUMAN PRESCRIPTION DRUG,Fluconazole,,Fluconazole,INJECTION,INTRAVENOUS,20120130,,ANDA,ANDA078698,Hikma Pharmaceuticals USA Inc.,FLUCONAZOLE,2,mg/mL,"Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9670,HUMAN PRESCRIPTION DRUG,Cefotetan,,Cefotetan,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20111026,,ANDA,ANDA091031,Hikma Pharmaceuticals USA Inc.,CEFOTETAN,1,g/1,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9671,HUMAN PRESCRIPTION DRUG,Cefotetan,,Cefotetan,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20111026,,ANDA,ANDA091031,Hikma Pharmaceuticals USA Inc.,CEFOTETAN,2,g/1,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9673,HUMAN PRESCRIPTION DRUG,Levetiracetam,,Levetiracetam,INJECTION,INTRAVENOUS,20111013,,ANDA,ANDA090981,Hikma Pharmaceuticals USA Inc.,LEVETIRACETAM,100,mg/mL,Decreased Central Nervous System Disorganized Electrical Activity [PE],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9674,HUMAN PRESCRIPTION DRUG,Argatroban,,Argatroban,INJECTION,INTRAVENOUS,20120105,,NDA,NDA203049,Hikma Pharmaceuticals USA Inc.,ARGATROBAN,250,mg/2.5mL,"Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9678,HUMAN PRESCRIPTION DRUG,Ceftriaxone,,Ceftriaxone,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,20171004,,ANDA,ANDA090701,Hikma Pharmaceuticals USA Inc.,CEFTRIAXONE SODIUM,10,g/1,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9679,HUMAN PRESCRIPTION DRUG,Glycopyrrolate,,Glycopyrrolate,INJECTION,INTRAMUSCULAR; INTRAVENOUS,20110921,,ANDA,ANDA090963,Hikma Pharmaceuticals USA Inc.,GLYCOPYRROLATE,0.2,mg/mL,"Anticholinergic [EPC], Cholinergic Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9680,HUMAN PRESCRIPTION DRUG,Glycopyrrolate,,Glycopyrrolate,INJECTION,INTRAMUSCULAR; INTRAVENOUS,20110921,,ANDA,ANDA090963,Hikma Pharmaceuticals USA Inc.,GLYCOPYRROLATE,0.2,mg/mL,"Anticholinergic [EPC], Cholinergic Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9681,HUMAN PRESCRIPTION DRUG,Glycopyrrolate,,Glycopyrrolate,INJECTION,INTRAMUSCULAR; INTRAVENOUS,20110921,,ANDA,ANDA090963,Hikma Pharmaceuticals USA Inc.,GLYCOPYRROLATE,0.2,mg/mL,"Anticholinergic [EPC], Cholinergic Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9682,HUMAN PRESCRIPTION DRUG,Glycopyrrolate,,Glycopyrrolate,INJECTION,INTRAMUSCULAR; INTRAVENOUS,20110921,,ANDA,ANDA090963,Hikma Pharmaceuticals USA Inc.,GLYCOPYRROLATE,0.2,mg/mL,"Anticholinergic [EPC], Cholinergic Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9683,HUMAN PRESCRIPTION DRUG,Flumazenil,,Flumazenil,"INJECTION, SOLUTION",INTRAVENOUS,20090323,,ANDA,ANDA078527,Hikma Pharmaceuticals USA Inc.,FLUMAZENIL,0.1,mg/mL,Benzodiazepine Antagonist [EPC],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9684,HUMAN PRESCRIPTION DRUG,Flumazenil,,Flumazenil,"INJECTION, SOLUTION",INTRAVENOUS,20090323,,ANDA,ANDA078527,Hikma Pharmaceuticals USA Inc.,FLUMAZENIL,0.1,mg/mL,Benzodiazepine Antagonist [EPC],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9689,HUMAN PRESCRIPTION DRUG,Nicardipine Hydrochloride,,Nicardipine Hydrochloride,INJECTION,INTRAVENOUS,20120302,,NDA,NDA022276,Hikma Pharmaceuticals USA Inc.,NICARDIPINE HYDROCHLORIDE,25,mg/10mL,"Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9701,HUMAN PRESCRIPTION DRUG,Irinotecan Hydrochloride,,Irinotecan Hydrochloride,INJECTION,INTRAVENOUS,20101220,,ANDA,ANDA091032,Hikma Pharmaceuticals USA Inc.,IRINOTECAN HYDROCHLORIDE,20,mg/mL,"Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9702,HUMAN PRESCRIPTION DRUG,Irinotecan Hydrochloride,,Irinotecan Hydrochloride,INJECTION,INTRAVENOUS,20101220,,ANDA,ANDA091032,Hikma Pharmaceuticals USA Inc.,IRINOTECAN HYDROCHLORIDE,20,mg/mL,"Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9708,HUMAN PRESCRIPTION DRUG,Milrinone Lactate,,Milrinone Lactate,"INJECTION, SOLUTION",INTRAVENOUS,20101203,,ANDA,ANDA077966,Hikma Pharmaceuticals USA Inc.,MILRINONE LACTATE,1,mg/mL,"Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9709,HUMAN PRESCRIPTION DRUG,Milrinone Lactate,,Milrinone Lactate,"INJECTION, SOLUTION",INTRAVENOUS,20101203,,ANDA,ANDA077966,Hikma Pharmaceuticals USA Inc.,MILRINONE LACTATE,1,mg/mL,"Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9710,HUMAN PRESCRIPTION DRUG,Milrinone Lactate,,Milrinone Lactate,"INJECTION, SOLUTION",INTRAVENOUS,20101203,,ANDA,ANDA077966,Hikma Pharmaceuticals USA Inc.,MILRINONE LACTATE,1,mg/mL,"Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9718,HUMAN PRESCRIPTION DRUG,Milrinone Lactate in Dextrose,,Milrinone Lactate in Dextrose,"INJECTION, SOLUTION",INTRAVENOUS,20100121,,ANDA,ANDA090038,Hikma Pharmaceuticals USA Inc.,MILRINONE LACTATE,200,ug/mL,"Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9719,HUMAN PRESCRIPTION DRUG,Milrinone Lactate in Dextrose,,Milrinone Lactate in Dextrose,"INJECTION, SOLUTION",INTRAVENOUS,20100121,,ANDA,ANDA090038,Hikma Pharmaceuticals USA Inc.,MILRINONE LACTATE,200,ug/mL,"Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9720,HUMAN PRESCRIPTION DRUG,Levofloxacin,,Levofloxacin,"INJECTION, SOLUTION",INTRAVENOUS,20110916,,ANDA,ANDA091375,Hikma Pharmaceuticals USA Inc.,LEVOFLOXACIN,750,mg/150mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9721,HUMAN PRESCRIPTION DRUG,Levofloxacin,,Levofloxacin,"INJECTION, SOLUTION",INTRAVENOUS,20110916,,ANDA,ANDA091375,Hikma Pharmaceuticals USA Inc.,LEVOFLOXACIN,500,mg/100mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9722,HUMAN PRESCRIPTION DRUG,Levofloxacin,,Levofloxacin,"INJECTION, SOLUTION",INTRAVENOUS,20110916,,ANDA,ANDA091375,Hikma Pharmaceuticals USA Inc.,LEVOFLOXACIN,250,mg/50mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9723,HUMAN PRESCRIPTION DRUG,Clonidine Hydrochloride,,Clonidine Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,20110101,,ANDA,ANDA200300,Hikma Pharmaceuticals USA Inc.,CLONIDINE HYDROCHLORIDE,500,ug/mL,"Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9724,HUMAN PRESCRIPTION DRUG,Clonidine Hydrochloride,,Clonidine Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,20110101,,ANDA,ANDA200300,Hikma Pharmaceuticals USA Inc.,CLONIDINE HYDROCHLORIDE,100,ug/mL,"Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9725,HUMAN PRESCRIPTION DRUG,Progesterone,,Progesterone,INJECTION,INTRAMUSCULAR,20101028,,ANDA,ANDA091033,Hikma Pharmaceuticals USA Inc.,PROGESTERONE,50,mg/1,"Progesterone [CS], Progesterone [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9726,HUMAN PRESCRIPTION DRUG,Testosterone Cypionate,,Testosterone Cypionate,INJECTION,INTRAMUSCULAR,20120501,,ANDA,ANDA091244,Hikma Pharmaceuticals USA Inc.,TESTOSTERONE CYPIONATE,200,mg/mL,"Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]",CIII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9729,HUMAN PRESCRIPTION DRUG,Benztropine Mesylate,,Benztropine Mesylate,INJECTION,INTRAMUSCULAR; INTRAVENOUS,20090901,,ANDA,ANDA090287,Hikma Pharmaceuticals USA Inc.,BENZTROPINE MESYLATE,1,mg/mL,"Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9742,HUMAN PRESCRIPTION DRUG,Oxytocin,,Oxytocin,INJECTION,INTRAMUSCULAR; INTRAVENOUS,20130213,,ANDA,ANDA200219,West-Ward Pharmaceuticals Corp,OXYTOCIN,10,[USP'U]/mL,"Increased Uterine Smooth Muscle Contraction or Tone [PE], Oxytocic [EPC], Oxytocin [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
